D-type cyclins in Xenopus laevis by Cockerill, M.J.
D-type cyclins in Xenopus laevis 
A thesis submitted to the University of London for the 
degree of Doctor of Philosophy 
by 
Matthew James Cockerill 
Imperial Caeca Research Fund 
CIM Nall LtA n mj xies 
South Mimen 
Hu 
1945 
1 
University College 
Gower Street 
t ry 
\ýftp 
In memory of John Load an 
(1971-1995) 
Abstract 
I have isolated two D-type cyclins and a putative kinase partner related to Cdk4 from the 
frog Xenopus laevis. Three D-type cyclins have previously been isolated from 
mammalian species, where they are thought to be involved in the control of cell 
proliferation via the regulation the GO-+G 1 and G 1--IS transitions. 
The RNA and protein levels of D-type cyclins and Cdk4 were followed during Xenopus 
early embryonic development. The two D-type cyclins and Cdk4 are absent during the 
early rapid cleavage phase of Xenopus development. Cyclin D1 mRNA and protein can 
first be detected after the mid-blastula transition (MBT), and while Cdk4 mRNA is 
present throughout development the protein is only detectable after MBT. I have been 
unable to detect cyclin D2 mRNA or protein in embryos or adult tissues, although the D2 
clone was originally isolated from an oocyte cDNA library. 
When translated in vitro, Xenopus cyclins D1 and D2 preferentially associate with 
recombinant Cdk4 protein, and bind less strongly to Cdc2 and Cdk2. Cdk4 in 
combination with either cyclin Dl or cyclin D2 is also able to form a ternary complex 
with retinoblastoma protein (pRb), and cyclin D2-Cdk4 was able to phosphorylate the 
pRb to which it was bound. 
Whole-mount in situ hybridization revealed that cyclin Dl, Cdk4 and pRb mRNAs are 
localised to distinct regions of the developing embryo, in contrast to other cyclins which 
tend to be distributed rather homogeneously, if they are present at all. In particular, cyclin 
D1 mRNA is strongly localised to the developing eye and other neural regions of the 
developing embryonic head. 
Dominant-negative mutants of Cdk4 were constructed by mutating the essential lysine 33 
amino acid residue to arginine. The mRNA encoding this kinase-dead Cdk4 was injected 
into fertilized eggs to look for effects resulting from lack of Cdk4 function after MBT, 
when Cdk4 protein is first expressed. No discernible abnormal phenotype was seen, 
however, in agreement with previously reported results obtained in human cultured cells. 
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Chapter 1 
Introduction 
'Down a coal-mine, under a frog' 
Hungarian expression 
The cell cycle 
The ability of cells to reproduce themselves is one of the fundamental characteristics of 
life. Cellular duplication involves two key steps. First, a cell must copy its genome, so 
that it can pass on its genetic information to both of its progeny. This is the 'S' phase of 
the cell cycle, so named because it involves synthesis of DNA. Secondly, the cell must 
physically divide in two, with one copy of its genetic material going to each daughter cell. 
The complex process of segregating sister chromatids between daughter cells constitutes 
mitosis or the 'M' phase of the cell cycle. Some time after the completion of mitosis, 
actively growing cells re-enter S phase, and the cycle begins again. 
Cells cannot continue to divide indefinitely without growing. To regulate their size they 
must coordinate the continuous process of growth with the discrete process of cell 
division. In most eukaryotic cells, S phase and M phase do not follow on directly from 
one another. Gap phases, known as G1 and G2, are interposed before S phase and M 
phase respectively. The relationships between the different phases of the cell cycle are set 
out in figure I. 1. Both in the yeast Saccharomyces cerevisiae and in higher eukaryotic 
cells, the major point at which cell growth and cell proliferation are coordinated is during 
the G1 phase of the cell cycle, although in cycling cells growth continues during all stages 
of the cell cycle except mitosis, when gene expression temporarily ceases. 
DNA 
syndwsis 
a 
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Figure 1.1 The eakaryotk cell cycle 
Entry into S phase in eukaryotes is frequently subject to regulation by extra-cellular 
signals. Examples of negative regulation of the G 1/S transition, causing arrest in G 1, 
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include the effect of mating-factor in S. cerevisiae, and the effect of TGF-ß on certain 
mammalian cell lines. In S. cerevisiae, passage through the G 1/S transition is the default 
pathway for cells provided with sufficient nutrients. No positive growth factors are 
needed. This contrasts with the situation in mammalian cells where one or more growth 
factors are generally required by cultured cells both for survival and for proliferation. 
Mouse embryonic stem cells are the only mammalian cells known which do not require 
growth factors to progress through G 1. 
Cultured higher eukaryotic cells starved of growth factors arrest in G 1, and similarly 
during the development of most multicellular organisms, cells which leave the cell cycle 
to differentiate, or because of a lack of growth factors, tend to do so in G1 (Pardee, 1974). 
This GI arrest is a qualitatively distinct cell cycle state of metabolic quiescence, and is 
often referred to as GO (Pardee, 1989). 
Actively growing cells which have entered S phase will usually continue through a 
complete round of cell division, even if growth factors are withdrawn during early S 
phase. This suggests that the major point at which growth is coordinated with cell 
division in eukaryotes is during GI (Hartwell et al., 1974; Pardee, 1974). 
In addition to coordination with growth, the cell cycle in adult eukaryotic cells is 
controlled by checkpoints which ensure that cells do not begin to divide until DNA 
replication is complete, and do not attempt DNA replication or mitosis in the presence of 
damaged DNA (reviewed by Murray, 1994). When these checkpoints have been passed, 
however, positive feedback mechanisms ensure that, once started, both S and M phases 
run to completion, regardless of signals from the environment. 
The cell cycle in embryos and adults 
In an adult multicellular organism, cell division is highly regulated and a dynamic 
equilibrium of cell growth and cell death is maintained. During the later stages of 
embryogenesis too, the cell cycle is differentially regulated depending on the 
developmental pathway followed by each individual cell, and the inductive interactions in 
which it participates. 
During the first phase of embryogenesis, however, the cell cycle is very different. A 
single-celled zygote must divide many times to produce the large number of cells needed 
for subsequent morphogenesis. Often these early divisions are very rapid. In externally 
developing organisms such as Xenopus laevis, the egg contains large stockpiles of 
maternal mRNA and protein, which enable early development to occur in the absence of 
overall growth. Since they do not need to grow, embryonic cells may dispense with the 
gap phases of the cell cycle altogether, and alternate between S and M phases. All the 
necessary proteins for entry into S phase are already in place by the end of the preceding 
M phase. 
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In Drosophila melanogaster, the first 13 cell cycles occur synchronously and extremely 
rapidly - as often as every 8 minutes (Rabinowitz, 1941; Foe, 1989). This is possible 
because the Drosophila embryo dispenses with the final stage of mitosis, cytokinesis, and 
develops as a syncytial collection of nuclei until the 14th cell cycle. In Xenopus laevis the 
early cell cycle consists of more conventional cleavage divisions, but the first 12 divisions 
after fertilization nevertheless occur very rapidly (every 30 minutes). These early 
cleavages are synchronous, with no readily detectable gap phases, and with few feedback 
controls on entry into S and M phase (Newport and Kirschner, 1982; Kimelman et al., 
1987). The 12 cleavage divisions are followed by an extended interphase, known as the 
mid-blastula transition, or MBT (Newport and Kirschner, 1982), during which many 
significant biochemical changes occur. 
At MBT, zygotic transcription becomes detectable, embryonic cells acquire motility and 
the cell cycle becomes more closely regulated (Newport and Kirschner, 1982; Kimelman 
et al., 1987). Following the 12th cell cycle, gap phases gradually appear, the cell cycle 
lengthens and subsequent divisions are increasingly asynchronous (Kimelman et al., 
1987; Howe et al., 1995), although local correlations in the timing of cell division may 
remain (Hartenstein, 1989). The lengthening of the cell cycle during and after gastrulation 
is not solely a consequence of the insertion of gap phases, however. S phase lengthens 
from 10 minutes during cleavage to around 5 hours in late neurula stages (Graham and 
Morgan, 1966). A further change to the cell cycle following MBT is that feedback 
mechanisms appear which prevent entry into mitosis in the presence of unreplicated or 
damaged DNA (Dasso and Newport, 1990), and which prevent entry into mitotic 
anaphase before spindle assembly is complete (Minshull et al., 1994). 
MPF, a universal regulator of the cell cycle 
It has long been known, as a result of nuclear-transfer and cell-fusion experiments, that 
mitotic cells contain a dominant factor which is able to drive nuclei transferred from cells 
at any point in the cell cycle into M phase (Gurdon, 1968; Johnson and Rao, 1970; Rao 
and Johnson. 1970). Similarly, cytoplasm from metaphase-arrested, unfertilized 
Xenopus eggs, when injected into immature Xenopus oocytes, causes the oocytes to 
advance into metaphase (Masui and Markert. 1971). This dominant factor present during 
M phase became known as M phase promoting factor, maturation promoting factor, or 
MPF. The function of MPF is conserved across diverse species (Masui and Markert, 
1971; Reynhout and Smith. 1974). MPF was purified from Xenopus eggs and was found 
to contain two polypeptides of 32 kDa and 45 kDa (Lohka et al., 1988). It was 
subsequently shown that the 32 kDa polypeptide corresponded to the Xenopus homologue 
of the known yeast cell cycle regulatory protein p34CDC18/cdc2 (Dunphy et al., 1988; 
Gautier et al., 1988), while the 45 kDa polypeptide was identified as a B-type cyclin 
(Gautier et al., 1988; Draetta et al., 1989; Labb6 et al., 1989; Meijer et al., 1989). CycIins 
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had previously been identified by their involvement with the early cell cycles of marine 
invertebrates (Evans et al., 1983). 
Cyclin-dependent kinases 
p34CDc28cdc2 is a 34 kDa serine/threonine protein kinase which preferentially 
phosphorylates serine or threonine residues which are followed by a proline residue. The 
CDC28 gene was originally identified in the yeast S. cerevisiae, via mutants which 
caused cells to arrest in G1 although the cells continued to grow. The cell cycle in wild- 
type S. cerevisiae is unusual, in that division is highly asymmetric, and bud formation 
begins as early as late G1. Many cdc28 loss of function mutations were found to cause 
cells to arrest prior to bud formation (Hartwell et al., 1970). The point at which these 
cdc28 mutants arrest is known as START. This is the point at which GI cells become 
committed to passing through another complete round of DNA replication and cell 
division, rather than following the alternate pathway of cell cycle arrest and mating with a 
cell of the opposite mating type (Hartwell et al., 1974). A homologue of CDC28, known 
as cdc2+ was identified in the fission yeast Schizosaccharomyces pombe, using a similar 
screen (Nurse et al., 1976). In this case, the phenotype of temperature-sensitive mutants, 
when shifted to the restrictive temperature, was to block entry into mitosis. The loss of 
any gene essential for mitosis might cause such phenotype, but dominant alleles 
(cdc2D mutants) were also found which could force cells into mitosis prematurely. This 
suggested an important regulatory role for cdc2 in the cell cycle. Later it was shown that 
in S. cerevisiae and also in S. pombe, p34CDC28/cdc2 plays an essential role in both the 
G1/S and G2/M transitions (Piggott et al., 1982; Reed and Wittenberg, 1990). The 
function of CDC28/cdc2 is conserved between the two yeasts, and moreover, CDC28 
homologues capable of complementing cdc28u mutations at both the G1/S and G2/M 
boundaries in S. cerevisiae have also been found in higher eukaryotes (reviewed by 
Nurse, 1990). 
Cdc28 is unusual for a protein kinase in that its activity is dependent on the presence of a 
regulatory subunit. The purification of MPF from Xenopus identified this regulatory 
subunit as a cyclin. Cdc28 was thus the founder member of a family of related proteins 
known as the cyclin-dependent kinases. 
Cydins 
Cyclins were originaUy identified as molecules whose translation was induced in clam 
and sea urchin eggs following , and whose levels then proceeded to oscillate in 
synchrony with the cell cycle during the cleavage phase of embryonic development, 
peaking in the M phase of each cell cycle, but then being suddenly and specifically 
destroyed as the cells left M phase, as shown diagramatically in figure 1.2 (Evans et al., 
1983). This periodic expression pattern led to these proteins being named "cyclins". 
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synthesized cyclin 
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Figure 1.2 ('yd in Ie%ek osciIlate (luring the clea%age phase (It de%eIopment of marine 
in%ertrbrate 
The cvclin. identified in marine invertebrates were cif two types, referred to as A and 13. 
Cyclins A and B are both involved in progression through G2 and the G2/M transition 
and are therefore known as mitotic cyclins. A- and B-type cyelim can be clearly 
differentiated by their sequences, and also behave in different ways biochemically. Cyclin 
A protein and cyclin A-associated kinase activity accumulate earlier in the cell cycle, and 
more gradually, than cvclin B. In addition, cyclin A hinds effectively in vitro to either 
Cdc2 or Cdk2, while B-type cyclins show a strong preference for ('dc2. Finally, while B- 
type mitotic cyclins seem to be found in all eukaryotes, cyclin A has not been found in 
yeasts. 
Cyctins have no known enzymatic activity themselves, but act as a regulatory subunit. 
essential for the activity of cvclin-dependent kinases such as p34r 'DX' 5t `I' ' C'yclins may 
he required for activation of Cdks by regulatory kinases and phosphatases, and probably 
also influence the substrate specificity of ('dks, either directly, by binding to substrates, or 
indirectly by influencing the sub-cellular localisation of the kinase (Pines and Iluntcr. 
1991). 
tititotic cyclins are expressed periodically during the cell cycle, and are generally not 
present during GI and earls S phase, which poses the question: Which molecules are 
bound by p34r'D 2&(-dt 2when it performs its essential G I/S role in yeasts? S. potnbe 
seems atypical here, as it appears that the 13-type cyclin ('dc 13 is the main activator of 
Cdc2 throughout the cell cycle, although levels of C dc 13 are much higher during tit 
phase than during the earlier parts of the cell cycle. No cyclins specific to GI hate been 
found ºn S. pumpe. This contrasts with the situation in S. ceret"i. swe, where three GI 
cyclins known as the (ins were isolated as a result of various genetic screens. C'LN/ and 
CLV2 were identified by their ability to rescue a temperature sensitive mutation in the 
CDC'28 gene (Hadwiger et al., 1989), while ('L, V3, also known as I%III1 or I)AF/, w as 
identified via a dominant mutant which caused shortening of G 1, reduced cell site and 
failure to arrest in GIw hen exposed to mating factor i Cross, 1988: Nash et al., l98h i. 
The Clns are related in sequence, ('Inl and Cln2 being especially similar and showing 
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51 ýk amino acid identity with each other, while C'ln3 is much less similar, showing only 
20-25 << identity in pairwise comparison with the other (ins. The C'lns are distantly related 
in sequence to other cyclins, but the similarity is essentially limited to the cyclin box. 
The creation of strains of S. c ereºisiue deficient in all three CLN genes allowed libraries 
from higher eukaryutes to he screened for cl)NAs capahle cif replacing (1 eyrlin function 
in yeast. Surprisingly, mitotic cyclins, especially in truncated form, were found to rescue 
these Cln-deficient yeast efficiently (Lew et al., 1991 ). However, novel cyclins from 
higher eukar rtes were also discovered by this method, including cyclin C (Lew et al., 
1991), cyclin Di Lew et al., 1991 ; Xiong et al., 1991) and cyclin Ei Kotf et al., 1991, Lew 
etal., 1991). 
The cyclins identified by this screen were no more closely related in sequence to the (Ins 
than to the mitotic cyclins, but cyclins D and E have subsequently been shown to he 
important regulator-, of the GI phase of the mammalian cell cycle (see later in this 
introduction). 
The sequence similarity between different families of cyclins is almost entirely limited to 
a region of around 1(X) amino acids known as the cyclin hex. The recently determined X- 
ray crystal structure of cyclin A (Jeffrey et al., lß)95. Jane Endicote and Tim Hunt, 
personal communication) confirms that the cyclin txox region forms an a-helix-rich core 
to the cvclin molecule. 
Cychn A 
Cychn B 
Mammalian - 
Cychn D 
L 
Cychn E 
S. pombe ---i cdc 13 
(B-type) 
S. cerevisiae 
CLN 
--- 
CLBI and 2t ý- 1- 
CL83 and 4 -- 
CLB5and6 
Figure 1.3 The cyclin box and the cyclin protein family 
Stale diagram showing the relatº%r st/es of sohle ut the better Studied . uh-tarnºIIes of 
cwhn%. The rseitn boxes () are . ºli_ncd , \Is shuýý it are the ikºsºlºuns art ttic ddestru. tit 1t1 box t YAº and PEST rich sequences I 
18 
The primary sequence structure of the different cyclins relative to the cyclin box is shown 
in figure 1.3, and a similarity tree is shown in figure 1.4, which was generated from the 
alignment of cyclin boxes shown in figure 1.5. The similarity between the most divergent 
cyclins, even in the cyclin box region, is so weak as to be almost undetectable in pairwise 
comparison, and successful alignment of cyclins relies on the profile of sequence 
conservation across the cyclin box which becomes evident in large alignments. 
Cin1 
Ctn2 
S. cereviiae 
G, cychns 
Human D3 
Mouse D3 
Human D2 
Higher eukaryole 
Mouse D2 G1 cydins 
Ftog 02 (D-type) 
Human Di 
Mouse Dl 
Frog D1 
Cb3 
Cb4 
Cdc13 
Cig2 S. cerev e 
Cig 1 and S. pombe 
Cbl mitotic cycNna 
Cb2 
Cb6 
Cm 
Hunan B2 
Frog 82 
Human 61 
Frog 81 
Frog 84 
Higher 
Cow A eukaryote 
Human A IM 
Frog A2 
Frog Al 
Sea Urchin A 
Chicken 83 
Frog E Hiyf( eukaryole 
Human E G1 cycW* 
Drosophda E (E-type) 
C3n3 
Haan 
OdD 
riorr 
S. cenh Pds 
(PhoOD-Ake cy'ceins) 
Figure IA UPGMA tree comparing similarity in the cyclin box region between some 
ei the different families of cycWM 
The tree was created from a pileup alignment using the GCG programs distances 
and drawt ree. Distances were calculated with correction for multiple substitution, and 
the best-fit tree was created by the UPGMA method 
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The cell cycle of S. cerevisiae - one Cdk, many 
cyclins 
This thesis is especially concerned with the G1/S transition, since evidence described later 
in this introduction strongly suggests a role for D-type cyclins in G1. Before looking at 
higher eukaryotes it is helpful initially to look at the cell cycle in S. cerevisiae, the model 
organism in which the GUS transition is perhaps best understood. S. pombe will be 
mentioned only in passing, since although a great deal of work on the regulation of 
p34CDC281cdc2 by phosphorylation has been carried out in fission yeast, relatively little is 
known about the involvement of Cdks and cyclins in regulating S-phase entry in S. pombe. 
Cdks and cyclins 
Cdc28 is the main Cdk involved in cell cycle regulation in S. cerevisiae. In combination 
with a variety of cyclins, it is required for both the G1/S and G2/M transitions (reviewed 
by Reed (1992) and Nasmyth (1993). 
During G 1, Cln cyclins accumulate and eventually cause the cell to pass START and 
enter S phase, rather than following one of the available alternate pathways: continued 
growth without division, or (for a haploid cell) conjugation with a cell of the opposite 
mating type to form a diploid cell. Over-expression of any one of the Clns has the effect 
of shortening G1 and reducing cell size, but in wild-type cells, the initial regulator of the 
timing of the G1/S decision appears to be Cln3. Cln3 protein is present throughout G1, 
though at very low levels compared to the amount of Cln 1 and Cln2 present later during 
G1 (Nash et al., 1988; Wittenberg et al., 1990). Cln3 is complexed to Cdc28 but there is 
only a very low level of associated kinase activity (Tyers et al., 1993). These low levels of 
Cln3/Cdc28 kinase stimulate transcription of the CLN1 and CLN2 genes by 
phosphorylating the heterodimeric transcription factor Swi4/Swi6 (Nasmyth and Dirick, 
1991; Ogas et al., 1991; Tyers et al., 1993), resulting in powerful amplification of the 
initially weak Cln3 signal. Cln3 also stimulates transcription of two other cyclin genes, 
HCS26 and ORFD, leading to speculation that, in combination with their Cdk partner 
Pho85, these cyclins may also be involved in cell cycle control (see later in this 
introduction). 
S. cerevisiae has at least 6 B-type cyclins, known as the Clbs, and their role in the cell 
cycle extends beyond the prototypical G2/M transition (reviewed by Nasmyth, 1993). 
Clb5 and Clb6 proteins are degraded at the end of mitosis like other B-type cyclins, but 
are synthesized from late GI and are required for some aspects of S phase downstream of 
the G1/S transition (Epstein and Cross, 1992; Schwob and Nasmyth, 1993). 
CLB genes 1-5 are required for the assembly and function of mitotic spindles (Fitch et al., 
1992; Richardson et al., 1992; Schwob and Nasmyth, 1993). The transcription of 
CLB3 and CLB4 begins in S phase, while CLB1 and CLB2 are first transcribed in G2. All 
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these B-type cyclins are destroyed at the end of the cell cycle. Multiple positive-feedback 
mechanisms act, to ensure that the cell proceeds through the cell cycle directionally and in 
complete steps. Clb2/Cdc28 kinase activates the expression of the CLB1 and CLB2 genes 
(Amon et al., 1993), while Clbl- and Clb2-associated kinases repress transcription of the 
CLN genes (Amon et al., 1993). Clbs cannot accumulate during G1 as the B-type cyclin 
destruction machinery, activated at the end of mitosis, remains active until switched off 
by active Cln-associated kinase in late GI (Amon et al., 1994). 
Regulation of Cdc28 by phosphorylation 
Cdc28/Cdc2, in budding yeast, fission yeast and higher eukaryotes, is regulated not only 
by interaction with proteins such as cyclins, but also by phosphorylation (reviewed by 
Coleman and Dunphy, 1994). The role of phosphorylation in regulating Cdc28/Cdc2 
activity is best understood at the G2/N4 transition. Phosphorylation on threonine 14 and 
tyrosine 15, which in S. pombe is carried out by the Wee 1 kinase, inhibits the 
Cdc28/Cdc2 kinase (Gould and Nurse, 1989; Krek and Nigg, 1991; Norbury et al., 1991) 
and is probably responsible for the inactivity of Cdc2/cyclin B complexes prior to the 
G2/M transition. In contrast, phosphorylation of threonine 161 is required for activity 
(Gould et al., 1991; Krek and Nigg, 1992). 
Activation of the Cdc2/cyclin B M-phase kinase (MPF) by phosphorylation is subject to 
positive feedback, explaining the sudden rise in MPF activity relative to gradual cyclin 
accumulation during late G2 (Minshull et al., 1990), and the amplification of MPF seen in 
cytoplasmic transfer experiments using Xenopus oocytes (Masui and Markert, 1971). One 
pathway for positive feedback is the phosphorylation of the Cdc25 phosphatase, 
responsible for removing the inhibitory phosphate on tyrosine 15. This phosphorylation, 
catalysed by active MPF and other M-phase-associated kinases (Izumi et al., 1992; 
Kumagai and Dunphy, 1992; Izumi and Mailer, 1993), stimulates the activity of Cdc25, 
which in turn causes more MPF to become activated by dephosphorylation. An unknown 
M-phase-specific kinase also contributes to the positive feedback by phosphorylating and 
hence negatively regulating the kinase responsible for phosphorylating tyrosine 15 (Tang 
et al., 1993). 
Cdk inhibitors 
In addition to regulation by the accumulation of cyclins and by phosphorylation, Cdks are 
regulated by protein inhibitory molecules which bind either to the free Cdk or to the 
cyclin/Cdk complex, inhibiting its kinase activity. The first such protein to be identified 
was p4OS1C1 (Mendenhall, 1993), which in S. cerevisiae keeps Cdc28/Clb complexes 
inactive until after the onset of S phase. Phosphorylation of p4OS1CI by active Cdc28/Cln 
complexes probably negates its inhibitory effect, allowing active Clb complexes to 
accumulate. 
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FAR], a gene in S. cerevisiae identified by mutations that prevented G1 arrest in response 
to mating factor, also codes for a protein Cdk inhibitor. In this case, the inhibitor 
physically associates with Cdc28/Cln complexes (Peter et al., 1993). By inactivating all 
three CLNs it is able to prevent G1 cells from passing through START. 
In yeast, Cdk inhibitors thus serve as an extra level of control, allowing cells to gradually 
build up large quantities of Cdks and cyclins, and then to activate them suddenly, 
producing the abrupt biochemical changes necessary for control of the cell cycle. This has 
been described as the `dams and sluices' model of cell cycle regulation (Nasmyth and 
Hunt, 1993). Results described later in this introduction confirm the importance of Cdk 
inhibitors in the regulation of the cell cycle in diverse eukaryotes including frogs and 
mammals. 
Cdks, cyclins and Cdk inhibitors with non-cell-cycle functions 
Cyclin-dependent kinases are similar in sequence to many other serine-threonine protein 
kinases, including the MAP kinases, which are involved in signal transduction in all 
eukaryotes (Herskowitz, 1995). 
Although MAP kinases are likewise regulated by phosphorylation, they differ profoundly 
from Cdks in that they do not need to form a complex with a positive regulatory molecule 
such as cyclin in order to be active as kinases. Cdks show no significant level of kinase 
activity unless they bind a cyclin subunit. 
Several protein kinases have been identified in yeast which do bind to cyclin-like 
proteins, and are similar in sequence to Cdc28, but which do not appear to play a major 
role in cell cycle control. 
The Kin28 kinase, together with its cyclin Ccl1, is a component of transcription factor 
TFIIH, responsible for phosphorylating the CTD (C-terminal domain) of RNA 
polymerase II in S. cerevisiae (Valay et al., 1993; Feaver et al., 1994). 
PHO85 and PHO80, two genes involved in the regulation of transcription in response to 
the environment, have been shown to encode a cyclin/Cdk complex. In the presence of 
high concentration of inorganic phosphate, Pho85, the Cdk, acting together with Pho80, 
the cyclin, phosphorylates Pho4, a transcriptional activator, and thereby negatively 
regulates the PHOS gene which encodes a secreted acid phosphatase. In conditions of 
phosphate starvation, the Pho85 kinase is inhibited by Pho8l (Hirst et al., 1994; 
Schneider et al., 1994). Pho8l contains four ankyrin repeats, which suggests that it may 
be related to the INK4 inhibitors which inhibit Cdk4 and Cdk6 in mammalian cells, as 
described later. In association with two other S. cerevisiae cyclins, originally named OrfD 
and Hcs26 but now known as PclI and Pcl2 (Pho85 cyclins), it is possible that Pho85 
may also have a peripheral role in the cell cycle control (Espinoza et al., 1994; Measday 
et al., 1994), but the details remain unclear. 
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Cdks and cyclins in the higher eukaryotic cell 
cycle 
The study of budding yeast shows how a single celled eukaryotic organism can regulate 
its cell cycle using a single Cdk in combination with several different cyclins and multiple 
mechanisms of feedback which ensure directionality and make progression from step to 
step of the cell cycle into a reliable all-or-nothing event. 
The situation in higher eukaryotes is more complicated, not least because a multiplicity of 
Cdks seem to be involved. The constraints which decide when cell division is appropriate 
are much more complex in higher eukaryotes, since multicellularity requires complex 
developmental programs and involves social interactions which control cell survival, 
growth and proliferation. The main point at which these additional controls on cell 
division act is at the G1/S transition, and my doctoral work has focused on molecules 
thought to regulate this part of the cell cycle. Before looking at the higher eukaryotic 
GUS transition in detail though, it is worth surveying the roles of each of the different 
Cdks and Cdk inhibitors so far identified in higher eukaryotes. 
Cdc2 (Cdkl) 
Although p34CDC281Cdc2 is present throughout the cell cycle and is universally required in 
eukaryotes for entry into M phase, in higher eukaryotes it does not seem to be essential 
for entry into S phase. In mammalian cells, S-phase entry is prevented neither by 
microinjection of anti-Cdc2 antibodies (Riabowol et al., 1989), nor by over-expression of 
dominant-negative kinase-dead mutant Cdc2 protein (van den Heuvel and Harlow, 1993), 
although either of these treatments can prevent or delay entry into M phase. Mammalian 
cells carrying a temperature sensitive cdc2 mutation are blocked only at the G2/M 
transition (Hamaguchi et al., 1992), not at G1/S, and Xenopus egg extracts remain able to 
initiate DNA replication even after the majority of the p34CDC281cdc2 protein has been 
removed by immunodepletion (Fang and Newport, 1991). 
Much research has been done attempting to identify physiologically relevant substrates of 
active Cdc2 at the G2/M transition (reviewed by Nigg 1993). The best candidate 
substrates are those which become hyper-phosphorylated during M phase and which are 
phosphorylated on the same sites in vivo as they are in vitro by purified MPF. The main 
candidates thus identified are components of the cytoskeleton such as vimentin, 
caldesmon and the nuclear lamins. It is possible that histone H1 phosphorylation by MPF 
is linked to chromatin condensation, but although this protein is widely used as a 
convenient substrate for MPF assays, whether its phosphorylation is of phsiological 
relevance is open to question. 
In vivo, MPF directly phosphorylates many molecules that are structurally involved in the 
processes of mitosis. Although MPF also phosphorylates regulatory kinases such as c-src 
and c-abl, it is not yet clear to what extent this influences their activity (Norbury and 
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Nurse, 1992; Nigg, 1993). The predominant role of MPF as a "workhorse" kinase, 
phosphorylating structural substrates such as lamins, may explain why large amounts of 
pre-accumulated MPF must be rapidly activated at the G2/M transition. However, 
regulation of progression through mitosis may well depend on the regulation of as yet 
unknown downstream kinases by MPF. 
Cdk2 
Cdk2 is the Cdk most similar to Cdc2, showing over 60 % amino acid identity. It was 
isolated from humans by PCR on the basis of its sequence similarity to Cdc2 (Meyerson 
et al., 1992), and as a gene product capable of rescuing CDC28-deficient S. 
cerevisiae (Elledge and Spottswood, 1991). A homologue was also isolated from 
Xenopus by differential hybridization screening (Paris et al., 1991). In contrast to Cdc2, a 
great deal of evidence suggests that Cdk2 is required for the G1/S transition. 
Overexpression of dominant-negative kinase-dead Cdk2 in growing human cultured cells 
causes a large increase in the population of G1 cells, suggesting that progression through 
the GUS transition is being slowed (van den Heuvel and Harlow, 1993). Antibodies to 
Cdk2 microinjected into mammalian cells prevent entry into S phase (Tsai et al., 1993b), 
and Xenopus egg extracts immunodepleted for Cdk2 cannot replicate DNA (Fang and 
Newport, 1991). Mouse cell lines carrying a temperature sensitive mutation in the Cdk2 
gene arrest in G1 when switched to the restrictive temperature (Yasuda et al., 1992). 
In mammalian cultured cells Cdk2 is found associated with cyclin A (Tsai et al., 1993b), 
but in Xenopus CSF extract its major endogenous partner appears to be cyclin E 
(Strausfeld et al., in preparation). When cotranslated in vitro with various cyclins, Cdk2 is 
found to associate with both cyclins A and E, and also with cyclin D. 
The determination of the X-ray crystal structure of Cdk2 (De Bondt et al., 1993), and, 
more recently, of the Cdk2/cyclin A complex (Jeffrey et al., 1995; Jane Endicote and Tim 
Hunt, personal communication), should greatly aid understanding of the regulation of 
Cdk/cyclin complexes. 
Cdk3 
Cdk3 was identified by PCR methods using primers directed against the conserved 
regions of Cdc2 (Meyerson et al., 1992). Cdk3 shows 76 % amino acid identity to Cdk2. 
Like human Cdc2 and Cdk2, Cdk3 can complement cdc28 mutations in S. cerevisiae 
(Meyerson et al., 1992). Moreover, expression of dominant-negative Cdk3 blocks human 
cultured cells in G1 (van den Heuvel and Harlow, 1993). Taken together, these data 
strongly suggest a cell-cycle role for Cdk3. However, levels of Cdk3 in most cells are 
very low, and little is known about its normal in vivo function. No cyclins have been 
shown to bind to Cdk3 either in vivo, or in vitro. 
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Cdk4 
Cdk4 was isolated by oligonucleotide-hybridization screening, directed against highly 
conserved regions of serine/threonine protein kinases (Hanks, 1987). It is 45 % amino 
acid identical to Cdc2. Cdk4 appears to bind only to the D-type cyclins in 
vitro (Matsushime et al., 1992; Ewen et al., 1993a; Kato et al., 1993), and is their major 
partner in human fibroblasts (Won et al., 1992) and in mouse macrophage precursors 
(Matsushime et al., 1994). Unlike Cdc2 or Cdk2, active Cdk4/cyclin D kinase will not 
phosphorylate histone H 1. pRb, however, is a good substrate for the Cdk4/cyclin D kinase 
reconstituted in an insect cell expression system (Matsushime et al., 1992; Dowdy et al., 
1993; Kato et al., 1993) and also for Cdk4/cyclin D complexes immunoprecipitated from 
cultured cells (Kato et al., 1993; Matsushime et al., 1994). It is unclear, however, whether 
Cdk4/cyclin D is the most important contributor to pRb phosphorylation at the GI/S 
transition in vivo. Cyclin E- and cyclin A-associated kinase activities are also capable of 
phosphorylating pRb in vitro, and are present in vivo at approximately the right time 
during the cell cycle. Distinctively, however, D-type cyclins have been shown to form 
stable complexes with pRb in vitro. Like Cdc2, Cdk4 must be phosphorylated on a 
threonine residue (equivalent to threonine 161 in Cdc2) in order to be active (Kato et al., 
1994b). 
Cdk5 
Cdk5 was identified by PCR (Meyerson et al., 1992), and was also isolated from bovine 
brain, where it is found associated with a 35 kDa protein superficially unrelated in 
sequence to cyclins (Lew et al., 1992; Ishiguro et al., 1994). However, the crystal 
structure of cyclin A is now known (Jeffrey et al., 1995; Jane Endicote and 
Tim Hunt, 
personal communication), and molecular modelling studies suggest that 
despite the lack 
of sequence similarity, the 35 kDa Cdk5-associated protein is very likely to share a 
characteristic fold with the cyclin family. 
Cdk5 is found predominantly in non-dividing neural tissue, where it 
has been shown to 
phosphorylate neurofilaments (Tsai et al., 1994). It therefore seems unlikely that 
it acts as 
a positive regulator of the cell cycle. It has, however, been found associated with 
D-type 
cyclins in human diploid lung fibroblasts (Xiong et al., 1992). It 
is not known whether 
this has physiological significance or whether it just reflects the promiscuity of 
Cdk 
binding by D-type cyclins. 
Cdk6 
Cdk6 was identified by PCR (Meyerson et al., 1992) and together with 
Cdk 'with which it 
shares 71 % amino acid identity, it forms a closely related sub-family of the cdks. 
Like 
Cdk4, Cdk6 associates with the D-type family of cyclins. In lymphocytes, 
Cdk6 is the 
predominant partner of D-type cyclins (Bates et al., 1994a; Matsushime et al., 
1994; 
Meyerson and Harlow, 1994). Like Cdk4, dominant-negative Cdk6 
does not have a 
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significant effect on the cell cycle when over-expressed in tumour cell lines (van den 
Heuvel and Harlow, 1993). Cdk6 has a similar substrate specificity to Cdk4, in that 
reconstituted Cdk6/D-type cyclin complexes, expressed in insect cells, will phosphorylate 
pRb, but not histone H1. The same substrate preference is found for Cdk6 
immunoprecipitates from lymphocytes (Meyerson and Harlow, 1994). 
Cdk7 
Purification of Cdc2-activating kinase (CAK) activity from Xenopus egg extracts led to 
the identification of the catalytic subunit of the kinase as p40M015 (Fesquet et al., 1993; 
Poon et al., 1993; Solomon et al., 1993) a Cdc2-like kinase previously identified by PCR 
methods (Shuttleworth et al., 1990) and now known as Cdk7. More recently, the Cdk7 in 
purified CAK has been shown to be complexed with a novel cyclin, cyclin H (Fisher and 
Morgan, 1994). In addition to its CAK activity, which consists of phosphorylating Cdc2, 
Cdk2 and probably Cdk4 (Kato et al., 1994b) on the residue equivalent to threonine 161 
of S. pombe Cdc2, the Cdk7/cyclin H complex has also been identified as a component of 
transcription factor TFIIH. TFIIH phosphorylates the C-terminal domain (CTD) of RNA 
polymerase II (Gu et al., 1992; Feaver et al., 1994; Serizawa et al., 1995). The 
Cdk7/cyclin H complex may also be involved in DNA repair (Roy et al., 1994). Although 
the CTD-kinase in S. cerevisiae also consists of a cyclin and a Cdk, Ccl I and Kin28 
(Valay et al., 1993; Feaver et al., 1994), it is unclear whether this complex is responsible 
for CAK activity in yeast. 
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Figure 1.6 Known roles of Cdks and cyclins during the cell cycle 
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Inhibitors of Cdks in higher eukaryotes 
As in yeast, a number of protein inhibitors of Cdks have been discovered in higher 
eukaryotes, which may have an important role in cell cycle regulation. 
p21Cip1 
p2lCiP1 was the first higher eukaryote Cdk inhibitor protein to be identified. It was found 
associated with a variety of cyclin/Cdk complexes in human fibroblasts (Gu et al., 1992; 
Harper et al., 1993; Xiong et al., 1993). CipI shows broad specificity and can potently 
inhibit the kinase activity of Cdk2 and Cdk4 complexes. Much higher levels are needed to 
inhibit Cdc2 kinase, however (Gu et al., 1992; Xiong et al., 1993). 
Cipl was also independently isolated as an mRNA (WAF1) induced by the expression of 
wild-type (but not mutant) p53 tumour suppressor protein in a human brain-tumour cell 
line (El-Deiry et al., 1993). Through p53, Cipl is involved in G1 arrest in response toy- 
irradiation and other DNA damage. Cipl protein is induced in a p53 dependent manner 
and, by inhibiting G1 cyclin/Cdk complexes, causes damaged cells to arrest in G1 (Xiong 
et al., 1993; Dulic et al., 1994). 
p27K'pl 
p271P1 is a Cdk inhibitor closely related in sequence to p2 I CiP I (Polyak et al., 1994b). 
Like Cip 1, it can inhibit several different Cdks, including Cdk2, Cdk4 and Cdk6. Kip 1 
has been implicated in G1 arrest in response to transforming growth factor-ß (TGF-ß) and 
cell-cell contact in Mv1Lu mink lung epithelial cells (Polyak et al., 1994a; Polyak et aI., 
1994b; Toyoshima and Hunter, 1994), and in response to cAMP in murine macrophages 
(Kato et al., 1994a). It is not entirely clear which of the Cdks inhibited by Kip 1 is 
responsible for these effects, but over-expression of exogenous Kip 1 is known to be 
sufficient to arrest My 1 Lu cells in G1 (Polyak et al., 1994b). 
TGF-(3 treatment down-regulates Cdk4 in MvlLu cells, and cells over-expressing Cdk4 
are resistant to TGF-ß arrest (Ewen et al., 1993b), which might suggest that Cdk4 is the 
crucial kinase inhibited by Kip 1. However, this is strange, given that dominant negative 
Cdk4 had no detectable effect on the cell cycle in any of the cell lines in which it was 
expressed (van den Heuvel and Harlow, 1993). An attractive alternative hypothesis, 
suggested by Kato et al. (1994a) is that the target of Kip 1 is Cdk2/cyclin E, as suggested 
by Koff et al. (1993), and that over-expressed Cdk4/cyclin D complexes relieve the cell 
cycle arrest by competing for KipI binding with Cdk2/cyclin E. However, in human 
keratinocytes, the mechanism of action of TGF-ß seems to involve a different, unrelated 
Cdk inhibitor (p 154) (Hannon and Beach, 1994), which specifically inhibits Cdk4 and 
Cdk6 but not Cdk2, casting doubt on this interpretation. 
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Kip 1 is reported to act by preventing CAK (Cdk7/cyclin H) from phosphorylating 
threonine 161 and thereby activating cyclin/Cdk complexes (Kato et al., 1994a), although 
Kipl does not bind to or directly inactivate CAK (Kato et al., 1994a; Polyak et al., 
1994a). 
INK4 proteins 
p 161NK4 (inhibitor of Cdk4) was identified in a two hybrid screen as a human protein 
which specifically interacts with Cdk4 (Serrano et al., 1993). It was the first member of a 
large family of related INK4 proteins which now also includes p 151NK4, p 18NK4 and 
p191NK4 (Hannon and Beach, 1994; Chan et al., 1995; Hirai et al., 1995), all of which 
contain four ankyrin repeats. The INK4 family of cdk inhibitors have a narrower 
specificity than either CipI or Kip I, inhibiting only the closely related kinases Cdk4 and 
Cdk6 (Serrano et al., 1993; Guan et al., 1994; Hannon and Beach, 1994). Contradicting 
earlier reports, Hirai et al. (1995) found that INK4 inhibitors are able to inhibit intact 
cyclin/Cdk complexes and do not necessarily function by displacing the D-type cyclin. 
Unlike Cipl, however, INK4 proteins do not seem to bind to cyclins unless the cyclins 
are part of a cdk/cyclin complex. 
There is evidence that deletion or mutation of the p 16INK4 gene, and other INK4 genes, 
may be a common genetic change in cancerous cells, although this seems to be less 
common in primary tumour cells than in tumour cell lines (Kamb et al., 1994; Nobori et 
al., 1994; Spruck III et al., 1994). 
There is a striking negative correlation between expression of p l6INK4 and the pRb 
tumour-suppressor protein in cancer cells. Cell lines lacking functional pRb have 
constitutively high levels of pl61NK4, and conversely tumour cells carrying mutations in 
p 16INK4 express high levels of pRb (Okamoto et al., 1994; Otterson et al., 1994; Parry et 
al., 1995). 
p 191NK4 expressed in human fibroblasts is able to block the cell cycle in G 1(Hirai et al., 
1995), and over-expression of p l61NK4 and p 18INK4 is able to block cell growth in human 
U-2 osteosarcoma cells but not in pRb-deficient Saos-2 cells (Guan et al., 1994). The 
close regulatory link between Cdk4/Cdk6, D-type cyclins and pRb is discussed in the next 
section. 
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The GI/S transition: Cyclins, DNA replication, 
growth control and cancer 
Cyclins A and E 
Cyclin A accumulates significantly earlier during the cell cycle than the B-type cyclins, 
and, unlike B-type cyclins, it is found associated with Cdk2. The kinase activity of Cdk2 
peaks at the G1/S transition (Gu et al., 1992; Lees et al., 1992), which initially prompted 
speculation that cyclin A might have a role in entry into S phase. However, it is now 
generally agreed that cyclin A-associated kinase activity does not become significant until 
mid S phase. Recent work has provided much stronger evidence for cyclin E as the cyclin 
partner regulating the function of Cdk2 around the G1/S transition. 
Firstly, levels of cyclin E protein, and the kinase activity associated with cyclin E, show a 
strong periodicity through the the cell cycle, with levels peaking around the time of the 
GUS transition (Lew et al., 1991; Dulic et al., 1992; Koff et al., 1992). Secondly, cyclin E 
over-expression can contract the G1 phase of cultured cells (Ohtsubo and Roberts, 1993; 
Quelle et al., 1993; Resnitzky et al., 1994), and microinjection of cyclin E antibodies can 
block cells in GI but not later in the cell cycle (Ohtsubo et al., 1995). 
Direct evidence for the importance of cyclin E to DNA replication comes from 
biochemical experiments in Xenopus cell-free extracts. If DNA is added to extracts made 
from activated Xenopus eggs, it is assembled into nuclei and efficiently replicated. 
p13sucl beads can be used to deplete these extracts of Cdk2 and Cdc2, and this treatment 
strongly inhibits DNA replication in the extract (Blow and Nurse, 1990). DNA replication 
activity can be rescued by addition of purified recombinant Cdk2/cyclin E complexes 
(Jackson et al., in preparation; Strausfeld et al., in preparation). 
Addition of Cipl to Xenopus DNA replication extracts inhibits Cdk2 associated kinase 
activity and thereby inhibits DNA replication (Adachi and Laemmli, 1994; Shivji et al., 
1994; Strausfeld et al., 1994). Here too, the addition of recombinant cyclin E can rescue 
DNA replication activity (Strausfeld et al., 1994). Cyclin A (but not cyclin B or cyclin 
D1) is also active in these rescue assays, and in the case of pl3sucl depletion, is more 
active than cyclin E, probably because pl3sucl depletion removes almost all Cdk2 from 
the extract, but not all Cdc2. Cyclin A, but not cyclin E, can form active complexes with 
Cdc2, and these Cdc2/cyclin A complexes seem to be able to promote DNA replication, 
at least in this cell free system (Strausfeld et al., in preparation). However, cyclin E is the 
major partner of Cdk2 in these Xenopus egg extracts, and the timing of cyclin A 
expression during the cell cycle of cultured cells suggests that it is unlikely to function in 
vivo at the G1/S transition, although it may have a role later in S phase. Furthermore, both 
depletion of extracts with cyclin E antisera, and direct addition of cyclin E antiserum to 
extract are able to inhibit DNA replication activity (Jackson et al., in preparation). 
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Sub-cellular localisation studies show that cyclin A is confined to the nucleus during S 
phase, and co-localises with sites of DNA replication (Cardosa et al., 1993), strongly 
suggesting that cyclin A is normally involved in DNA replication. In cultured cells, anti- 
sense cyclin A and cyclin A antibodies can both inhibit progress through S phase (Girard 
et al., 1991; Pagano et al., 1992). However, progression from mitosis into the next S 
phase in Xenopus extracts requires no new protein synthesis (Harland and Laskey, 1980; 
Blow and Laskey, 1988; Fang and Newport, 1991), and since cyclin A is degraded at the 
end of mitosis, this too suggests that cyclin A is unlikely to be necessary for S phase in all 
cell cycles. During the early embryonic cell cycle, when S-phase entry follows on 
immediately from exit from mitosis, presumably an S-phase-promoting factor sufficient 
to cause entry into S phase from G1 is present in non-limiting amounts. Bearing this in 
mind, it is interesting that cyclin E levels remain high throughout these early embryonic 
cell cycles, but drop precipitously at MBT (Rempel et al., 1995; Strausfeld et al., in 
preparation) at a time when the length of G1 is starting to be regulated. 
Strong parallels exist here with the situation in Drosophila. Drosophila embryos contain 
constitutively high levels of maternal cyclin E during the early rapid cell cycles, but 
cyclin E is down-regulated during the final mitotic cell cycle (Knoblich et al., 1994). The 
pattern of continuing cyclin E expression correlates precisely with those domains of the 
Drosophila embryo where endoreduplication is occurring. Endoreduplication is important 
in Drosophila development, and consists of consecutive S phases which take place 
without intervening mitosis. 
Over-expression of exogenous cyclin E from a heat-shock promoter after what would 
normally be the final mitosis is sufficient to drive G1 cells, but not those cells which have 
arrested in G2, into S phase and through a complete additional cell cycle (Knoblich et al., 
1994). Drosophila homozygous for a loss-of-function mutation in the cyclin E gene 
develop normally during the first cell cycles, when maternal cyclin E is present, but arrest 
before entering S phase after the 16th mitotic cycle, when maternal E stocks are 
exhausted. 
All this evidence suggests that cyclin E is vital for entry into S phase, perhaps directing 
the phosphorylation of proteins involved in the initiation of DNA replication. 
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D-type cyclins - the link with cancer 
Cyclin D1 was first identified as a bcl-1 linked candidate proto-oncogene, genetically 
rearranged and over-expressed in several parathyroid adenomas (Arnold et al., 1991; 
Motokura et al., 1991). Subsequently, D-type cyclins, predominantly cyclin Dl, have 
been found to be translocated or amplified, and overexpressed, in many types of cancer, 
as reviewed by Draetta (1994), Hunter and Pines (1994) and Steel (1994). Confirming its 
identity as a proto-oncogene, cyclin Dl has been shown to cooperate with either 
ras (Lovec et al., 1994) or adenovirus E1A (Hinds et al., 1994) in the transformation of 
rodent fibroblasts. As described above, deletions of the INK4 Cdk4/Cdk6 inhibitors are 
also associated with cancer, providing further evidence for the role of D-type-cyclin- 
associated kinase activity in the onset of cancer. 
Although cyclin E is found to be highly expressed in some breast cancers (Keyomarsi and 
Pardee, 1993; Keyomarsi et al., 1994), evidence for a causal link between cyclin E and 
tumorigenesis is comparatively scarce, which may possibly reflect the role of cyclin E in 
the mechanics of S-phase entry. There is an important distinction between growth and 
proliferation. The high levels of cyclin E in the cleaving embryo may be partly 
responsible for the rapid proliferation of cells caused by immediate S-phase entry 
following exit from mitosis, but unlike cancer cells, early Xenopus and 
Drosophila embryos do not need to grow, since they can rely on maternal stockpiles of 
proteins and mRNAs. Perhaps mis-regulation of cyclin E in adult cells, by causing 
premature division without a parallel increase in growth rate, does not convey selective 
advantage to tumour cells. 
The complex interactions between the tumour suppressor protein pRb and the D-type 
cyclins, described below, may begin to explain the link between D-type cyclins, growth 
regulation and cancer. 
D-type cyclins and cellular response to mitogens 
As well as being identified as a proto-oncogene, and by complementation of Cln-deficient 
yeast strains (Lew et al., 1991; Xiong et al., 1991), cyclin D1 was independently cloned 
by subtractive hybridization, as a gene expressed by murine macrophages in response to 
stimulation by colony-stimulating-factor 1 (Matsushime et al., 1991). The closely related 
cyclins D2 and D3 were then found by hybridization screening on the basis of sequence 
similarity. 
D-type cyclins are differentially expressed in cultured cell lines. Some cell lines do not 
express any of the known D-type cyclins, while others express several (Matsushime et al., 
1991; Inaba et al., 1992). Murine macrophage precursors, but not T-lymphoid or myeloid 
cell lines, express cyclin D1, while cyclin D2 is expressed in all these types of cells, and 
cyclin D3 is expressed in some lymphoid cells but not in macrophage precursors 
(Matsushime et al., 1991). This suggests that cyclin D function may not be necessary in 
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all dividing cells, and that there may be redundancy in the function of the different D-type 
cyclins. D-type cyclins are expressed as part of the delayed early mitogen response (the 
activation of their transcription requires new protein synthesis and can be inhibited by 
cycloheximide). This is still significantly earlier than cyclin E, which does not accumulate 
to high levels until very near the G1/S transition (Koff et al., 1991). D-type cyclin mRNA 
levels tend to remain high as long as mitogenic stimulus is present, often showing no cell 
cycle periodicity at all (Bürger et al., 1994), in contrast to levels of cyclin E (Koff et al., 
1991; Koff et al., 1992). However, D-type cyclins are very labile and so removal of 
mitogens prior to S phase causes D-type levels to drop rapidly, correlating with the failure 
of cells to enter S phase (Matsushime et al., 1991; Won et al., 1992) . 
Like cyclin E, D-type cyclins, when over-expressed, cause shortening of G 1, reduced cell 
size and reduced mitogen dependence (Quelle et al., 1993; Resnitzky et al., 1994). Unlike 
cyclin E, however, over-expressed D-type cyclins have their greatest effects when 
accelerating the stimulation of quiescent cells out of GO, rather than when speeding up the 
cell cycle progression in cycling cells (Resnitzky et al., 1994). The effects of cyclin D and 
cyclin E expressed together are greater than either alone, suggesting that they may be 
controlling distinct regulatory events. 
Supporting a controlling role for D-type cyclins in the mitogen dependence of late G 1, 
microinjection of antibodies against cyclin D1 or expression of anti-sense cyclin D1 
mRNA by transient transfection of plasmids can prevent S-phase entry, but only until late 
G1 (Baldin et al., 1993; Lukas et al., 1994; Lukas et al., 1995). Once S phase has begun, 
cells will continue through the next mitosis, even if mitogens are withdrawn. Similarly, 
injection of cyclin D antibodies and expression of anti-sense cyclin D mRNA both fail to 
arrest the cell cycle once S phase has begun. 
The retinoblastoma tumour suppressor 
The human retinoblastoma tumour suppressor gene (RB-1) was identified as the source of 
a familial predisposition to certain types of cancer, principally retinoblastoma, in which 
individuals at risk are heterozygous for a loss of function mutation in the RB-1 gene 
(Fung et al., 1987; Lee et al., 1987; Friend et al., 1989). Retinoblastomas occur when the 
remaining RB-1 gene is lost by somatic mutation, as originally proposed by Knudson 
(1971). 
Wild-type pRb (the protein product of the retinoblastoma gene) has a growth-inhibitory 
effect when introduced into cells lacking functional pRb either by retroviral infection 
(Huang et al., 1988), microinjection (Goodrich et al., 1991), or transient transfection (Qin 
et al., 1992). 
The pRb protein is believed to regulate entry into S phase by binding to key 
transcriptional activators, including the E2F family, preventing them from stimulating the 
transcription of gene products required for the initiation of DNA replication. In cells 
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expressing the retinoblastoma tumour suppressor gene product (pRb), the phosphorylation 
of pRb around the Gl/S transition leads to the release of these transcription factors 
(Chellappan et al., 1991; Hiebert et al., 1991). Specific dephosphorylation of pRb occurs 
during mitosis (Ludlow et al., 1993), in preparation for the next G1. 
In Saos-2 osteosarcoma cells, which normally lack pRb, the G1 growth arrest caused by 
expression of exogenous pRb can be relieved by expression of cyclins A, E and D1, but 
not B1 (Hinds et al., 1992). This growth arrest can also be relieved by expression of the 
transcription factor E2F (Zhu et al., 1993), supporting the above model of G1 control by 
pRb. 
Two pRb-related proteins known as p 107 and p 130 have also been identified, originally 
as cellular proteins which associated with tumour virus proteins such as human 
adenovirus E1A (Yee and Branton, 1985). Like pRb (Weintraub et al., 1992), p107 and 
p 130 switch the function of E2F from transcriptional activator to transcriptional repressor, 
although they may interact with different members of the E2F gene family (Müller, 
1995). p 107 and p 130, rather than pRb, are the predominant proteins associated with E2F 
transcription factor activity in quiescent cells (reviewed by Müller, 1995). Association 
between E2F and pRb occurs later in G 1. 
Physical sequestration of pRb by tumour virus proteins such as adenovirus E1A and 
SV40 large T antigen releases E2F, bypassing the requirement for pRb to be 
phosphorylated to allow progression through the cell cycle (Ludlow et al., 1989; Nevins, 
1992). E2F-1 expression in quiescent fibroblasts is sufficient to promote entry into S 
phase (Johnson et al., 1993), which contrasts with the limited ability of D-type cyclins to 
reduce mitogen dependence, and the limited shortening of G1 caused by over-expression 
of D-type cyclins (Resnitzky et al., 1992; Quelle et al., 1993). This suggests that E2F is 
downstream of cyclin D1 on the pathway leading to S phase, and that release of active 
E2F may be dependent on other rate-limiting signals independent of cyclin Dl. 
RB-1 is an essential gene in mice. Mice homozygous for Rb loss of function mutations die 
during embryogenesis (Clarke et al., 1992; Jacks et al., 1992; Lee et al., 1992). Although 
the development of most organs proceeds normally in these animals, some ectopic cell 
division occurs in the central and peripheral nervous system, outside of normally 
neurogenic regions. Apoptotic cell death also occurs in the nervous system and 
haematopoetic system, suggesting that pRb may have a role in cellular survival, in 
addition to its cell cycle regulatory role (Lee et al., 1994). Curiously, mice heterozygous 
for pRb loss of function do not develop retinoblastomas, although they are strongly 
predisposed to other types of tumour. It remains mysterious why a gene which appears to 
have an essential function in the regulation proliferation of many different cell-types 
should be associated in humans so strongly with a single form of cancer. 
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D-type cyclins and pRb 
Unlike Cdk2 (the main partner of cyclin E), the Cdks which exclusively bind D-type 
cyclins, Cdk4 and Cdk6 (Matsushime et al., 1992; Xiong et al., 1992), show a strong 
substrate preference for pRb over histone H1 (Matsushime et al., 1992; Meyerson and 
Harlow, 1994). However, other Cdks (Cdc2 and Cdk2) can also phosphorylate pRb, and 
the timing of pRb hyper-phosphorylation during the cell cycle corresponds more closely 
with the peak of cyclin E-associated kinase activity late in G1 than with Cdk4/cyclin D- 
associated activity which appears significantly earlier (Koff et al., 1991; Dulic et al., 
1992). A further caveat to the role of D-type cyclins in inactivating pRb is that a mutant 
form of cyclin D1 that is unable to bind pRb has been reported to be more effective than 
wild-type cyclin D1 in overcoming pRb-induced growth suppression (Dowdy et al., 
1993), leading to the suggestion of a possible downstream function for D1 that might be 
regulated by its interaction with pRb. 
D-type cyclins directly bind to hypophosphorylated pRb in insect cells over-expressing 
the two proteins, in reticulocyte lysate in vitro translation, and in vivo in human diploid 
fibroblasts (Dowdy et al., 1993; Ewen et al., 1993a; Kato et al., 1993). Co-expression of 
cyclin D2 (but not cyclin D 1) with pRb in cell normally lacking pRb protein has been 
reported to lead to pRb phosphorylation (Ewen et al., 1993a). Moreover, cyclin D, Cdk4 
and Cdk6 immunoprecipitates from mammalian cultured cells are all able to 
phosphorylate pRb, but not histone H1 (Matsushime et al., 1994; Meyerson and Harlow, 
1994). Perplexingly, however, when D-type cyclins are used to rescue Saos-2 cells 
arrested in G1 by pRb expression, they do so without inducing appreciable hyper- 
phosphorylation of pRb (Hinds et al., 1992). This puzzle may be partially explained by 
the recent discovery that Cdk4/cyclin D complexes can also phosphorylate E2F-1 protein 
on physiologically relevant sites, greatly reducing its affinity for pRb (Fagan et al., 1994). 
At least one function of the cyclin D/Cdk complex thus seems to be disrupt the E2F/pRb 
complex, by phosphorylating one or other of these two components. 
Transient transfection studies using promoter reporter constructs suggest that cyclin D1, 
pRb and E2F-1 are involved in a tight regulatory loop. Strikingly, expression of pRb, 
which normally acts as a transcriptional repressor via E2F, is found to stimulate the 
transcription of cyclin D1 mRNA (Müller et al., 1994). Although pRb expression is able 
to block cell division in some cell lines which normally lack pRb, many other types of 
cells continue to progress through the cell cycle in the presence of pRb. In cells where a 
pRb is expressed, transient transfection experiments suggest that up-regulation of cyclin 
D1 occurs, which may make it possible for the pRb block to be overcome allowing cell 
division to occur, but in a regulated manner which can be blocked by microinjection of 
cyclin D1 antibodies. Presumably the cyclin D 1/pRb regulatory balancing act is subject to 
regulation by external signals in vivo. 
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The cyclin D1 promoter contains an E2F binding site, and expression of E2F is also able 
to induce cyclin D1 expression (Sala et al., 1994). It remains unclear whether induction of 
cyclin D1 expression by pRb is dependent on the E2F binding site, or whether it occurs 
via another transcription factor binding site. Perhaps pRb/E2F complexes, acting, 
atypically, as transcriptional activators, stimulate cyclin D1 via the E2F site and hence 
indirectly bring about their own dissociation. Alternatively, pRb and E2F may act on the 
promoter via different sites, with only free E2F being able to stimulate the promoter, not 
pRb-bound E2F. In this case, the dissociation of pRb and E2F induced by cyclin D- 
dependent phosphorylation may cause increased expression of cyclin D1, and the 
resulting positive feedback may help to drive the cell through G1. 
It seems that rather than being a fundamental component of the cell cycle machinery, 
cyclin D is needed to overcome a block on the cell cycle imposed by pRb. If pRb is either 
absent or already inactivated, either by phosphorylation or by sequestration by a tumour 
virus protein, cyclin D ceases to be necessary for progress through the cell cycle. In cells 
which lack pRb, anti-cyclin D1 antibodies do not delay progress through G 1/S, but 
ectopic expression of pRb in these cells makes S-phase entry dependent on cyclin D1 
(Lukas et al., 1994). p161NK4 up-regulation also correlates with a lack of functional pRb 
in mammalian tumour cell lines (Shapiro et al., 1995), and may explain why active 
Cdk4/cyclin D complexes are not found in cells deficient for pRb (Bates et al., 1994b; 
Parry et al., 1995). 
Although anti-cyclin D1 antibodies and anti-sense cyclin D1 plasmids arrest cells in G 1, 
expression of either dominant negative Cdk4 or Cdk6 does not (van den Heuvel and 
Harlow, 1993), though most cells express predominantly either Cdk4 or Cdk6, not both. 
This hints at the model that cyclin D1 may exert some aspects of its functions 
independently of Cdks, inactivating pRb by binding to it rather than by phosphorylating 
it. This could be tested very simply by determining whether a point-mutant of cyclin D 1, 
incapable of binding to Cdk4, can overcome a pRb induced block on the cell cycle. 
Another possibility, suggested by Dowdy et al. (1993), is that cyclin D1 might have a role 
downstream of pRb, and that sequestration of cyclin D1 by pRb may regulate the 
downstream function of this cyclin. If this is the case, however, the requirement for cyclin 
D1 function must somehow be dependent on pRb since, as described above, in the 
absence of pRb cyclin D1 function seems unnecessary. 
Immunolocalisation by several groups suggests that cyclin Dl is predominantly a nuclear 
protein (Baldin et al., 1993; Sewing et al., 1993; Bürger et al., 1994). One group reports 
that the cyclin D1 protein visualised by immunofluorescence is lost from the nucleus just 
before the onset of S phase (Baldin et al., 1993), but their immunoblotting data are 
difficult to reconcile with this result, and others find cyclin D1 protein present in the 
nucleus throughout the cell cycle (Bürger et al., 1994). In a mammary epithelial cell line 
cyclin D1 over-expression has been reported to slow down progression through S phase 
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(Han et al., 1995), consistent with the hypothesis of Baldin et al. that, although 
progression through G1 requires cyclin D 1, S phase itself might be inhibited by the 
presence of nuclear cyclin D1. 
Cyclins in early Xenopus development 
Xenopus is a useful biochemical system for studying the early embryonic cell cycle. The 
early Xenopus cell cycle is driven by the cytoplasm, rather than the nucleus, as shown by 
experiments with enucleated oocytes (Hara et al., 1980). Cytoplasmic extracts can be 
prepared from activated eggs which will cycle in vitro (Murray and Kirschner, 1989; 
Murray, 1991). Extract cycling can be judged both biochemically, by following H1 kinase 
activity, and morphologically, since M phase extracts cause readily identifiable 
condensation of added sperm chromatin. 
The biochemical oscillator controlling the cell cycle of the early embryo and of 
embryonic extracts is insensitive to inhibitors of DNA replication such as aphidicolin, and 
to inhibitors of mitotic spindle assembly such as nocodazole (Hara et al., 1980; Kimelman 
et al., 1987; Murray and Kirschner, 1989). The early embryonic cycles do, however, 
normally require novel protein synthesis (Evans et al., 1983; Miake-Lye et al., 1983; 
Watanabe and Shimada, 1983; Gerhart et al., 1985). In extracts from activated eggs, 
either destroying endogenous mRNAs with nuclease, or inhibiting protein synthesis with 
cycloheximide arrests the cycle (Murray and Kirschner, 1989). Addition of cyclin mRNA 
(Murray and Kirschner, 1989), or in vitro translated cyclin protein (Murray and 
Kirschner, 1989) is sufficient to fulfil the protein synthesis requirement, and allows the 
extract to progress into M phase. 
Although clearly the early cell cycle involves many gene products which are present in 
the oocyte as maternal protein stockpiles, the above result suggests that during the early 
cleavage phase of Xenopus development, mitotic cyclins accumulation may be largely 
responsible for the timing of cell division. However, in adult cells from higher 
eukaryotes, mitotic cyclin over-expression is typically unable to alter the rate of 
progression through the cell cycle, whereas G1 cyclins can have this effect (Resnitzky et 
al., 1994). The mid-blastula transition in Xenopus is therefore an interesting point at 
which to examine the role of G1 cyclins, as it corresponds to the transition between the 
two different forms of cell cycle control. 
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This thesis 
The results from Drosophila described earlier in this introduction demonstrate the 
involvement of one G1 cyclin, cyclin E, in the G1/S transition, and show how its 
regulation relates to the differences between the cell cycle during the early rapid cleavage 
divisions, and later in development, when the cell cycle is more regulated. Cyclin E is 
present at constitutively high levels during the early cell divisions, supporting the idea 
that it may be a component of an S-phase-promoting factor required for every cell cycle. 
D-type cyclins show several properties in common with cyclin E. As described above, 
when over-expressed in mammalian cells, both D- and E- type cyclins cause shortening of 
G 1. Similarly, injection of antibodies to either type of cyclin during G1 can prevent entry 
of cells into S phase. 
However, D-type cyclins have not as yet been reported in Drosophila, so their regulation 
with respect to the early synchronous cleavage phase of development has not been 
examined. 
I have isolated D-type cyclins and a Cdk4-like kinase partner from Xenopus. laevis in 
order to compare the expression of D-type cyclins during the early cleavage phase of 
Xenopus development, and during the later cell divisions which are subject to complex 
G1 controls. 
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Chapter 2 
Materials and Methods 
'Two days wrong! ' sighed the Hatter. 'I told you butter 
wouldn't suit the works! ' he added 
looking angrily at the March Hare. 
'It was the BEST butter, ' the March Hare meekly replied. 
'Yes, but some crumbs must have got in as well, ' the 
Hatter grumbled: you shouldn't have put it 
in with the bread-knife. ' 
Reagents and enzymes 
Unless otherwise stated, chemicals were purchased from BDH or Sigma, and were of 
AnaiR purity, or else the highest grade available. 
Enzymes used for molecular biology were purchased from New England Biolabs, and 
radiochemicals from Amersham, unless otherwise stated. 
Donated reagents 
Oligonucleotides 
Oligonucleotides were synthesized by the ICRF oligonucleotide unit (South Mimms). 
Libraries 
X-YES cDNA libraries from Xenopus egg, ovary and XTC cells were from Jeremy 
Minshull, (University of California, San Francisco). 
A further cDNA library from Xenopus ovary, in ? -GT 10, was from Douglas Melton 
(Harvard University, Cambridge, MA) 
Bluescript plasmid cDNA libraries from Xenopus total embryo cDNA were from Patrick 
Lemaire (Wellcome/CRC Institute, Cambridge). 
Growth factors 
Activin and FGF were from Jim Smith (National Institute for Medical Research, Mill Hill). 
Plasmid constructs 
Xenopus retinoblastoma cDNA plasmid (Destree et al., 1992) was from Kelvin Lam 
(Massachusetts General Hospital Cancer Center, Charlestown, MA). 
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Human retinoblastoma protein "pocket" fragment (amino acids 372-928) (Kaelin et al., 
1991), fused to the GST coding sequence in the bacterial expression plasmid pGEX-2T, 
was from Bill Kaelin (Dana-Faber Cancer Institute, Boston, MA). 
Xenopus Brachyury cDNA plasmid was from Jim Smith (National Institute for Medical 
Research, Mill Hill, England). 
Xenopus type 8 cytoskeletal actin cDNA plasmid was from Tim Mohun (National 
Institute for Medical Research, Mill Hill). 
Human p16 cDNA plasmid was from Dave Parry (ICRF, London). 
Proteins 
N-terminally histidine-tagged human p16 was from Dave Parry (ICRF, London). 
GST-tagged Xenopus Cdk2 and GST-tagged Xenopus cyclin Al were from Elspeth 
Stewart (now at Harvard Medical School, Cambridge, MA). 
GST-tagged human Cdk2 was from Katsumi Yamashita (now at Kanazawa University, 
Japan). 
GST-tagged Xenopus Cdk7 was from Randy Poon (now at the Scripps Institute, La Jolla). 
Antibodies 
Protein A-purified monoclonal anti-c-myc antibody, 9E10 (Evan et al., 1986), was 
supplied by the ICRF hybridoma unit (South Minims). 
Anti-Xenopus Cdc2 monoclonal antibody, A 17, was from Julian Gannon (ICRF, South 
Minims), and was used as hybridoma culture supernatant. 
Anti-Xenopus cyclin Al monoclonal antibody, XLA1-3, was from Dolores Harrison 
(ICRF, South Mimms) and was used as hybridoma culture supernatant. 
Affinity-purified anti-Xenopus cyclin E rabbit polyclonal serum was from Michael 
Howell (Ludwig Institute, London) 
Anti-human cyclin D1 rabbit polyclonal serum was from Gordon Peters (ICRF, London) 
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Commonly used buffers, solutions and media 
IP Buffer 20 mM EGTA, 50 mM NaF, 80 mM sodium ß-glycerophosphate, 
1 mM DTT, 0.25 mM PMSF, 0.1 mM Na3VO4 (pH 7.5) 
IP Buffer (no EGTA) 50 mM NaF, 80 mM sodium ß-glycerophosphate, 0.1 % (v/v) 
Triton X100,1 mM DTT, 0.25 mM PMSF, 0.1 mM Na3 V O4 
(pH 7.5) 
SDS Sample Buffer 2% (w/v) SDS, 80 mM Tris-Cl pH 6.8,10 % (v/v) glycerol, 
0.002 % (w/v) bromophenol blue 
5% (v/v) 2-mercaptoethanol, added just before use 
TE 10 mM Tris-Cl pH 8.0,1 mM EDTA 
TAE 40 mM Tris-acetate, 2 mM EDTA 
TBE 90 mM Tris-borate, 2 mM EDTA 
GTE 50 mM glucose, 25 mM Tris-Cl pH 8.0,10 mM EDTA 
SDS/NaOH 1% (w/v) SDS, 0.2 M NaOH 
KOAc 3M potassium acetate, 2M acetic acid 
pGEX lysis buffer 50 mM Tris pH 7.5,2 mM EDTA, 1 mM DTT 
0.25 mM PMSF, 2 mg/ml lysozyme 
LB (10 g Bactotryptone, 5g Yeast Extract, 10 g NaCl) per litre 
NETS 20 mM Tris-Cl pH 7.5,100 mM NaCl, 20 mM EDTA, 1% (w/v) 
SDS 
20x SSC 3M NaCl, 0.3 M sodium citrate pH 7.0 
50x Denhardt's reagent 1% (w/v) Ficoll 400,1 % (w/v) polyvinylpyrrolidone, 1% (w/v) 
bovine serum albumin 
lx MBS 88 mM NaCl, 1 mM KCI, 0.41 mM CaC12,0.33 mM Ca (NO3)2, 
0.82 mM MgSO4,2.4 mM NaHCO3,10 mM HEPES pH 7.4 
2x MEM 0.2 M MOPS pH 7.4,4 mM EGTA, 2 mM MgSO4 
Table 2.1 
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General molecular biology techniques 
Most techniques were performed as described in Sambrook et al. (1989) and Ausubel et 
al. (1991). Modifications and less standard techniques are shown below. 
Polymerase Chain Reaction (PCR) 
Preparatory PCR reactions were normally carried out in a volume of 50 µl, while PCR 
reactions used for screening bacterial colonies were generally 25 µl. Reaction components 
were normally present at the following final concentrations: 
20 ng/ml template plasmid DNA 
200 nM each oligonucleotide primer 
2%iM each dNTP 
20 U/ml Taq DNA polymerase (Perkin Elmer Cetus) 
lx Perkin Elmer Cetus PCR buffer 
(10 mM Tris-Cl pH 8.3,50 mM KCI, 1.5 mM MgC12,0.001 % (w/v) gelatin) 
PCR reactions including all components except polymerase were set up in 0.5 ml thin- 
walled microcentrifuge tubes. Several drops of paraffin oil were added on top of each 
reaction to limit evaporation during thermal cycling. 
Reactions were placed in a Perkin Elmer Cetus thermal cycler and denatured for one 
minute at 94 °C. The temperature was then reduced to 80 °C, polymerase was added, and 
thermal cycling was begun, using the following profile: 
94 °C for 30 seconds (denaturation) 
45-60 °C for 45 seconds (annealing) 
72 °C for 60-180 seconds (extending) 
Typically 35 cycles were used. At the end of the last cycle, the reactions were incubated 
at 72 °C for a further 10 minute extension period to ensure that second-strand synthesis 
was complete. 
The annealing temperature was adjusted between 45 °C and 60 °C, according to the length 
of the primers and the extent of complementarity between primers and template. In 
general, lower temperatures were used for degenerate oligonucleotides or 
oligonucleotides containing multiple missense mutations. The Macintosh program 
Amplify written by Bill Engels (University of Wisconsin, Madison) was used to predict 
whether oligonucleotides contained sufficient complementarity to act as effective primers, 
but it was found to be unnecessary to calculate predicted oligonucleotide melting 
temperatures precisely. 
Screening E. coli colonies for the presence of plasmid by PCR 
PCR was frequently used as a method for screening the colonies resulting from 
transformation of competent E. coli with plasmid ligations. 
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Colonies were picked using a sterile plastic inoculating needle (Nunc), the needle was 
gently touched into 10 µl of sterile water in a 0.5 ml microcentrifuge tube, and then the 
major part of the colony, which still adhered to the needle, was used to inoculate a 2.5 ml 
culture of LB containing 50 pg/ml ampicillin. The 10 µl bacterial template samples were 
incubated in a boiling water bath for 1 minute to lyse the bacteria and denature the 
plasmid DNA. The remaining components of the PCR reaction, including polymerase, 
were then added as a mix. After adding paraffin oil to limit evaporation, amplification 
was carried out as described earlier. 
Site-directed mutagenesis by PCR 
Where a convenient unique restriction enzyme site existed, site-directed mutagenesis was 
carried out using a single mutagenic oligonucleotide, as shown in figure 2.1a. When no 
convenient restriction site was present, internal mutagenesis was carried out using a 
protocol based on that of (Horton and Pease, 1991). Two complementary mutagenic 
oligonucleotides were constructed, and used in two separate PCR reactions, together with 
flanking primers, to amplify 5' and 3' DNA fragments (figure 2.1 b). The two PCR 
reactions were then directly mixed and diluted 100-fold. 1 tl of this diluted mixture was 
used as the template for a further PCR reaction, using the flanking 5' and 3' primers only. 
a 
4 
mutagenic primer 3' primer 
original DNA template 
amplified product, with a 
mutation at one end 
b 
sense mutagenlc 3'-flanldng 
ýý P rR 
2 4- 
Primer 
anti-ssnse 
ýýý PCR 1 : 
n"'tapenic pnmsr 
DNA template 
1 1 S-flanking 3-flanking Pnnw PCR 3 p""w 
1 products of PCR I and 
PCR 2 combined and 
1 
used as template 
final product carrying internal 
mutation 
Figure 2.1 PCR mutagenesis strategy 
(a) engineering restriction sites or tags onto the terminal region of a DNA fragment, with 
a single PCR reaction 
(b) internal site directed mutagenesis, via a two-step amplification process 
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Small-scale DNA preparation by boiling 
Colonies of bacteria were picked into 2.5 ml of media and grown in LB for 6 to 8 hours or 
overnight with the appropriate selection (typically 50 µg/ml ampicillin). An aliquot of 
each culture was taken, glycerol was added to a final concentration of 15 % (v/v), and this 
stock was stored at -80 °C. 1.5 ml of the remaining culture was pelleted by a5 minute 
microcentrifugation, and all but 100 µl of the LB was removed. The bacteria were 
resuspended in this LB and were lysed by the addition of 300 µl of STET (8 % (w/v) 
sucrose, 5% (v/v) Triton X-100,50 mM Tris-Cl pH 8.0,50 mM EDTA, 1 mg/ml freshly 
added lysozyme). These reactions were immediately heated at 100 °C in a boiling water 
bath for 90 seconds and then microcentrifuged at 4 °C for 10 minutes. The resulting 
supernatant was transferred to a new tube and the DNA was precipitated by the addition 
of an equal volume of propan-2-ol. The DNA was pelleted by a 10 minute centrifugation 
at 4 °C, washed with 80 % (v/v) ethanol and air-dried. The DNA pellet was resuspended 
in 25 µl TE buffer. 
Plasmid DNA prepared in this way, though it still contains significant amounts of tRNA, 
is suitable for double-stranded sequencing as described below. Typically, 8 µl of DNA 
was used per set of sequencing reactions. 
This plasmid DNA is also suitable for restriction digestion. However, it is helpful to add 1 
µl of 1 mg/ml RNase A per 20 µl of restriction digest, to increase the visibility of small 
restriction fragments. 
Large-scale DNA preparation by alkaline lysis 
For most common uses of plasmid DNA, such as sub-cloning, sequencing, transforming 
competent cells and in vitro transcription using T7 RNA polymerase, caesium chloride- 
based methods for plasmid purification proved unnecessary. I used the following rapid 
method for large-scale DNA preparation. 
A freshly grown 2.5 ml overnight culture of bacteria in LB plus selective antibiotic was 
inoculated into 400 ml of LB plus antibiotic. After between 6 and 18 hours, bacteria were 
pelleted by centrifugation at 3000 rpm for 5 minutes in a Sorvall GS-3 rotor, and then 
resuspended in 20 ml GTE. The bacteria were lysed by adding 40 ml SDS/NaOH and 
several inversions, followed by neutralisation with 30 ml KOAc. The debris of bacterial 
proteins and chromosomal DNA was pelleted by centrifugation at 5 000 rpm in a Sorvall 
GSA rotor for 10 minutes and the supernatant filtered through four layers of cheesecloth. 
Nucleic acids were precipitated by the addition of 56 ml of propan-2-ol and pelleted by 
centrifugation at 8 000 rpm in a Sorvall GSA rotor for 10 minutes. The pellet was 
resuspended in 10 ml of TE buffer and the rRNA was precipitated by addition of 4 ml 
10 M LiCI and incubation on ice for 10 minutes. The rRNA was pelleted by 
centrifugation at 10 000 rpm in a Sorvall SS-34 rotor for 10 minutes and the DNA in the 
supernatant precipitated by the addition of 8.6 ml propan-2-ol. The DNA was then 
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pelleted by centrifugation at 10 000 rpm in a Sorvall SS-34 rotor for 10 minutes, washed 
with 80 % (v/v) ethanol, and dried in a vacuum dessicator for 5 minutes. The DNA pellet 
was resuspended in 750 µl TE buffer and to it was added 40 µl of a 10 mg/ml solution of 
boiled RNase A. After incubation at 37 °C for 15 minutes, 90 Al of lOx proteinase K 
solution was added (500 µg/ml proteinase K, 5% (w/v) SDS, 100 mM Tris-Cl pH 7.5,50 
mM EDTA) and the mixture was incubated at 37 °C for a further 30 minutes. This was 
then extracted three times with a 1: 1 (v/v) mixture of phenol and chloroform. The DNA 
was precipitated by the addition of 0.1 volumes of 4M ammonium acetate and 0.6 
volumes of propan-2-ol, pelleted by microcentrifugation for 15 minutes at room 
temperature, washed with 80 % (v/v) ethanol, and resuspended in 200 µl TE. 
Purification of DNA fragments from agarose gels 
DNA fragments were separated by electrophoresis on 1% (w/v) agarose gels (SeaKem 
ME agarose, FMC) in TAE containing 0.5 µg/ml ethidium bromide. The DNA fragments 
were visualised by brief UV illumination, and the agarose containing them was excised. 
The agarose was chopped into small pieces with a sterile razor blade and dissolved by 
incubation in saturated Nal solution (90.8 g Nal and 1.5 g Na2SO3, dissolved in 100 ml 
H2O and filtered) at 55 °C for 10 minutes. 5 µl of acid-washed silica was added to the 
dissolved agarose solution and this mixture was incubated at room temperature for 5 
minutes, with occasional mixing. Using a 15 second microcentrifugation to pellet the 
silica, it was washed 3 times with 1 ml EtOH/NET (50 % (v/v) ethanol, 50 mm NaCl, 5 
mM Tris-Cl, pH 7.5,0.5 mM EDTA) followed by a single wash in 80 % (v/v) ethanol. 
DNA was eluted from the silica by incubation with 20 µl H2O at 55 °C for 10 minutes. A 
two minute microcentrifugation was used to pellet the silica and to allow the DNA 
solution to be removed. Further microcentrifugations were carried out as necessary to 
remove silica that had been carried over. The efficiency of recovery of the DNA fragment 
was checked by mixing 1 µl of fragment solution with 10 91 of 5 µg/ml ethidium bromide 
solution, and comparing, by eye, the fluorescence of the mixture with plasmid DNA 
concentration standards, under UV illumination. 
Plasmid and M13 bacteriophage DNA 
In the case of plasmids, 1 µl of 1 nM primer solution and 1 µl of 1N NaOH were added 
to 4 µg plasmid DNA, in a final volume of 10 Al H2O. This was incubated at 68 °C for 10 
minutes to denature the plasmid DNA, then 4 µl of TDMN buffer (280 mM TES, 120 
mM HCl, 80 mM MgC12,200 mM NaCl, 50 mM DTT) was added to neutralise the 
NaOH. Reactions were allowed to stand for 10 minutes at room temperature while primer 
annealing took place, then used immediately for sequencing with Sequenase modified T7 
DNA polymerase (USB), according to the Sequenase manual. [35S]-dATP was used as a 
radioactive label. Reactions were electrophoresed on 6% (w/v) acrylamide denaturing 
gels, prepared using Sequagel ready-made solutions (National Diagnostics). After 
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electrophoresis, fixation for 20 minutes in sequencing fix (10 % (v/v) acetic acid, 10 % 
(v/v) methanol), and drying, gels were exposed overnight to n-max autoradiographic film 
(Amersham). 
Sequencing of single-stranded M13 bacteriophage DNA was carried out similarly, except 
that the initial denaturation and neutralisation steps were omitted. Instead, 1 µl of 1 nM 
primer solution and 2 µl of 5x Sequenase reaction buffer (USB) were mixed with 50 ng of 
M13 DNA in final volume of 10 µl. After heating at 65 °C for 2 minutes, the reactions 
were left to anneal at room temperature for 10 minutes, then sequencing was carried out 
according to the Sequenase manual. 
Synthesis of radio-labelled DNA probe for hybridizations 
a[32P]-dCTP-labelled DNA probe for RNA blot hybridisations and library screenings 
was made by random-primed DNA synthesis using the Megaprime kit from Amersham. 
Probe was synthesized at 37 °C, denatured for five minutes in a boiling water bath, and 
used immediately. 
T7 RNA polymerase transcription to produce capped mRNA 
This protocol for T7 RNA polymerase transcription of plasmids is based on that by 
Nielsen and Shapiro (1986) Plasmid DNA containing the cDNA of interest downstream 
of a T7 promoter was linearized by restriction digestion at the 3' end of the 3' UTR. 
Linearisation was found to be necessary for the production of efficiently transcribable 
RNA, as T7 terminator sequences were not fully effective. After digestion, linear DNA 
was purified by extraction with a 1: 1 (v/v) mixture of phenol and chloroform, followed by 
two extraction with chloroform alone and ethanol precipitation. The DNA was washed 
with 80 % (v/v) ethanol and resuspended in H2O at a concentration of 1 mg/ml. 
Capped mRNA was synthesized in a 100 µl reaction containing the following components: 
50 µg/ml linear DNA 
1 mm rATP, 1 mM rUTP, 1 mM rCTP, 100 µM rGTP 
5 mM DTT 
15 mM MgCl2 
10 mm Tris-Cl pH 8.0 
250 U/ml RNAguard (Pharmacia) 
0.5 mM RNA Cap Structure Analogue 7 mG(5')ppp(5')G sodium salt 
(New England Biolabs) 
60 µl/ml T7 RNA polymerase (purified by Shaun Mackie or Anne 
McBride, Cambridge University). 
After 30 minutes at 37 °C, additional rGTP was added to a final concentration of 1 mM 
and the reaction was incubated at 37 °C for a further 60 minutes. To stop the reaction and 
dissolve the precipitate which appeared during transcription, an equal volume of 2% 
(w/v) SDS, 100 mM EDTA was added. The cleared reaction mix was then extracted twice 
with a 1: 1 (v/v) mixture of phenol and with chloroform alone and the nucleic acid was 
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precipitated with an equal volume of 4M ammonium acetate and 5 volumes of ethanol. 
The nucleic acid was pelleted by microcentrifugation for 20 minutes, washed with 80 % 
(v/v) ethanol, resuspended in 50 µl H2O and stored at -80 °C. 
cDNA library screening techniques 
Initial screening of libraries by PCR using degenerate primers 
To initially identify cDNA sequences from Xenopus similar to known D-type cyclins, and 
later, to identify Cdk4-like cDNA sequences, sequences were amplified from cDNA 
libraries using degenerate oligonucleotide primers. Primers were designed to be 
complementary to DNA coding for highly conserved amino acids, and to minimize 
degeneracy, primers were chosen to avoid amino acids such as serine and leucine which 
can be represented by many different codons, especially at the 3' end of the primer where 
exact complementarity is crucial for successful amplification. 
A restriction enzyme site was incorporated into the 5' sequence of degenerate primers and 
vector primers to facilitate sub-cloning, and a few extra nucleotides were included 5' of 
the restriction site to permit efficient cleavage by the restriction enzyme concerned. 
Information from the New England Biolabs catalogue was used to determine how many 
flanking nucleotides are necessary for efficient cleavage. 
Amplification was generally performed using one degenerate primer corresponding to the 
intended target, and one primer complementary to flanking sequences in the vector 
carrying the cDNA library. This was found to be more successful than attempting to 
amplify with two degenerate oligonucleotides, which tended to produce high levels of 
background amplification, but no specific bands. 
PCR was performed as normal except that plasmid template was replaced with 1 tl of 
lambda bacteriophage supernatant (containing around 1010 pfu per ml) or 1 tg of plasmid 
library DNA. 
Amplification products were separated by electrophoresis through a1% (w/v) agarose- 
TAE gel, DNA fragments were excised, purified using silica powder, restriction-digested, 
sub-cloned into the plasmid Bluescript KS (Promega) and end-sequenced using forward 
and reverse standard sequencing primers (FSP and RSP). 
Screening lambda cDNA libraries by DNA hybridization 
Xenopus cDNA fragments identified using PCR methods were used to identify full length 
cDNAs in lambda bacteriophage libraries by conventional screening using radio-labelled 
probe. 
Library screening was based on the procedure described in Sambrook et al. (1989). 
Libraries were plated at a density of approximately 105 plaques per 130 mm plate, and 
duplicate plaque lifts were taken using Hybond N+ positively charged nylon membrane 
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(Amersham). Care was taken to record the relative orientation of membrane and plate 
using a hypodermic needle coated in India ink to pierce the membrane and mark the 
underlying plate in at least three asymmetrical positions. 
The use of a positively charged nylon membrane allowed lambda DNA denaturation and 
fixation to the membrane to be combined into a single step, following Amersham's 
recommendations for alkaline fixation. 
Membranes were then pre-hybridized in heat-sealed plastic bags for 2 hours at 42 'C, with 
shaking, using around 10 ml per membrane of the following pre-hybridization buffer: 
50 % (v/v) formamide, 6x SSC, 50 mM PIPES pH 6.8,5x Denhardt's, 1% (w/v) SDS, 
100. tg/ml denatured sheared salmon sperm DNA. Normally only two membranes were 
placed in each bag, with the surfaces carrying DNA facing outwards to expose them to 
free circulation of buffer. 
Pre-hybridization buffer was then replaced with hybridization buffer containing denatured 
radiolabelled probe. The hybridization buffer used was identical to the prehybridization 
buffer except that it contained dextran sulphate added to a final concentration of 10 % 
(w/v). Mixing probe with hybridization buffer before using it to replace the pre- 
hybridization buffer was found to be preferable to adding the probe to the hybridization 
buffer in situ, because high local concentrations of probe during mixing caused 
background problems. 
Membranes were hybridized with probe overnight at 42 'C with shaking, then washed 
under stringent conditions at 65 °C as follows (100 ml per membrane per wash): 
[Ix SSC, 0.1 % (w/v) SDS, 0.2 % sodium pyrophosphate 20 minutes ]x2 
[ 0. lx SSC, 0.1 % (w/v) SDS, 0.2 % sodium pyrophosphate 20 minutes ]x2 
Membranes were then dried and autoradiographed overnight. Plugs of top agar were taken 
from plates in locations were both duplicate plaque lifts had shown strong signals. Some 
contaminating signals coincided on duplicate lifts, but with practise genuine positive 
plaques became quite easy to distinguish from such signals, as they had a 
characteristically tailed, comet-like appearance. Lambda bacteriophage was eluted from 
the agar plug and screening was repeated several times at progressively lower plaque 
densities until plaque purity was achieved. In the case of lambda-YES libraries, the 
bacteriophage was then converted to the plasmid form by cre-lox excision (Elledge et al., 
1991), achieved by infecting the bacterial strain BNN 132 with the lambda-YES 
bacteriophage to be converted. In other cases, the cDNA was transferred to Bluescript KS 
by PCR subcloning, using primers complementary to lambda vector flanking sequences. 
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Sequencing of full length cDNA clones 
Random sub-cloning into M13mp18 bacteriophage 
This was performed exactly as described by Bankier et al. (1987). A restriction fragment 
containing the cDNA of interest was self-ligated, sonicated using a Heat Systems XL2010 
sonicator, and end-repaired with T7 DNA polymerase and Klenow DNA polymerase. It is 
crucial for end-repair efficiency that the T7 polymerase be fresh. The sonicated, end- 
repaired fragments were then sub-cloned into SmaI-cut M13mp18, and sequenced. 
The main advantage of this M 13-based approach is that sequence derived from the single- 
stranded DNA produced by M13 bacteriophage is generally of superior quality to that 
obtained by direct sequencing of double-stranded plasmids. The disadvantages are that it 
can be difficult to achieve adequate cloning efficiencies with end-repaired sonicated 
DNA, and that the coverage of the cDNA by sub-clones is likely to be uneven, since the 
clones are random. The sequencing process can therefore be time-consuming and 
wasteful. 
Creating an ordered series of plasmid deletion subclones 
Since, during the latter part of my work, a fast and effective method for sequencing 
plasmid minipreps was available, I chose to use the ordered plasmid deletion method 
(Henikoff, 1984), which I found to be more predictable and less trouble than the M 13- 
based "shotgun" approach. Promega's commercial `Erase-a-base' system was used 
according to the manufacturers instructions. 
Briefly, exonuclease III is used to specifically digest the recessed strand at a DNA end 
with a 5' overhang, while a 3' overhang protects the other end of the linearized plasmid 
molecule. Si nuclease is used to digest the single-stranded DNA thus produced, and 
finally the resultant double-strand-deleted molecule is self-ligated and used to transform 
competent bacteria. By stopping exonuclease III digestion at appropriate time points, 
deletions can be obtained at intervals of 150 bp. This length of deletion was chosen 
because manual plasmid sequencing produces 200-250 of reliable sequence per clone, so 
150 bp deletions allowed a reasonable amount of overlap for sequence assembly. To 
allow both strands to be fully sequenced, two sets of deletions had to be created, one 
deleting the cDNA 5' to 3, the other deleting it 3' to 5', since any individual deletion 
clone can only be usefully sequenced on one strand as it has only been unidirectionally 
deleted. 
Plasmid deletion clones were sequenced with forward sequencing primer, as described 
earlier in this chapter. 
49 'ý.. 
Sequence assembly 
Contiguous cDNA sequences for Xenopus cyclins D1 and D2 were assembled from the 
sequence fragments obtained by M13 sequencing using the program sap, written by 
Roger Staden (Cambridge University), running on a DEC VAX 4600. Later, for the 
assembly of Cdk4 sequences, the Macintosh program Sequencher (Gene Codes, Ann 
Arbor, Michigan). I found Sequencher to be a far more effective tool than sap. The 
contig covering the Cdk4 coding sequence is shown schematically in figure 2.2. 
Preparation and analysis of RNA 
Preparation of total RNA from Xenopus embryos and adult tissues 
Total RNA was prepared using the guanadinium isothiocyanate/acid-phenol single-step 
method (Chomczynski and Sacchi, 1987). Briefly, samples of tissue were homogenized in 
denaturing solution (4 M guanadinium isothiocyanate, 25 mM sodium citrate, 0.5 % (v/v) 
sarcosyl, 0.1 M 2-mercaptoethanol). The following amounts of denaturing solution were 
used for each type of sample: 
Embryos 60 µl per embryo 
Adult tissue 12 ml per gram of tissue 
Cultured cells 12 ml per 108 cells 
Adult tissues were first frozen in liquid nitrogen and crushed with a pestle and mortar, 
before using a Dounce homogenizer to resuspend in denaturing solution. Eggs and 
embryos were generally homogenized using a small pestle which was designed to fit 
snugly into 1.5 ml microcentrifuge tubes. Cultured cells were homogenized simply by 
pipetting denaturing solution over the base of tissue-culture dishes. 
The following procedure is for a typical preparation of RNA from 10 embryos in a 
microcentrifuge tube, homogenized in 600 tl of denaturing solution. All volumes were 
adjusted proportionately when different amounts of denaturing solution were used and 
when using larger volumes, preparations were carried out in Corex centrifuge tubes (Du 
Pont), in which case centrifugations were carried out at 10 000 rpm in a Sorvall SS-34 
rotor. 
To the denaturing solution homogenate was added 60 µJ 2M sodium acetate pH 4.0, and 
this was mixed by inversion. 600 µl of phenol/chloroform (25: 24: 1 (v/v) phenol, 
chloroform, isoamylalcohol) was added, and the mixture was shaken hard or vortexed for 
10 seconds, incubated on ice for 15 minutes and then microcentrifuged for 20 minutes. 
The aqueous phase was taken, with care to avoid the unwanted material at the interface, 
mixed with an equal volume of propan-2-ol, and left at -20 °C for at least an hour to 
precipitate RNA. After microcentrifugation for 20 minutes, the RNA pellet was 
resuspended in a further 250 µl of denaturing solution. RNA was precipitated for a second 
time with an equal volume of isopropanol, one hour incubation at -20 °C, and 
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microcentrifugation for 20 minutes. Finally, the pellet was washed with 0.6 ml 70 % (v/v) 
ethanol, dried for 15 minutes under vacuum, and resuspended in 40 tl H20. The yield 
was determined by measuring the absorbance of a 1: 400 (v/v) dilution of the RNA at 
260 nm. 
RNA blotting and hybridization 
Horizontal submarine agarose gel electrophoresis apparatus (BRL) was soaked in 2N 
NaOH for one hour to inactivate RNases, then thoroughly rinsed with deionized water. 
14 cm x 11 cm gels were used, which provided ten wells capable of taking 10 µg of total 
RNA each, without overloading. 
Formaldehyde-agarose denaturing gels were made by first dissolving 1g of agarose 
(SeaKem ME agarose, FMC) in 75 ml deionized H2O by microwaving until boiling, then 
adding 10 ml lOx MOPS buffer (0.2 M MOPS, 50 mM sodium acetate, 10 mM EDTA 
pH 7.0) followed by 17 ml 37 % (w/v) formaldehyde solution. Once set, the gel was 
soaked in MOPS-formaldehyde running buffer (1 x MOPS buffer, 5% (w/v) 
formaldehyde) until needed. 
RNA samples of 10 µg each, in between 2 µl and 10 µl of buffer, were denatured by 
adding 2 µl lOx MOPS buffer, 3.5 µl 37% (w/v) formaldehyde and 10 µl formamide, 
vortexing, and then heating at 65 °C for 5 minutes. After adding 2 µl of RNA loading 
buffer (50 % glycerol, 1 mM EDTA pH 8.0,0.25 % (w/v) bromophenol blue, 0.25 % 
(w/v) xylene cyanol), samples were loaded onto the formaldehyde-agarose gel and 
electrophoresed at 90 V for approximately 3 hours until the bromophenol blue had 
migrated 80 % of the way along the gel. 
RNA was transferred to Hybond-N nylon membrane by overnight capillary blotting using 
20x SSC as the transfer buffer. The RNA was then fixed to the membrane by baking at 
80 °C for 2 hours. 
RNA blot hybridization was carried out using radioactively-labelled random-primed 
probe, with the same conditions and buffers for hybridization, prehybridization and 
stringency washing as were used for library screening. 
Washed RNA blots were covered in Saran wrap (Dow Chemical Company) and 
autoradiographed, with exposure times of between 12 hours and 4 days. 
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In vitro translation and associated techniques 
Translation of mRNA in CSF and reticulocyte lysate 
In vitro translations were generally carried out in a 50: 50 (v/v) mixture of CSF Xenopus 
egg extract and nuclease treated reticulocyte lysate. CSF extract was made in the lab by 
Elspeth Stewart, Andrea Klotzbücher, Michael Howell and others, as described in 
(Murray, 1991). Micrococcal nuclease treated reticulocyte lysate was prepared in the 
laboratory by Tim Hunt and others. 
Rabbit reticulocyte lysate (40 µl) was supplemented with 5 µl of 0.2 M creatine 
phosphate, 5 p1 of KM (2 mM KCI, 11 mM MgC12,1 mM EDTA), 5 µl of amino acid 
mix (3 mM L-leucine, 3 mM L-valine and 2 mM all other amino acids except 
L-methionine and L-cysteine, pH 7.2) and 5 µl trans [35S]-label, 10 mCi/ml (a mixture of 
[35S]-methionine and [35S]-cysteine from ICN, #51006). An equal volume of this mix 
was added to freshly-thawed CSF-arrested egg extract, to which a 1/20th volume of trans 
[35S]-label had already been added. Aliquots of this mixture of rabbit reticulocyte lysate 
and CSF-arrested egg extract were then added to 0.5 ml microcentrifuge tubes containing 
the synthetic mRNA(s) to be translated, and any bacterially expressed proteins to be 
included in the translation. Typically, 1/10th volume of each RNA or protein was added, 
up to a maximum of 3 µl per 10 µl of extract mixture. Both proteins and mRNAs were 
used at concentrations of approximately 1 mg/ml. The translation reaction was incubated 
at 23 °C for 2 hours, then an equal volume of RNase stop solution was added (10 mM 
EDTA, 100 µg/ml RNase A). For analysis by SDS-PAGE, 2 µl of this mixture was added 
to 20 p1 SDS sample buffer, mixed and boiled for 2 minutes and 10 µl of this was loaded 
onto the polyacrylamide gel. This amount of extract was the maximum that could be run 
in one lane without overloading the gel. After Coomassie staining and drying, gels were 
autoradiographed using ß-max film (Amersham), exposing for between 16 and 48 hours. 
The remaining translation mixture was used for glutathione-Sepharose affinity- 
purifications, or for immunoprecipitations. 
Glutathione-Sepharose affinity-purification 
100 µl of IP buffer was added to each translation/RNase stop mixture, and samples were 
vortexed and then microcentrifuged for 5 minutes to pellet insoluble material present in 
the CSF extract. If 1r i Skr is omitted, the insoluble material copurifies with the 
glutathione-Sepharose, causing serious background problems. 
10 µ1 of glutathione-Sepharose bead slurry (Pharmacia) per reaction to be purified was 
equilibrated by several washes in IP buffer and distributed using a cut off Gilson P200 
pipette tip into fresh 0.5 ml microcentrifuge tubes, using an excess of buffer to ensure 
equal amounts were transferred. The supernatant from the centrifuged translation reaction 
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was then added to the glutathione-Sepharose beads, and the samples, now in a total 
volume of around 250 µl IP buffer, were rotated at room temperature for 20 minutes to 
allow the GST-proteins to bind to the glutathione-Sepharose. The beads were then 
washed 3 times with 400 µl IP buffer per wash, by vortexing with the buffer, 
microcentrifuging for 15 seconds, and then aspirating the supernatant using a drawn out 
Pasteur pipette to avoid disturbing the beads. A final addition of 200 µl IP buffer was 
used to transfer the beads to fresh microcentrifuge tubes, and after microcentrifugation 
and removal of IP buffer the beads were resuspended in 20 µl of SDS sample buffer. 
Samples were boiled and 10 µl was used for SDS-PAGE, followed by autoradiography. 
Immunoprecipitations 
Immunoprecipitations were performed analogously to glutathione-affinity-purification. 
After the initial microcentrifugation of the in vitro translation/IP buffer mixture, antibody 
was added to the cleared supernatant (1 µl of crude serum or 100 µl of hybridoma culture 
supernatant), and the mixture was incubated on ice for an hour. Protein A-Sepharose 
beads (Pharmacia), equilibrated in IP buffer, were then aliquoted into fresh microfuge 
tubes (5 µl packed volume of beads per tube) and the antibody/translation mixture was 
then rotated together with these beads for 20 minutes at room temperature. Washes were 
performed as for glutathione-affinity purifications, described above. 
pRb and Histone Hl phosphorylation assays 
To test the affinity purified glutathione-Sepharose associated protein-complexes for 
kinase activity, purifications were carried out as described above, up to and including the 
third 400 µl IP buffer wash. The 4th wash was carried out in 200 µl of 50 mM Hepes pH 
7.5,0.1 mM Na3VO4,1 mM NaF, 1 mM DTT, 0.25 mM PMSF, and was normally used 
to split the beads equally between two fresh tubes. One half of the beads were simply 
spun down and resuspended in SDS sample buffer, while the other half was used for the 
kinase assay. 
For the kinase assay, beads were resuspended in 20 µl of 50 mM Hepes pH 7.5,0.1 M 
MgC12,0.1 mM Na3VO4,1 mM NaF, 2.5 mM EGTA, 10 mM sodium f3- 
glycerophosphate, 1 mM DTT, 20 µM non-radiolabelled ATP, 0.25 µg/ml substrate 
(normally either human GST-pRb pocket protein or histone H 1) and 1/40th volume 
y[32P]-ATP (1000 µCi/ml). Kinase reactions were incubated for 30 minutes at 30 °C, 
with occasional agitation. On completion, the reactions were mixed with an equal volume 
of SDS sample buffer, boiled for 2 minutes, and 10 µl per sample was used for SDS- 
PAGE followed by autoradiography. 
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Preparation and analysis of proteins 
Preparation of GST-fusion proteins expressed in E. coli 
Coding sequences were sub-cloned by PCR into the vector pGEX-KG, which contains a 
glycine-rich "kinker" sequence (PGISGGGGG), following the thrombin cleavage site 
between the GST-domain and the inserted coding sequence, which greatly improves the 
efficiency of thrombin cleavage. 
Competent E. coli of the strain TG1 were transformed with pGEX-KG expression 
plasmid carrying the coding sequence of interest. Colonies were inoculated into LB 
containing 50 µg/ml ampicillin, and 400 ml of culture with absorbance at 600 nm of 
between 0.5 and 0.8 was induced by adding IPTG to a final concentration of 0.5 mM, and 
growing bacteria at room temperature with vigorous shaking for between 4 hours and 
overnight. 
Cells were pelleted by centrifugation for 10 minutes at 3000 rpm in a Sorvall GS-3 rotor, 
then resuspended in 25 ml pGEX lysis buffer (50 mM Tris Cl pH 7.5,2.5 mM EDTA, 
1 mM DTT, 0.25 mM PMSF, 2 mg/ml lysozyme). After a 15 minute incubation on ice the 
viscous cell lysate was sonicated using a Heat Systems sonicator (model XL2010) to 
shear chromosomal DNA. The lysate was then centrifuged at 12 000 rpm in an SS-34 
Sorvall rotor for 30 minutes, and the resulting supernatant was dialysed overnight against 
2 litres of glutathione column buffer (1 x PBS, 0.25 M KCI, 1.0 mM DTT) to remove free 
glutathione. The dialysed supernatant was filtered through a 0.45 pM filter (Nalgene) and 
loaded onto a2 ml packed bed-volume glutathione-agarose column pre-equilibrated with 
glutathione column buffer. 
The column was then washed with 10 volumes of column buffer containing 0.1 % (v/v) 
Tween-20, followed by 3 volumes of column buffer without added detergent. GST- 
protein was then eluted with glutathione elution buffer (5 mM glutathione (reduced form), 
50 mM Tris pH 8.1,0.25 M KCI, 1 mM DTT), taking fractions of 1 ml. When it was 
desirable to remove the GST moiety (for example, when producing protein for 
immunising rabbits), protein was not eluted using free glutathione in this way, but was 
released from the glutathione beads by thrombin cleavage, according to the protocol of 
Guan and Dixon (1991). 
SDS-PAGE was used to analyse induced and uninduced crude bacterial samples, the 
insoluble pellet and the supernatant from the initial lysate, and the eluate fractions. The 
fractions corresponding to the elution peak were pooled and dialysed against GST-protein 
buffer (20 mM Tris-Cl pH 7.5,0.15 M KCI, 1 mM EDTA, 1 mM EGTA, 0.25 mM 
PMSF, 1 mM 2-mercaptoethanol). Results of a typical GST-fusion purification are shown 
in figure 2.3. 
55 
Preparation of His6- and Hisio-tagged proteins expressed in E. coli 
Coding sequences were sub-cloned by PCR either into Pet 16b (Novagen), which adds an 
N-terminal tag of 10 histidines, or into Pet2lb (Novagen) which adds a C-terminal tag of 
6 histidines. The plasmids were transformed into competent E. coli of the strain 
BL21(DE3)pLysS and bacteria were grown up and induced at room temperature with 
IPTG exactly as described for GST-protein purification. Lysates were prepared and the 
recombinant protein was purified according to the manufacturer's recommendations. 
Since both Cdks and cyclins are often extremely insoluble when expressed with histidine 
tags, in general proteins had to be purified using 6M guanadinium hydrochloride as a 
denaturant. 
For antibody production, denatured protein was not eluted from the Nie+-agarose. Instead, 
washed beads carrying the denatured protein were used directly for immunising rabbits. 
Histidine-tagged proteins to be used for affinity purification of antibodies were eluted 
directly from the Nie+-agarose by washing the beads in coupling buffer (0.1 M NaHCO3 
pH 8.3,0.5 M NaCl), supplemented with 0.2 % (v/v) SDS. In the few cases where it was 
necessary to obtain native histidine-tagged protein, the protein was purified initially in the 
denatured form, and was then rapidly diluted in lx PBS to allow refolding to occur, 
avoiding the aggregation which often results when concentrated solutions of denatured 
histidine-tagged proteins are dialysed. This dilute solution was then concentrated by re- 
purification on Nie+-agarose under non-denaturing conditions. 
Results of typical preparations of histidine-tagged proteins are shown in figure 2.4. 
Preparation of yolk-protein-free extracts of Xenopus embryos 
Western blotting of total Xenopus embryonic lysates, made by resuspending embryos 
directly in SDS loading buffer, is problematic because the large quantities of yolk protein 
limit the amount of extract which can be loaded per lane to about 0.125 embryo 
equivalents, and also lead to a strong non-specific background signal, at least when using 
ECL detection methods. This problem was overcome by using the following extraction 
protocol, which left the yolk protein insoluble. Xenopus embryos were homogenised by 
pipetting up and down in IP buffer (20 mM EGTA, 50 mM NaF, 80 mM sodium 
ß-glycerophosphate, 1 mM DTT, 0.25 mM PMSF, 0.1 mM Na3VO4, pH 7.5). 10 µl of IP 
buffer was used per embryo. The homogenate was then incubated on ice for 15 minutes, 
and microcentrifuged for 10 minutes. The supernatant was taken and mixed 1: 1 (v/v) with 
SDS loading buffer. This supernatant contains almost no yolk protein, and so 0.5 embryo 
equivalents can be run per lane of an SDS-PAGE gel. 
56 
SDS polyacrylamide gel electrophoresis (SDS-PAGE) 
The method of SDS-PAGE was modified from Anderson et al. (1973). The main change 
was that neither the stacking nor the resolving gels contained SDS. 15 % (w/v) 
acrylamide resolving gels were used throughout. Mixes of the resolving and stacking gels 
were prepared frequently from stock solutions and stored at 4 T. The composition of the 
gel mixes was as follows: 
Component Resolving gel, 15 % (w/v) Stacking gel 
30 % (w/v) acrylamide 50.0 ml 25.0 ml 
1% (w/v) bisacrylamide 8.6 ml 20.0 ml 
1.5 M Tris-Cl, pH 8.8 25.0 ml - 
1.0 M Tris-Cl, pH 6.8 - 18.8 m1 
H2O 16.4 ml 86.2 ml 
100 m1 150 m1 
Table 2.2 SDS-PAGE gel mixes 
Stocks of 30 % (w/v) acrylamide and 1% (w/v) bisacrylamide were deionized with 
MB5113 mixed bed ion exchange resin (BDH) and filtered through a 0.22 µm filter 
(Millipore). 
Resolving gel mixes were polymerized using a final concentration of 0.05 % (v/v) 
TEMED (N, N, N', N'-tetramethyl-ethylenediamine) and 0.05 % (w/v) ammonium 
persulphate. Stacking gel mixes were polymerised with a final concentration of 0.1 % 
(v/v) TEMED and 0.1 % (w/v) ammonium persulphate. Minigels (12 cm x8 cm) and 
standard size gels (20 cm x 13 cm) were cast and run using apparatus from Cambridge 
Electrophoresis. Samples to be analysed by SDS-PAGE were resuspended in SDS sample 
buffer (80 mM Tris-Cl pH 6.8,2 % (w/v) SDS, 10 % (v/v) glycerol, 0.002 % (w/v) 
bromophenol blue and 50 µ1/m1 2-mercaptoethanol, added just before use). Typically, 
liquid samples were mixed 1: 1 (v/v) with SDS sample buffer. Samples were then 
denatured by incubating in a boiling water bath for 2 minutes. 
The running buffer used for electrophoresis contained 25 mM Tris base, 192 mM glycine, 
0.1 % (w/v) SDS. Mini gels were run with a limiting voltage of 150 V at the beginning of 
the run, increasing to 250 V for the second half of the run. Standard gels were run with a 
limiting voltage of 200 V at the beginning of the run, increasing to 300 V during the 
second half of the run. Electrophoresis was continued until the bromophenol blue dye 
front had just run off the bottom of the gel. 
57 
5 
ýýýý5 ýýýýýý ýr 
ýa ýý ýQ ýý of ý° ýa ýo` ýý rý ýa Jý oýý ýý ýý Jý\ýa\ýýýýýýo 
123456 
i 
So %4b* 
Eluate fractions 
(5mM glutathione) 
7 
Molecular 
weight 
/ kDa 
89 10 11 12 13 14 15 16 17 18 
- 116 
- 92.5 
- 66 
- 57.5 
- 45 
- 29 
Figure 2.3 GST-cyclin D1 purification on glutathione-agarose 
Cyclin Dl was expressed in E. co/i using the pGEX-KG expression vector. Clarified 
bacterial lysate was passed over a glutathione-agarose column, the column was washed, 
and the purified GST-fusion protein was specifically eluted using 50 mM Tris-Cl pH S. 1. 
0.25 M KC1,1 mM DTT, 5 mM glutathione (reduced form). Fractions were analysed on 
an SDS-PAGE gel, stained with Coomassie blue 
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Figure 2.4 Hisl,, -tagged proteins purified on Nie+-agarose 
His, ()-tagged proteins, after purification in denatured form in the presence of 6 NI 
guanadinium hydrochloride, were analysed by SDS-PAGE and Cooninassie blue staining 
58 
Western Blotting 
Protein samples were separated by SDS-PAGE, the gel was soaked in transfer buffer (20 
mM Tris base, 150 mM glycine, 0.1 % (w/v) SDS, 20 % (v/v) methanol) for 30 minutes 
and the proteins were transferred to Hybond C-super supported nitrocellulose membrane 
(Amersham), using a semi-dry transfer apparatus (Hoefer), according to the 
manufacturers instructions. Selected lanes on the blot were labelled by running 2 µl of a 
0.5 mg/ml solution of the pink dye Pyronin Y (Aldrich) in SDS sample buffer (without 2- 
mercaptoethanol) on the polyacrylamide gel. This dye transfers from the gel to the 
nitrocellulose with the proteins. The membrane was stained with 0.2 % (w/v) Ponceau S 
in 3% (w/v) trichloroacetic acid and destained with distilled water. The positions of the 
molecular-weight markers and the positions of the lanes were marked on the membrane 
with a pencil and the Ponceau staining was washed off using lx PBS. The membrane was 
blocked with TBST (10 mM Tris-Cl pH 8.0,150 mM NaCl, 0.05 % (v/v) Tween-20) 
containing 4% (w/v) skimmed milk powder at 4 °C overnight and then incubated with 
primary antibody at room temperature for between 1 and 2 hours. For monoclonal 
antibodies, antibody was used in one of two forms, either undiluted hybridoma culture 
supernatant, or 10 pg/ml of protein-A-purified IgG, in TBST containing 2% (w/v) 
skimmed milk powder. For rabbit polyclonal antibodies, antibody was used either as a 
1: 1000 (v/v) dilution of unpurified rabbit serum, or as a 10 µg/ml solution of affinity- 
purified antibody, in TBST containing 2% (w/v) milk was used. 
After primary antibody incubation, the membrane was washed at room temperature, twice 
with TBST containing 4% (w/v) skimmed milk powder and then three times with TBST 
containing 2% (w/v) skimmed milk powder, each wash lasting at least 10 minutes. The 
primary antibody was detected by probing the membrane with a 1: 5000 (v/v) dilution of 
secondary antibody conjugated to horseradish peroxidase, in TBST containing 2% (w/v) 
skimmed milk powder, for one hour at room temperature. A rabbit anti-mouse conjugate 
(DAKO) was used for monoclonals and a swine anti-rabbit conjugate (DAKO) for 
polyclonal rabbit sera. The membrane was washed twice with TBST containing 2% (w/v) 
skimmed milk powder and then three times with TBST alone. Signal was visualized using 
the Amersham enhanced chemiluminescence system (ECL), according to the 
manufacturer's instructions. 
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Antibody production 
Immunisation of rabbits 
Rabbits were given a series of 5 injections (400 µl per injection) at 2 week intervals, with 
a 50: 50 (v/v) mixture of Freund's adjuvant and the antigen of interest. Three different 
forms of antigen were used in the course of this thesis work: cleaved GST-protein, 
denatured His I 0-tagged protein bound to Nie+-agarose, and artificially synthesized 
peptide coupled to keyhole limpet haemocyanin. Test bleeds were taken before each 
injection and one month after the final injection, rabbits were bled out. 
Binding of antigen to activated Sepharose 
Antibodies raised against histidine-tagged proteins were affinity purified using GST- 
tagged versions of the same protein, and vice versa. This specifically removed antibodies 
specific for the tag rather than for the protein of interest. Antibodies raised against 
coupled peptides were purified against the same peptide, since no alternate antigen was 
available. Hislo-tagged proteins to be used for affinity purification of antibodies were 
solubilized from the Nie+-agarose beads to which they were bound by boiling for 2 
minutes in 0.1 M NaHCO3 pH 8.3,0.5 M NaCl, 0.2 % (v/v) SDS. Other proteins and 
peptides were diluted in coupling buffer (0.1 M NaHCO3 pH 8.3,0.5 M NaCl). If 
necessary, the proteins were first dialysed to remove Tris salts, which interfere with the 
coupling process. Cyanogen-bromide-activated Sepharose (Pharmacia) was allowed to 
swell for several hours in 1 mM HCl, then 3 ml of the swollen beads were transferred to a 
column and washed extensively with 1 mM HCI. Approximately 1 mg of the ligand to be 
coupled was passed over the column, after which the matrix was washed, firstly with 
coupling buffer to remove excess ligand, and then with 0.1 M Tris pH 8.0,0.5 M Tris-Cl 
for 2 hours to deactivate the remaining active groups. The matrix was then washed with 
0.1 M sodium acetate pH 4.0,0.5 M NaCl followed by 0.1 M Tris pH 8.0,0.5 M NaCl, 
and this pH 4.0/pH 8.0 cycle was repeated twice more. 
Affinity-purification of antisera 
The affinity matrix resulting from the coupling reaction described in the previous section 
was washed with 100 mM sodium citrate pH 3.0, then placed in a column and 
equilibrated in 1x PBS. 10 ml of serum was passed several times over the affinity matrix, 
over the course of an hour. The column was then washed with 50 ml of lx PBS, 
0.1 % (v/v) NP40,0.5 M NaCl, followed by 50 ml of lx PBS, 0.5 M NaCl. 
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Purified antibody was eluted using 10 ml 100 mM sodium citrate pH 3.0, and the eluate 
was collected in a tube already containing 3 ml 1M Tris-Cl pH 8.8, which neutralised the 
citrate, and so allowed the antibody to refold correctly. After dialysis against lx PBS, 
quantification by SDS-PAGE and Coomassie staining, affinity-purified antibodies were 
stored at -80 T. 
Antibodies made and used in the course of this work 
Several rabbits were immunised with proteins and peptides in the course of this work. 
The following table lists the most specific and sensitive antibodies obtained, which were 
used extensively in the work described in this thesis. 
Antibody Antigen used for rabbit Antigen used for Detection limit for 
name immunisation affinity-purification immunoblotting 
MJC 1 Thrombin cleaved GST His 1 0-tagged cyclin D1 0.1 ng 
cyclin D1, GST removed 
MJC2 D2 N-terminal peptide D2 N-terminal peptide 0.5 ng 
coupled to KLH 
MJC7 His I0-tagged Cdk4 GST-Cdk4 0.1 ng 
Table 2.3 
Xenopus embryology 
In vitro fertilization of Xenopus eggs and collection of staged embryos 
Female Xenopus were pre-injected with 50 units of pregnant mare serum gonadotrophin 
between two and five days before collection of eggs. Late in the afternoon on the day 
before the collection of eggs, females were induced to ovulate by injection of 150 U 
human chorionic gonadotrophin. Eggs for fertilization were collected the following day 
by manual expression into a dry glass petri-dish. 
Eggs were fertilized by lightly brushing with a minced fragment of Xenopus testis. Testes 
were kept for up to 24 hours at 4 °C in 60 % (v/v) Leibovitz medium (Gibco). 5 minutes 
after fertilization, the eggs were flushed with a large volume of 0.1x MB S. After a further 
30 minutes, in most cases eggs had rotated within the jelly coat so that the animal 
hemisphere was uppermost. Eggs were then dejellied by swirling in a solution of 2% 
(w/v) L-cysteine in deionized water for around 10 minutes, followed by several washes 
with 0.1x MB S. Embryos were allowed to develop either at room temperature or at 16 °C. 
Since embryonic development at 16 °C is around 3-fold slower than development at room 
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temperature, it can be used to stagger embryonic development, avoiding the need to 
collect developmental time points at anti-social times. 
Stages of embryonic development were determined according to Nieuwkoop and Faber 
(1967). Samples of 10,20 or 50 embryos to be used for RNA blotting or immunoblotting 
were frozen in liquid nitrogen and stored at -80 °C until needed. 
Animal cap excision and mesoderm induction 
This was performed as described by Dawid (1991). Caps were excised at stage 8, 
according to Nieuwkoop and Faber (1967), and incubated at 15 °C overnight in lx MBS, 
containing either FGF (0.5 µg/ml), activin (16 U/ml) or no inducing factor. 
Microinjection of fertilized eggs 
Microinjections of 2 cell embryos were performed as described by Vize et al. (1991), 
using a Narishige IM200 microinjector. 
mRNA to be used for microinjection was T7 transcribed as usual, just as for in 
vitro translations, but the the product was then DNase treated and passed over a G50- 
Sephadex (Pharmacia) spin-column to remove DNA and unincorporated ribonucleotides. 
Fertilized embryos were dejellied and transferred to lx MBS, 4% (w/v) Ficoll, then 
injected in both hemispheres with approximately 50 nl mRNA at a concentration of 0.2 
mg/ml. After microinjection, embryos were incubated for several hours in lx MBS, 4% 
(w/v) Ficoll, and were then transferred to 0.1x MBS prior to gastrulation. 
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Whole mount mRNA in situ hybridization of 
Xenopus embryos 
This protocol is based on Harland (1991). 
Digoxygenin dUTP-labelled RNA probe synthesis 
T7 transcription was used to synthesize anti-sense RNA probes (and sense RNA probes, 
as a negative control) labelled with digoxygenin-dUTP. 
20 µl transcription reactions contained: 
10 mm Tris pH 8.0 
15 mM MgC12 
1 µg linear plasmid DNA 
1 mM rATP 
1 mm rCTP 
1 mm rGTP 
0.65 mM rUTP 
0.35 mM digoxygenin-dUTP (Boehringer #1209 256) 
37.5 mM DTT 
5 gCi a[32P]-dGTP (as a trace to monitor yields) 
1000 U/ml RNAguard RNAse inhibitor (Pharmacia) 
100 91/m1 T7 polymerase 
Transcription reactions were incubated at 37 °C for 2 hours, then 25 U of RNase-free 
DNase 1 (Boehringer) was added, followed by 15 minutes further incubation at 37 °C. 
The reaction volume was then made up to 100 µl with NETS, a 2. tl sample was taken for 
yield calculation, and each transcription reaction was then passed over a G50-Sephadex 
(Pharmacia) spin-column, previously equilibrated with 0.1 % (w/v) SDS, 0.3 M sodium 
acetate pH 5.2. This spin column treatment removes DNA fragments and unincorporated 
ribonucleotides. RNA from the flow-through of the spin column was precipitated by 
adding 2.5 volumes of cold ethanol, chilling for 20 minutes at -20 °C, and 
microcentrifuging for 20 minutes at 4 °C. The RNA pellet was washed with 70 % (v/v) 
ethanol, resuspended in 50 µl 40 mM NaHCO3,60 mM Na2CO3. A1 µl sample was 
taken at this point for yield calculations. The probe was then hydrolysed by incubating at 
60 °C for 45 minutes. This hydrolysis reduces the size of the probe RNA molecules to 
around 300 nucleotides, allowing them to penetrate Xenopus embryos more efficiently. 
After hydrolysis, the RNA probe was ethanol precipitated, washed in 80 % (v/v) ethanol, 
and resuspended at 10 µg/ml in in situ hybridization buffer (IS-HYB), which contained 50 
% (v/v) formamide, 5x SSC, 1 mg/ml Torula RNA (Sigma #R6625), 100 µg/ml heparin, 
lx Denhardt's, 0.1 % (v/v) Tween 20,0.1 % (v/v) CHAPS (Sigma #C3023), 5 mM 
EDTA. 
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The yield was calculated using the following formula: 
Mass of RNA synthesized = (post-spin-column cpm/pre-spin-column cpm)x33 µg 
Typically, the synthesis yielded around 7 µg of probe, corresponding to 20 % 
incorporation. 
Fixation of embryos 
Pigmented Xenopus embryos were collected at time-points throughout development. To 
allow penetration of reagents during the hybridization process, the vitelline membrane 
was removed at the time of collection. Embryos were first treated with 5 µg/ml 
proteinase K in 0.1x MBS for 10 minutes at room temperature, to loosen the vitelline 
membrane. The membrane was then carefully removed using No. 5 extra-fine forceps 
(BDH). Puncturing the blastocoel with forceps has been recommended as a means of 
preventing background staining in early stage embryos but made little difference, in my 
experience, when using the Boehringer Mannheim substrate. 
Between 25 and 50 embryos per time point, with the vitelline membrane removed, were 
transferred to a5 ml screw-cap glass vial, washed with 5 ml H2O, and then fixed with 
5 ml MEMFA (0.1 M MOPS pH 7.4,2 mM EGTA, 1 mM MgSO4,3.7 % (w/v) 
formaldehyde). MEMFA was made up as needed using a stock of 2x MEM and fresh 
37 % (w/v) formaldehyde. Following 1 and 2 hours incubation with MEMFA on a 
rotating wheel, embryos were dehydrated by removing MEMFA, replacing it with 100 % 
methanol and rotating vials for 5 minutes. This methanol was removed and 5 ml of fresh 
methanol was added, then the embryos were stored at -20 °C until needed for in 
situ hybridization (dehydrated embryos may be kept at -20 °C almost indefinitely). 
Hybridization 
One 5 ml vial was used for each probe to be hybridized. At least 4 embryos per 
developmental stage to be examined were put into each vial, with up to a maximum of 50 
embryos per vial. Embryos at very early stages, which needed especially careful 
treatment, were sometimes hybridized in separate vials. When carrying out washes, liquid 
was removed from vials by vacuum aspiration, but around 50 µl of liquid was left behind 
to prevent damage to embryos resulting from contact with the air water interface. 
Embryos were rehydrated by successive 5 minute washes, with rotation, in: 
100 % methanol 
75 % (v/v) methanol 
50 % (v/v) methanol 
25 % (v/v) methanol, 75 % (v/v) PTw (1 x PBS, 0.1 % (v/v) Tween-20) 
100 % PTw (3 washes) 
The last PTw wash was replaced by 1 ml of PTw containing 5 µg/ml proteinase K, and 
incubated with rocking on a nutator (Clay-Adams) for 10 minutes at room temperature. 
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Too short a proteinase K treatment will not produce good permeablization of the embryo, 
but too long a treatment risks excessive damage to the embryo epidermis. 
Embryos were then rinsed twice, for five minutes, in 5 ml 0.1 M triethanolamine pH 7.8, 
rocking horizontally on a nutator. 
To the rinsed embryos in 5 ml fresh 0.1 M triethanolamine pH 7.8,11.25 p. 1 acetic 
anhydride was added, followed by 5 minutes rocking on a nutator. Another 11.25 µl 
acetic anhydride was then added, and embryos were rocked for a further 5 minutes. 
Embryos were rinsed twice for 5 minutes in 5 ml PTw, with rotation, then re-fixed in 5 ml 
of 4% (v/v) paraformaldehyde fix (a 1: 4 (v/v) mixture of PTw and 20 % (v/v) 
paraformaldehyde), for 20 minutes with rotation. 
After 3 washes in 5 ml of PTw for 5 minutes each, all but 500 µl of PTw was removed 
and 250 µl in situ hybridization buffer added. This mixture was then removed and 
replaced with 500 µl of IS-HYB, and embryos were incubated at 60 °C with shaking. 
After 10 minutes the buffer was replaced with 500 gl of fresh IS-HYB, and embryos were 
incubated at 60 °C with shaking. After 2 hours of pre-hybridization, the buffer was 
replaced with 500 µl of probe solution (0.5 µg/ml in IS-HYB), and hybridized overnight 
with shaking at 60 T. 
Post-hybridization washes 
After hybridization, the embryos were washed according to the following regimen (5 ml 
per wash, with shaking or rocking): 
Temp Time 
IS-HYB 
50 % IS-HYB, 50 % (2x SSC, 0.3 % CHAPS) 
25 % IS-HYB, 75 % (2x SSC, 0.3 % CHAPS) 
2x SSC, 0.3 % CHAPS 
2x SSC, 0.3 % CHAPS, 20 µg/ml RNase A, 
10 U/ml RNase TI 
2x SSC, 0.3 % CHAPS 
0.2x SSC, 0.3 % CHAPS 
PTw + 0.3 % CHAPS 
PTw 
Antibody incubation 
60 °C 10 minutes 
60 °C 10 minutes 
60 °C 10 minutes 
60 °C 20 minutes ]x 2 
37 °C 30 minutes 
rt 10 minutes 
60 °C 30 minutes ]x 2 
60 °C 10 minutes ]x 2 
rt 10 minutes 
PTw was then replaced with 5 ml PBT (1 x PBS, 2 mg/ml BSA, 0.1 % (v/v) Triton X-100) 
and vials were rocked horizontally for 15 minutes. This was then replaced with 500 .d of 
80 % PBT, 20 % heat treated lamb serum (Gibco). Lamb serum had been heat-treated at 
55 °C for 30 minutes. Vials were rocked vertically at room temperature for one hour. 
This solution was then replaced with a 1: 2000 (v/v) dilution of affinity-purified sheep 
anti-digoxygenin antibody Fab fragments coupled to alkaline phosphatase (Boehringer 
#1093 274), and embryos were rocked overnight at 4 °C. 
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Excess antibody was subsequently removed by washing at least 5 times, for 1 hour each 
time, with 5 ml PBT at room temperature, followed by a further overnight wash in PBT at 
4 T. 
Signal detection and examination of embryos 
After a brief rinse in H2O, signal was developed by incubating the embryos with 0.5 ml 
of undiluted BM purple precipitating AP-substrate (Boehringer #1442 074). The staining 
reaction was allowed to continue for a maximum of 6 hours. Longer detection periods 
were found to be unsatisfactory as background staining occurred in all embryos, including 
those hybridized with sense probe. The Boehringer substrate was found to give far lower 
levels of background staining than the conventional alkaline phosphatase substrate of 
NBT/BCIP. 
When staining was satisfactory, embryos were rinsed in H2O, and then fixed for 3 hours, 
rotating with 5 ml of MEMPFA (0.1 M MOPS pH 7.4,2 mM EGTA, 1 mM MgSO4,4 % 
(v/v) paraformaldehyde). Embryos were then bleached by incubating in 70 % (v/v) 
methanol, 30 % (v/v) H202 solution (20 volume), with rotation, under strong fluorescent 
light, for between 24 and 72 hours. Bleached embryos were dehydrated by rotating for 5 
minutes in 100 % methanol, and were stored at -20 °C in methanol. 
Embryos to be photographed were transferred to 80 % (v/v) methanol in a plastic petri 
dish, since in 100 % methanol, embryos are very brittle and therefore difficult to 
manipulate. When it was necessary to position embryos accurately for photography, a 
petri dish coated in 1% (w/v) agarose was used, again filled with 80 % (v/v) ethanol. 
Indentations in the agarose were made, into which embryos could placed. Initially, I used 
the clearing agent BB/BA (also known as Murray's clearing agent), a 2: 1 (v/v) mixture of 
benzyl benzoate and benzoic acid, which has the same refractive index as yolk platelets 
and is thus able to make Xenopus embryos almost transparent. However, I found that I 
obtained better photographs using uncleared embryos, since the majority of staining was 
on the surface. 
Embryos were examined under a Wild M3Z stereo-microscope and were photographed 
either using a JVC KY-F55 CCD colour video camera together with a Falcon video 
capture board (Graphics Unlimited, Cambridge, UK), fitted to a Macintosh computer, or 
using a 35 mm camera to take slides, which were then digitized using a slide scanner. 
Sectioning of whole mount in situ hybridized embryos 
After being photographed as whole mounts, embryos in 5 ml glass vials were fully 
dehydrated with several rinses in 100 % ethanol, then incubated twice, for 30 minutes 
each time, with Histoclear (National Diagnostics), a non-toxic dewaxing agent. Half the 
Histoclear was removed and replaced with molten wax at 60 °C (Fibrowax, BDH). After 
incubating at 60 °C for 20 minutes, the liquid mixture was removed and replaced with 
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100 % molten wax. After replacing the wax three more times, with a 20 minute 
incubation at 60 °C each time, selected embryos were embedded by allowing wax to cool 
gradually in a small glass dish, and using red-hot syringe needles to arrange embryos 
while the wax set. Embedded embryos were sectioned with a Reichart-Jung microtome 
into 10 p. m sections, and ribbons of sections were transferred to glass microscope slides 
by floating on a water bath at 45 T. After overnight drying, sections were dewaxed with 
two 10 minute washes in Histoclear, then permanently mounted in DePeX mounting 
medium (BDH). Sections were examined and photographed with a Zeiss Axioskop using 
Nomarski optics. 
ESPll constructs for in vitro translation and 
microinjection 
Due to the translational control mechanisms which operate in the early Xenopus embryo 
(Richter, 1987), mRNAs must contain appropriate 5' and 3' UTR signals, in order to be 
efficiently expressed when microinjected into Xenopus eggs or when translated in 
vitro. in Xenopus cell-free extracts. 
ESP11 is a T7 expression plasmid created in the laboratory by Elspeth Stewart. It 
contains the translational leader sequence of the influenza virus NS protein, together with 
the 3' UTR of Xenopus cyclin A. Coding sequences spliced into ESP11 are generally 
expressed efficiently both in CSF-extract, and when injected into eggs and early embryos. 
Figure 2.5 shows the structure of the ESP11 based clones used for expressing cyclin D1, 
cyclin D2 and Cdk4. Each coding-sequence was sub-cloned into ESP11 both with and 
without an N-terminal c-myc tag. The c-myc-tagged version allowed proteins to be 
recognized by the 9E10 anti-c-myc antibody, and also significantly shifted the mobility of 
most proteins. This was useful, since wild type Cdk4 and cyclin D2 comigrated using our 
SDS-PAGE system, making the results of binding experiments difficult to interpret. To 
circumvent this problem, c-myc-tagged Cdk4 was used in nearly all in vitro binding 
experiments. 
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82 BamH I 
87 Nco 
115 Bgl 11 
c-myc 
cyclin A 
ORF 
c-rnvc cyclin A 
(ESPI 1) 
cyclin A 
3' UTR 
1808 EcoRl 
1813 Nde I 
82 BamH I 
87 Nco I 82 BamH 1 b 
115 Bgl 11 C 87 IVoo 
cyclin D1 c-myc tag cyclin 
Dl 
ORF ORF 
ESP I1 cyclin D1 KP11 c-mrc cyclin D1 
cyclin A cyclin 
A 
3' UTR 3UTR 
'424EcoR1 
1457 EcoRl 
1429 Nde I 1462 Nde I 
Figure 2.5 Maps of ESP11-derived plasmids used to produce mRNA for in vitro 
translation and microinjection 
The coding sequences of Cdk4 and cyclins D1 and D2 were spliced into ESP 11, 
replacing the cyclin A coding sequence. but retaining the cyclin A 3' UTR and the 
influenza virus NS protein translational leader sequence. Selected restriction enzyme 
sites are shown. The numbering of the restriction enzyme sites refers to the number 
of nucleotides (in a clockwise direction) from the start of the T7 RNA polymerase 
promoter. The open reading frame (ORF), 3' untranslated region (3'UTR) and c-mvc 
epitope tag are indicated, where present 
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Figure 2.5 (continued) 
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Chapter 3 
Cloning cyclin D 1, cyclin D2 and Cdk4 
from Xenopus laevis 
Initial PCR amplification of Xenopus cyclin D2 
A partial cDNA clone from Xenopus laevis which had a predicted amino acid sequencc 
showing strong similarity to D-type cyclins had previously been obtained by Chris 
Hawkins from a Xenopus ovary cDNA library. However, this cDNA contained only a 
short region of cyclin-type sequence which was fused to unrelated sequence. The 
sequence of this clone was used to design oligonucleotide 18910, which was used to 
amplify D-type cyclin sequences from Xenopus cDNA libraries. Oligonucleotide 18910 
was designed to match a region of the cyclin box which is highly conserved between D- 
type cyclins in humans and mice (figure 3.1), and incorporated some degeneracy. The 
oligonucleotide did not include all possible codings for the amino acids concerned, as it 
was primarily designed to reisolate sequences corresponding to Chris Hawkins' D-type 
cyclin clone. 
Human cyclin D1 I VA T W1 M I., E V C E H iQ 
Mouse cyclin D1 T VA T W M L E V C E H Q 
Human cyclin D2 H VA T W M L H V C E I Q 
Mouse cyclin D2 H VA T W M C E T. ) 
Human cyclin D3 :, A W ii L V C iä 
Mouse cyclin D3 M IA W M L E V C H E Q 
T W M L E V C E 
Oligo 18910 ATGGGATCCý CYjrGGýTGýTGýACGTCýGYOA 
nucleotid e sequence 
BaniHi 
Figure 3.1 Design of oligonucleotide 18910 
The sequence of the oligonucleotide corresponds to a partially degenerate translation of 
the amino acid consensus 
Oligonucleotide 18910 was used together with lambda GT 10 forward and reverse 
sequencing primers to amplify sequences from a Xenopus ovary cDNA library (obtained 
from Douglas Melton). Typical results of such amplifications are shown in figure 3.2 
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Annealing 55 °C temperature 
1300bp 
700bp 
ell oll 
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ce7 
Annealing 
temperature 65 °C 
1300bp 
700bp 
Figure 3.2 Results of PCR amplification of cyclin D from an ovary cDNA library 
To amplify cyclin D sequences, oligonucleotide 1891O was used in combination with 
flanking vector primers. As a positive control, two non-degenerate cyclin A primers 
were used to amplify an internal cyclin A fragment 
As demonstrated by the differences between figures 3.2a and 3.2h. when amplifying from 
libraries using degenerate primers, a high annealing temperature of 65 C was eirund to he 
helpful to prevent the specific signal being overwhelmed by non-specific anmplilication. 
Sequences amplified using oligonucleottde 18910 were sub-cloned into the bacteriophage 
vector M 13mp 18. Partial sequencing of these M 13mp 18 clones confirmed that several of 
them encoded a D-type cyclin amino acid sequence, probably of a D2-type cyclin. The 
BumHI/EcoRI insert from one of these clones was then used to probe the same ovary 
cDNA library by conventional radioactive hybridization. Typical autoradiographs from 
such a screen are shown in figure 3.3. Several independent plaque-pure positive lambda 
bacteriophage clones were isolated and the two longest cDNA inserts were sub-cloned as 
EcoRI fragments into Bluescript KS, and then fully sequenced by shotgun cloning into 
M13mp18. One clone was found to be identical in sequence to that obtained (from the 
same library) by Chris Hawkins. In this clone, after 136 amino acids o ORF, all 
similarity to D-type cyclin sequence abruptly ended and a stop codon was soon 
encountered. The other cDNA insert sequenced, however, contained a 293 amino acid 
ORF encoding a full-length D-type cyclin similar to cyclin D2. The cDNA sequence has 
been deposited in the Genbank/EMBL database with accession number X89476. 
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Searching for more D-type cyclins 
Human cyclin 
Mouse cyclin 
Human cyclin 
Mouse cyclin 
Human cyclin 
Mouse cyclin 
D1 
D1 
D2 
D2 
D_ 
D3 
IVAT 
IT 
MVAT 
it VAT 
MA 
MA 
WMLEVCEEQ 
wMLEVC: EEQ 
WNLEVCEEQ 
W NLEVCFEQ 
>tij MLEVCEF ) 
Reverse translation 
(not fully degenerate) 
Oligo 24789 
(reverse-complement of 
back-translation) 
WMLEVCEE Q> 
I GGI TGýTGýAGGTNý GYýARý3AF CAG 
TCGGGATCCTGYTCYTCRCANACCTCCAGCATCCA 
BamHl 
Figure 3.4 Design of oligonucleotide 24789 
The sequence of the oligonucleotide corresponds to a region of amino acid conservation 
between all D-type cyclins, which was back translated, then reversed and complemented 
To look for further D-type cyclins, sequences were amplified from a Xenopus XTC ccII 
cDNA library (from Jeremy Minshull) using the original oligonucleotide 18910, and also 
a new degenerate oligonucleotide, 24789, which was complementary to essentially the 
same cyclin-box region as 18910, but in the opposite direction (figure 3.4). From the 
XTC cell library, I isolated cyclin D 1-like sequences, and also the cyclin D2 sequence 
previously isolated from the ovary library. Sequence data from initial partial cDNA 
clones obtained by PCR encompassed the region corresponding to the 5' end of the cyclin 
D1 coding sequence, allowing an oligonucleotide to be designed which would prime at 
this 5' terminus (oligonucleotide 20293,5'-AAGGGTGCCATGGAACTGCTATGC-3'). 
The downstream region of the Xenopus cyclin D1 cDNA sequence, including the entire 
293 amino acid ORF, was then directly amplified from the XTC cell cDNA library by 
PCR, sub-cloned into Bluescript II KS, and sequenced by shotgun cloning into 
bacteriophage M13mp18. The cDNA sequence has been deposited in the Genbank/EMBL 
database with accession number X89475. 
Although several more degenerate oligonucleotides were synthesised in an attempt to 
isolate Xenopus cyclin D3, no cyclin D3-like sequences were amplified from any of the 
libraries tested (including ovary, egg, XTC, and several embryonic libraries). Low- 
stringency hybridization screening using the human cyclin D3 coding sequence as a probe 
similarly failed to identify cyclin D3-like sequences in ovary or XTC cell libraries. The 
close conservation of sequence between Xenopus cyclin D1 and D2 and their human 
homologues suggests that Xenopus probably does have a cyclin D3 homologue, but it 
may not be represented in any of the libraries I examined. 
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Xenopus Cdk4 
In mammalian cells, D-type cyclins had been shown to associate with both Cdk4 and 
Cdk6. Cdk4 and Cdk6 are closely related in sequence and form a distinct sub-family of 
cyclin-dependent kinases. This allowed the similarity between them to be used to design 
degenerate oligonucleotides to amplify Cdk4-or Cdk6-like sequences from Xenopus 
cDNA libraries. A Cdk4 like sequence was eventually successfully amplified, sub-cloned 
and sequenced from a Xenopus embryonic cDNA plasmid library in Bluescript (from 
Patrick Lemaire), using oligonucleotide 30881 (figure 3.5). The cDNA fragment obtained 
was then used as a hybridization probe to isolate intact cDNA clones from the XTC cell 
lambda cDNA library (which had the advantage of having a larger average insert size 
than the plasmid library). The largest of the cDNA inserts isolated was then sequenced 
using the Erase-a-Base exonuclease III deletion kit (Promega) and was found to contain a 
320 amino acid ORF encoding a Cdk4-like cyclin-dependent kinase. The cDNA sequence 
was deposited in the Genbank/EMBL database with accession number X89477. 
Mouse cdk4 y, I S V G C I F A F M F 
Rat cdk4 W S V G C I F A E M F 
Human cdk4 W S V C C I F A E M .. 
Human cdk6 W S V G C I F A E M F 
Human cdk5 W ; G C: I F A E A 
Xenopus cdc2 w S ~~; . 
I F A S I A 
C 1 r' A E M F 
Oligo 30881 AGCGGATCCýGýATHýTYOCOGARIATGýT 
nucleotide sequence BamHl 
Figure 3.5 Design of oligonucleotide for Cdk4/Cdk6 amplification 
The sequence of the oligonucleotide corresponds to a reverse translation of the local 
amino acid consensus for Cdk4 and Cdk6 
Discussion 
Comparisons with other species 
The sequences of the three cDNA sequences obtained, including translations of their open 
reading frames, are listed in Appendices 1,2 and 3. The relationship between these 
sequences and the families of known cyclins and Cdks is indicated in figure 3.6 by 
cladograms, derived from multiple-alignment sequence-similarity scores using the 
Unweighted Pair Group Method with Arithmetic Averages. Conceptual translations of 
Xenopus cyclins D1 and D2 show 78 % and 83 % amino acid identity with the human 
sequences, respectively, whereas Xenopus cyclin D1 and cyclin D2 are only 64 % amino 
acid identical. Xenopus Cdk4 shows 71 % amino acid identity to human Cdk4 and 65 % 
to human Cdk6, making its identification as the Xenopus homologue of Cdk4 rather 
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uncertain. It remains to be seen whether a Cdk6 homologue exists in Xenopus, or whether 
the Cdk4-like kinase isolated here is the sole representative of the Cdk4/Cdk6 family in 
frogs. 
Interestingly, the sequence of Xenopus cyclin D1 differs at the N-terminus from the 
human and mouse sequences, lacking the 2 amino acid insertion (HQ) seen in the 
mammalian sequences (figure 3.7). The insertion lies just next to the "pocket-binding" 
motif reported to be responsible for the ability of D-type cyclins to bind pRb (Dowdy eI 
al., 1993). 
Frog Dl ME--LLCCEVD 
Mouse Dl MEHQLLCCEVE 
Human Dl MEHQLLCCEVE 
Frog D2 ME--LLCCEGD 
Mouse D2 ME--LLCCEVD 
Human D2 ME--LLCHEVD 
Mouse D3 ME--LLCCEGT 
Human D3 ME--LLCCEGT 
Consensus ME--LLCCEV. 
Rb binding ----LXCXE-- 
motif 
Figure 3.7 Xenopus cyclin D1 is atypical of Dl-type cyclins in the N-terminal pRb- 
binding region 
The isolation of two D-type cyclin cDNAs and a cDNA coding for a Cdk4-like kinase 
from Xenopus laevis suggests that at least some of the regulatory network governing the 
G 1-+S transition is conserved between Xenopus and mammals. Xenopus provides an 
experimental system more closely related to humans than either Drosophila or yeast, 
within which questions can be asked about G1 regulation which may be relevant to 
understanding the aberrant regulation of cell division in human cancer. The 
Xenopus system has the advantage of accessibility during embryonic development, 
allowing levels of protein and mRNA expression to be readily followed. The mid-blastula 
transition (Newport and Kirschner, 1982) is a particularly interesting control point, since 
around this time during development, the Xenopus embryo switches from synchronous 
rapid cell cycles which lack gap phases and which are not subject to feedback controls, to 
more regulated, asynchronous cycles, which are influenced by intercellular signals. What 
is known about D-type cyclins from studies in mammalian cells suggests that they exert 
their influence during the regulated cell cycle, and are involved in response to mitogenic 
factors (Matsushime et al., 1991). I was therefore interested to see how the developmental 
regulation of D-type cyclin and Cdk4 expression related to the timing of the mid-blastula 
transition. 
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Chapter 4 
Expression of cyclin D 1, cyclin D2 and 
Cdk4 during Xenopus laevis development 
Comparison of mitotic cyclin and D-type cyclin expression 
In Xenopus laevis, A- and B-type mitotic cyclins are stockpiled as maternal mRNAs in 
the developing oocyte and the egg (figure 4.1 a-d). All cell cycles probably require A- and 
B-type cyclins for progress through mitosis, and especially high levels might be expected 
to be required during the early cleavages, since mitotic cyclins are destroyed at every 
mitosis and yet must re-accumulate within 20 minutes to levels sufficient to drive the 
cleaving cells through mitosis. Cyclin E maternal mRNA is also present at high levels in 
the egg and during the early cleavages (Rempel et al., 1995; Mike Howell, personal 
communication). In Drosophila, expression of cyclin E seems to be absolutely required 
for progression into S phase, once maternal cyclin E has been exhausted (Knoblich et al., 
1994). A plausible interpretation of the high level of cyclin E mRNA and protein in the 
cleavage stage Xenopus embryo is that the constitutively high level of cyclin E is one of 
the adaptations of the cell cycle which allows it to proceed so rapidly in the early embryo, 
with immediate progression from M phase exit to S-phase entry. 
In contrast to the mitotic cyclin mRNAs, D-type cyclins are not stockpiled to high levels 
in the Xenopus egg. Figure 4.1e shows that, while cyclin D1 mRNA is detectable in 
tadpoles and in WAK cells and XTC cells (Xenopus tissue-culture cell lines), it is not 
detected in eggs. Cyclin D2 mRNA was not detected in eggs, tadpoles or cultured cells 
(figure 4.1 f), even though the Xenopus cyclin D2 cDNA clone was originally isolated 
from an ovary library, and was later re-isolated by PCR from an XTC cell library. 
Presumably cyclin D2 mRNA is present in these tissues, but at a very low level. The 
sensitivity of RNA blotting for cyclin D2 mRNA was comparable to that for cyclin D 1, 
and was capable of detecting 20 pg of mRNA in 10 p. g of total cellular RNA. This means 
it should have detected any message comprising more than 0.2 % (w/w) of total cellular 
mRNA. 
Regulation of RNA and protein expression at MBT 
Figure 4.2a shows expression of cyclin D1 during development in more detail. Cyclin DI 
mRNA is absent in eggs (lane 3) and since zygotic transcription during the cleavage 
phase of development is negligible, it is still absent at the onset of MBT (lane 4). By mid- 
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Figure 4.2 Cyclin D1 mRNA is undetectable during the early cleavages, but is 
induced following the mid blastula transition, whereas Cdk4 mRNA is present 
throughout development 
10 pg of total RNA per lane was separated by agarose gel electrophoresis, transferred 
to Hybond-N nylon membrane, and hybridized with the following random-primed 
probes: (a) cyclin Dl (h) Cdk4 (c) Cdc2 (d) actin 
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Developmental stage 
SfA 
18 12 16 26 
a 
b 
Bacterially 
expressed GST- 
fusion protein /ng 
37 45 0.1 1 10 
,, . 019 cyclin Dl 
C- . im º Cdk4 
Cdc2 
123456789 10 
Figure 4.3 Cyclin DI and Cdk4 proteins are both absent during the 
early embryonic cleavages, and become detectable following NIBT 
Cytosolic extracts from staged embryos were separated by SDS-PAGE. 
transferred to nitrocellulose, and immunublotted with affinity purified rabbit 
serum raised against bacterially expressed protein (a-c), or monoclonal 
hybridoma supernatant (d). as indicated 
0.5 embryo equivalents were loaded per lane 
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Figure 4.4 Cyclin D1 is detectable in immunoprecipitates from [35S]-methionine 
metabolically labelled WAK cells, but cyclin D2 is not 
Sub-confluent cells were metabolically labelled for 3 hours by incubation in 75 `/ (v/v) 
E4 culture medium (methionine-free) supplemented with 10(7, (v/v) dialysed foetal calf 
serum and 2(X) pCi 135S1-methionine per 15 cm diameter plate. Cells were lysed with 
1.5 ml per plate WAK lysis buffer (1% (v/v) NP40,150 mM NaCl, 20 mM EGTA. 50 
mM NaF, 50 mM Tris-Cl pH 8.0), then incubated with crude rabbit antiserum for 1 hour 
on ice. Bound proteins were purified using protein A-sepharose, washed three times with 
IP buffer, and then analysed by SDS-PAGE and autoradiography 
gastrulation (lane 5), cyclin D1 mRNA is easily detectable, though levels are still much 
lower than levels of mitotic cyclin mRNAs in the egg. Cyclin Dl mRNA remains present 
through neurula and tailbud stages (lanes 6 and 7), but levels have fallen somewhat by 
tadpole stage (lane 8). 
Cyclin D1 protein levels (figure 4.3a) essentially mirror those of the mRNA. The protein 
is not detected in the egg or in the embryo up to MBT (stage 8), but has accumulated 
significantly by stage 12 and remains present through to tadpole stages. This is in stark 
contrast to cyclin E protein, which is abundant during the early cleavages. but which is 
dramatically down-regulated around MBT (figure 4.3h), when maternal stockpiles of 
mRNA and protein are degraded. Cyclin E is then replaced by much lower levels of 
zygotic expression (Mike Howell, personal communication). During later development, 
accumulation of cyclin-E-associated kinase activity may he a rate-limiting step for entry 
into S phase, as it is in mammalian cells, and may thus contribute to the appearance of Gl 
in post-MBT embryos. 
Cyclin D1 was not detected by RNA blotting of adult tissues such as liver, muscle and 
skin (data not shown), but was found in Xenopus tissue-culture cell lines such as WAK 
cells and XTC cells (figure 4.2a). Figure 4.4 shows that cyclin Dl protein in W AK cells 
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is synthesised at a sufficient rate that after 3 hours metabolic labelling with [35S]- 
methionine, a labelled band corresponding to cyclin D1 is seen in anti-cyclin D1 
immunoprecipitates. Anti-cyclin D2 antibody can immunoprecipitate cyclin D2 from in 
vitro translations approximately as efficiently as the cyclin D1 antibody can 
immunoprecipitate cyclin D1 (data not shown). However, no band of a mobility 
corresponding in mobility to cyclin D2 is seen in immunoprecipitates from WAK cells 
using anti-cyclin D2 antibodies, though a weak band corresponding to cross-reacting 
cyclin D1 is seen. If cyclin D2 is expressed in these cells, it must, therefore, be only at a 
very low level relative to cyclin D1. 
Cdk4 mRNA levels remain fairly constant throughout development (figure 4.2b). 
However Cdk4 mRNA is probably not translated during oogenesis or pre-MBT 
development, since Cdk4 protein only becomes detectable after MBT (figure 4.3c). This 
type of translational control is common for Xenopus mRNAs (reviewed by Richter, 
1987). 
Cdc2 mRNA (figure 4.2c) and protein (figure 4.3d) are present throughout development, 
consistent with an essential role for Cdc2 in every cell cycle, throughout development. 
The drop in levels of actin mRNA around MBT (Figure 4.2d) is probably the result of 
maternal stockpiles of mRNA being destroyed and then gradually replaced by zygotic 
transcription, as is seen for many other mRNAs, including Xenopus pRb (Destrde et al., 
1992). Cyclin D1 and Cdk4 mRNAs are clearly not regulated in this way, however. 
Discussion 
The two known types of G1 cyclins in Xenopus show very different patterns of expression 
during development. Xenopus cyclin E protein is present at high levels during early 
cleavage but is down-regulated around MBT. In contrast, cyclin D1, and one of its 
putative kinase partners, Cdk4, are undetectable during cleavage but are expressed 
following MBT. 
Cyclin D2, if present at all, is expressed at extremely low levels throughout development. 
Xenopus cyclin D2 has been independently isolated by another laboratory (C. Jessus, 
personal communication), and this group confirms that cyclin D2 mRNA is extremely 
scarce in all tissues examined, and throughout development. 
Although many aspects of the cell cycle have been evolutionarily conserved in eukaryotes 
from yeasts to humans, the cyclins involved in the G1/S transition seem to be very 
different between higher and lower eukaryotes. Results from Drosophila, discussed in the 
introduction, suggest that an essential function for cyclin E in S-phase entry goes back 
evolutionarily at least as far as the common ancestor of arthropods and vertebrates. The 
role of cyclin D in Drosophila remains unexplored, however. The results of this chapter 
suggest that in vertebrates, cyclin D and cyclin E play very different roles in the cell cycle 
82 
in vivo, even though they have very similar effects when over-expressed in cultured cells 
(Ohtsubo and Roberts, 1993; Quelle et al., 1993; Resnitzky et al., 1994), and when 
negatively regulated by microinjection of antibodies into cultured cells (Baldin et al., 
1993; Ohtsubo et al., 1995). While cyclin E may be absolutely required for entry into S 
phase, D-type cyclins probably act in certain cells to couple the cell cycle to external 
signals. 
Mice lacking the cyclin D1 gene, although they exhibit certain minor histological 
abnormalities, appear to be basically healthy (Vera Fand, personal communication). This 
may reflect redundancy between the function of the three D-type cyclins identified in 
mammalian species. It will be very interesting to determine the phenotype of mice lacking 
multiple D-type cyclin genes. In S. cerevisiae, any one of the three CLN genes is 
sufficient to allow the cell cycle to continue. Is this the case with D-type cyclins? Higher 
eukaryotes have many more different cell types than yeast, each with its own distinctive 
pattern of gene expression, and G1 control is subject to far more complex regulation than 
it is in yeast. However since some cells express cyclin D1 as their only D-type cyclin, if 
cyclin D1 is not an essential gene then D-type cyclins cannot be indispensable for cell 
proliferation. 
Perhaps the D-type cyclins have a more specialised role. Two areas where cyclin D is 
thought to be important are the nervous system (see chapter 7 for in situ hybridization 
data), and the haematopoetic system (Matsushime et al., 1991). Both situations involve 
extensive regulated proliferation during development, followed by terminal 
differentiation. One highly speculative idea would be that D-type cyclins and associated 
molecules may be acting to control the proliferation of neural and lymphoid precursors, in 
such a way that proliferation can be reliably switched off as the cells differentiate. Given 
the close relationship between pRb and D-type cyclins, it is interesting to note that one of 
the main abnormalities which causes pRb gene-knockout mice to die in utero is not the 
excessive proliferation which might be expected, in view of pRb's perceived role as a 
growth suppressor, but rather aberrant cell death in the nervous and haematopoetic 
systems. 
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Chapter 5 
Interactions between Xenopus Cdk4, D-type 
cyclins and pRb in vitro 
During the cloning of cyclin D 1, cyclin D2 and Cdk4 from Xenopus, it became clear from 
work in mammalian cells that a likely target of Cdk4/cyclin D kinase was the 
retinoblastoma protein pRb. Cdk4/cyclin D complexes over-expressed in insect cells, 
together with pRb, induce hyper-phosphorylation of pRb, and D-type cyclins both 
physically bind to pRb in these cells, and co-immunoprecipitate with pRb from human 
cultured cells (Dowdy et al., 1993; Ewen et al., 1993a; Kato et al., 1993). Binding to pRb 
is dependent on a region at the N-terminus of the D-type cyclin molecule (Dowdy et al., 
1993), which fits the consensus sequence (L-x-C-x-E) for a pRb-pocket binding 
protein. This sequence is found in adenovirus 5 E1A protein, SV40 large T antigen, and 
human papilloma virus 16 E7 protein, and is required for their binding to pRb (Figge et 
al., 1988). pRb kinase activity (but not histone H1 kinase activity) has also been reported 
in cyclin D, Cdk4 and Cdk6 immunoprecipitates from cultured cell lines, after some 
initial technical difficulties (Kato et al., 1994b; Matsushime et al., 1994; Meyerson and 
Harlow, 1994). 
Evidence for the biological relevance of pRb/cyclin D binding comes from studies 
showing that expression of D-type cyclins can overcome the G1 cell-cycle block caused 
by expression of pRb in Saos-2 cells (Ewen et al., 1993a). Saos-2 cells normally do not 
express pRb, and when pRb is expressed exogenously, these cells arrest in G 1. 
Complementary results obtained by another group showed that in cell lines which do 
express pRb, cyclin D1 function is necessary for entry into S phase, but that this 
requirement can be overcome by inactivation of pRb, either by mutation or by expression 
of pRb-binding oncoproteins such as SV40 large T and adenovirus E1A (Lukas et al., 
1994; Lukas et al., 1995). 
Xenopus Cdk4 binds cyclin Dl and cydin D2 in vitro 
To measure the relative strength of physical association of cyclin D 1, cyclin D2, and 
Cdk4 with potential partners, I expressed the cDNAs in an in vitro translation system 
consisting of a 50: 50 (v/v) mixture of nuclease treated reticulocyte lysate and CSF 
extract. I used this mixture rather than pure reticulocyte lysate for the following reasons. 
" Immunoprecipitations carried out in pure reticulocyte lysate often result in artefactual 
associations - reticulocyte lysate seems to make proteins non-specifically "sticky". 
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" CSF provides frog proteins such as chaperones which may aid protein folding. Since 
frogs are cold-blooded animals, the different energetics of protein folding may 
demand different helper proteins from those found in reticulocyte lysate. 
" CSF contains high levels of CAK (Cdk activating kinase), which is required to 
activate Cdc2, Cdk2 and Cdk4 by phosphorylating threonine 161, or its equivalent. 
" CSF contains many endogenous translatable mRNAs including cyclins A, E and B, 
and these can serve as effective internal controls for many experiments. 
Pure CSF could not be used because it translates added mRNAs rather inefficiently unless 
some reticulocyte lysate is added. 
In Xenopus extracts the 5' and 3' untranslated regions can have a large influence on the 
efficiency of translation of an mRNA. To allow all mRNAs to be in vitro translated with 
similar efficiencies, the coding sequences of all genes were first sub-cloned into the 
ESP11 vector, as described in chapter 2. 
Initially, I used co-immunoprecipitation as my assay for in vitro binding. However, there 
is plentiful evidence that the ability of anti-Cdk or anti-cyclin antibodies to 
immunoprecipitate intact cyclin-Cdk complexes is very antibody-dependent (Kobayashi 
et al., 1992; Matsushime et al., 1994). Many antibodies recognise only the free form of 
the cyclin or the Cdk. Translating c-myc-tagged Cdk4 with cyclin D1 or cyclin D2 and 
immunoprecipitating with 9E10, an anti-c-myc antibody, a clear association was seen 
between Cdk4 and both cyclin D1 and cyclin D2 (figure 5.1), with cyclin D1 associating 
with Cdk4 more effectively than did cyclin D2 (figure 5. lb lanes 2,3). Human anti-cyclin 
D1 antibody (from Gordon Peters) also immunoprecipitated Cdk4/cyclin D complexes 
reasonably efficiently (figure 5.1b lane 1). However, the anti-cyclin D and anti-Cdk4 
antibodies which I raised against Xenopus proteins, although they immunoprecipitated 
unbound molecules efficiently, were unable to immunoprecipitate Cdk4/cyclin D 
complexes (data not shown). For this reason, I decided to use glutathione-affinity 
purification of GST-proteins and associated in vitro translated proteins as my main 
binding assay, and this produced reliable and reproducible results. Translations were 
carried out in the presence of GST-fusion proteins, since this was found to result in far 
more efficient formation of complexes than addition of fusion proteins after translation 
was complete. GST-fusions and associated proteins were purified using glutathione- 
Sepharose, and analysed by SDS-PAGE. 
Binding of GST-cyclins to translated Cdks 
Firstly, the binding of various translated Xenopus Cdks to GST-cyclin D1 and GST-cyclin 
D2 was compared (figure 5.2). Lanes 1-4 show that GST-cyclin D1 binds most efficiently 
to Cdk4, but also, more weakly, to Cdc2 and Cdk2. Lanes 5-8 show that GST-cyclin D2 
associates with Cdk4, although not as strongly as does cyclin D1, and cyclin D2 also 
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Figure 5.2 Translated Cdk4 associates with GST-cyclin DI and GST-cyclin D2 in vitro 
(a) Cdk mRNAs were translated in a 50: 50 (v/v) mixture o1 nuclease treated reticulocyte 
lysate and CSF extract, in the presence of GST-cyclins and 135S]-methiunine 
(h) GST-cyclin associated proteins were affinity purified using glutathione-sepharose 
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associates with Cdc2. GST-cyclin D2 does not bind binding to Cdk2 under these 
conditions. Lanes 9-12 show that association with GST-Cdks was specific and dependent 
on the Cdk moiety, since none of the translated Cdks bound significantly to GST itself. 
Binding of GST-Cdks to translated cyclins 
To confirm these results, a reciprocal experiment was performed, comparing the ability of 
Xenopus GST-Cdks to bind translated cyclins (figure 5.3). Lanes 1-5 show that, even 
when no cyclin mRNA is added, GST-Cdc2 and GST-Cdk2 associate with newly 
translated endogenous A- and B-type cyclins. Lanes 6-10 show that translated cyclin A 
strongly associates with GST-Cdc2 and GST-Cdk2, but not with GST-Cdk4 or GST- 
Cdk7. Translated cyclin D1 associates with GST-Cdk4, only more weakly with GST- 
Cdc2 and GST-Cdk2, and not at all with GST-Cdk7 (lanes 11-15). Cyclin D2 associates 
with GST-Cdc2, GST-Cdk2 and GST-Cdk4, all with relatively low efficiency, and does 
not associate at all with GST-Cdk7. 
GST-Cdk4/cyclin D1 complexes do not show kinase activity against 
histone 111, but this may result from misfolding of the GST-Cdk4 
Initially, to characterise the kinase activity of the Xenopus Cdk4 clone, I performed kinase 
assays on purified GST-Cdk/cyclin complexes, using either histone H1 or GST-pRb as a 
substrate (figure 5.4). A truncated human pRb "pocket domain" construct was used, as 
this was known to be a good substrate for Cdc2 and Cdk2, and is expressed in 
E. coli much more efficiently than the full length protein. 
GST-Cdk2, with or without translated cyclin A, served as a positive control. Lanes 5-6 
show that GST-Cdk2, when incubated in extract with no added exogenous cyclin mRNA, 
forms complexes with endogenous cyclins which are able to phosphorylate both pRb and 
histone H1. If cyclin A is translated in the presence of GST-Cdk2, it stimulates the kinase 
activity of Cdk2, including the phosphorylation of cyclins A and B. 
GST-Cdk4/cyclin D1 complexes did not phosphorylate histone H1 at all (lanes 12 and 
15). Only extremely low levels of pRb phosphorylation by Cdk4 are seen in lanes II and 
14, with cyclin D1 translation perhaps very slightly stimulating the pRb kinase activity of 
Cdk4. Similar experiments with cyclin D2 also failed to produce GST-Cdk4 associated 
kinase activity significantly above background levels. There are several plausible 
explanations for this. Xenopus Cdk4 may not fold correctly when expressed as a bacterial 
protein, Cdk4 may require an activator which is not present in CSF extract, or CSF 
extract miy 
., 
Cdk4 inhibitors. The first explanation seems most likely, in the light of 
subsequent experiments (below) which show that Cdk4 and cyclin D2 dependent pRb 
kinase activity can be purified physically associated with pRb from in vitro translations. 
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Figure 5.4 GST-Cdk4/cyclin D complexes do not have a comparable H1 kinase 
activity to GST-Cdk2/cyclin A complexes 
Cyclin mRNAs were translated in a 50: 50 (v/v) mixture of nucleased reticulocyte 
lysate and CSF extract, in the presence of GST-Cdks and [35S1-methionine. GST- 
Cdk associated proteins were affinity purified using glutathione-Sepharose. and a 
kinase assay was performed using histone H 1. pRh or no added substrate 
(a) GST-Cdk2 and no added cyclin (b) GST-Cdk2 and cyclin A1 (c) GST-Cdk4 and 
no added cyclin (d) GST-Cdk4 and cyclin D 1. 
The autoradiograph shows both I35SI-methionine and 132PI-phosphate labelling 
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Figure 5.5 Cyclin D1 and cyclin D2 both associate with pRb in vitro but only 
cyclin D2 can direct pRb phosphorylation in combination with Cdk4 
(a) D-type cyclins, alone, or in combination with Cdk4. were translated in ºvitro in 
a 50: 50 (v/v) mixture of nuclease-treated reticulocyte lysate and CSF extract, in the 
presence of GST-pRb and 135S1-methionine (h) GST-pRh and associated proteins 
were affinity-purified from the translations using glutathione-Sepharuse (c) GST- 
pRh associated Cdk/cyclin complexes were tested for pRh kinase activity by 
incubation with an excess of added GST-pRh and A32PI-ATP (d) Results of the 
kinase assay were quantitated by scanning densitometry of the resultant 
autoradiograph 
In lanes 8-10, the Cdk4-KR mutant was used in place cat wild-type Cdk4 
In lanes 11-13, translations included 50 µg/ml recombinant histidine-tagged human 
p 16 protein (a Cdk4 inhibitor) 
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Translated D-type cyclins physically associate with GST pRb, and cyclin 
D2 can direct pRb phosphorylation by Cdk4 
To test whether Xenopus cyclin D1 and cyclin D2 could bind to pRb, the cyclins were in 
vitro translated in the presence of the human GST-pRb pocket domain construct, and the 
GST-pRb was then affinity-purified using glutathione-Sepharose (figure 5.5 a, b). Lanes 3 
and 4 show that, translated alone, cyclin D1 and cyclin D2 associated with GST-pRb. 
Cyclin D1 reproducibly associated with GST-pRb significantly more strongly than did 
cyclin D2. Cdk4, on the other hand, translated alone, showed no affinity for GST-pRb 
(lane 5). When Cdk4 was translated in combination with cyclin D1 or cyclin D2, it was 
recruited by the D-type cyclins to the GST-pRb, forming a ternary complex (lanes 6 and 
7). When a kinase assay was performed on these purified complexes, adding an excess of 
GST-pRb as substrate, Cdk4/cyclin D2/GST-pRb (lane 7) were found to have significant 
pRb kinase activity, while Cdk4/cyclin D1/GST-pRb (lane 6) had no kinase activity 
above background. The Cdk4/cyclin D2 pRb kinase activity was unable to phosphorylate 
histone H1 (data not shown). To confirm that the pRb kinase activity was directly 
dependent on the activity of the Cdk4 kinase, the pRb kinase assay was also performed 
using Cdk4 which carried a point mutation in a key active site residue (lysine 33, which is 
a key part of the ATP binding site, was changed to an arginine). Although this mutant 
Cdk4 also formed a ternary complex together with either D-type cyclin and pRb, this did 
not result in the phosphorylation of pRb in either case (lanes 8-10). 
As a further check on the characteristics of the Cdk4/cyclin D2 kinase, the translations 
were carried out with wild-type Cdk4 but in the presence of histidine-tagged recombinant 
human p 16INK4 protein (a specific inhibitor of Cdk4 and Cdk6 in humans). When used in 
this way, p 16 was able to completely inhibit Cdk4/cyclin D2 kinase activity (lanes 11- 
13). It is clear from panel b however, that p16 is not achieving this inhibition by 
preventing Cdk4/cyclin D binding. Blocking physical association between p16 and cyclin 
D had been previously suggested as the mechanism of p16 function, but recently it has 
been suggested that p 16 is more likely to function by preventing CAK from activating 
Cdk4 (Kato et al., 1994a). This is consistent with my finding that p16 added directly to 
pRb kinase assays is not able to efficiently inhibit Cdk4/cyclin D2 kinase (data not 
shown). According to this model, if Cdk4 has already been phosphorylated by CAK 
during the in vitro translation then adding p16 subsequently will not be able to inhibit 
Cdk4 kinase activity. 
91 
Added fusion protein His 10-tagged p16 
Added mR NA 
-Mjmý "Mo. -aw - '. *00 SOW lwrw 
Translation 
am 
Purification on 
Nie+-agarose 
34 
Figure 5.6 p16 associates in vitro with Cdk4, but not with cyclin D1 or cyclin D2 
(a) Cdk4 or D-type cyclin mRNAs were translated in a 50: 50 (v/v) mixture oC nucleased 
reticulocyte lysate and CSF extract, in the presence of His1o-p16 and 135S1-methiunine 
(b) His 1 o-p 16 and associated proteins were affinity-purified using Ni'+-agaruse 
p16 binds specifically to Cdk4 but not to cyclin Dl or cyclin D2 
Direct association between human p 16 and Xenopus Cdk4 was demonstrated by in 
vitro translating Cdk4 or D-type cyclin in the presence of His-tagged p 16 and then 
affinity-purifying the His-tagged p 16 using Ni'+-agaruse (figure 5.6). Cdk4 co- 
precipitates with p 16 under these conditions (lane 4), unlike either cyclin DI or cyclin D2 
(lanes 2-3). 
Truncation of the cyclin D1 sequence prevents association with Cdk4 
Although the crystal structure of the Cdk2 molecule was obtained some time ago (De 
Bondt et al., 1993), no cyclin X-ray crystal structures had been reported while I was 
carrying out my doctoral work. I was therefore interested to determine whether a small 
fragment of cyclin D could be found which would retain the ability to bind Cdk4, as 
finding such a core fragment might aid crystallisation. 
The conservation between the different families of cyclins is almost entirely restricted to 
the 1(X) amino acid region known as the cyclin box, yet cyclins which are extremely 
evolutionary divergent retain the ability to functionally interact with p34C! )C28 in 
S. cerevisiae. For this reason it is surprising that, in general, the minimum size of a cyclin 
fragment that will bind Cdks seems to be around 25 kDa. Xenopus cyclin A is 419 amino 
acids long, but N-terminal truncations of more than around 161 amino acids, or C- 
terminal truncations of as little as 12 amino acids totally prevent binding to Cdc2 and 
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Cdk2 (Kobayashi et al., 1992; Stewart, 1994). D-type cyclins are around the same size as 
the smallest cyclin A sequence known to bind Cdks, and I decided to check whether 
significant deletions could be made to D-type cyclins, while still retaining the capacity to 
bind Cdk4. 
D-type cyclin sequences show fairly high conservation across their entire 300 amino acid 
sequence. The cyclin box is most strongly conserved between the different D-type 
cyclins, but about 100 amino acids of flanking region is conserved almost as strongly. 
The N- and C-terminal regions show significantly more divergence. PCR was used to 
make a C-terminal deletion (cyclin D1 AC) and an N- and C-terminal double deletion 
(cyclin DIANAC) of cyclin D1, removing the less strongly conserved flanking regions 
(figure 5.7a). The deletions were sub-cloned into the Pet2lb expression vector, which 
adds a C-terminal tag of six histidine residues. A His6 tag, rather than a GST tag, was 
used so as to keep the proteins as small as possible, but since Xenopus cyclin D1 is very 
insoluble when expressed as a histidine-tagged protein, the recombinant proteins had to 
be purified in denatured form, and then renatured by rapid dilution. Samples of the 
resultant purified proteins, separated by SDS-PAGE, are shown in figure 5.7b. While full 
length histidine-tagged cyclin D 1, like histidine-tagged p16, was able to form a complex 
with Cdk4 in in vitro translations which could be purified on Nie+-agarose, neither cyclin 
D 10C nor cyclin D 10NAC was able to bind Cdk4. The emergent result from all the 
deletion experiments carried out with cyclins is that although only the cyclin box region is 
strongly conserved between different families of cyclins, within each family extensive 
sequence outside the cyclin box is necessary for Cdk binding. The crystal structures for 
cyclins and cyclin/Cdk complexes which have very recently been obtained (Jeffrey et al., 
1995; Jane Endicote and Tim Hunt, personal communication) should allow a much better 
understanding of the cyclin box, and why it is in itself insufficient to promote Cdk 
binding. 
Cyclin Dl and p27KiPl 
One further aspect of the in vitro behaviour of Xenopus cyclin D1 was investigated in 
collaboration with Ulrich Strausfeld. He showed that GST-cyclin D1 was able to rescue 
DNA replication activity in Xenopus activated egg extracts which had been inhibited by 
addition of recombinant p27KiP1 Cdk inhibitor although, unlike cyclin A (Strausfeld et 
al., 1994), it had no effect on extracts inhibited by depletion with pl3sucI (data not 
shown). A likely explanation for this rescue, in line with the model proposed by Kato et 
al. (1994a) for the ability of Cdk4 over-expression to overcome p27KIPI mediated TGF- 
inhibition of growth, is that cyclin D or Cdk4-cyclin D complexes, by titrating out the 
p27KiP1 inhibitor, relieve the inhibition of Cdk2-cyclin E complexes, which are essential 
for entry into S phase (Fang and Newport, 1991; Jackson et al., in preparation; Strausfeld 
et al., in preparation). 
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Figure 5.7 Truncated forms of cyclin D1 do not bind to Cdk4 translated in vitro 
(a) schematic representation of deletion mutant constructs, expressed in Pct? lh 
(h) purified samples of renatured His6-tagged cyclin Dl proteins, separated by SDS- 
PAGE and stained with Coomassie blue 
(c) in vitro translation cif Cdk4 in 50: 50 (v/v) nucleased reticulocyte lysate/CSF extract, 
in the presence cal His(, -tagged cyclin Dl constructs or Hisf, -p 16, followed by 
purification of associated proteins with Ni-+-agarose 
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Discussion 
The two Xenopus D-type cyclins described here can both associate in vitro with Xenopus 
Cdk4. Although both cyclins also physically associate with pRb in vitro and can recruit 
Cdk4 to pRb, only cyclin D2 is able to direct Cdk4-mediated phosphorylation of pRb. 
The results of the GST-fusion protein binding assays support the idea that D-type cyclins 
themselves are promiscuous in the Cdks with which they will associate, while Cdk4 is 
highly specific and binds exclusively to D-type cyclins. There is a slight inconsistency in 
the above results, since GST-Cdk2 weakly binds translated cyclin D2 but GST-cyclin D2 
does not seem to bind translated Cdk2. Of these results, the former is probably more 
trustworthy, since GST-cyclin D2 was problematic to express and purify, and the small 
amount which was ultimately obtained was at a low concentration (0.25 mg/ml) and was 
badly degraded, possibly explaining why Cdk2 binding was not seen. 
D-type cyclins have been reported to associate with many different Cdks in vivo, 
including Cdc2, Cdk2, Cdk4, Cdk5 and Cdk6 (Matsushime et al., 1992; Xiong et al., 
1992; Zhang et al., 1993; Bates et al., 1994; Meyerson and Harlow, 1994). These findings 
are supported by the in vitro results reported in this chapter. However, the in 
vitro promiscuity of D-type cyclins does not extend to all Cdks. D-type cyclins do not 
bind in vitro to Xenopus Cdk7, the catalytic subunit of CAK, which in vivo is found 
associated exclusively with cyclin H (Fisher and Morgan, 1994). Strangely, Katsumi 
Yamashita in our laboratory isolated human cyclin D3 by two-hybrid screening using 
Cdk7 as bait, but was also unable to show any interaction between the Cdk7 and cyclin 
D3 when translated in vitro. It remains to be seen whether the two-hybrid result has any 
in vivo significance. 
The efficient binding of Xenopus cyclin D1 to pRb in vitro contrasts with the behaviour 
of human cyclins D1, D2 and D3 (Ewen et al., 1993a; Kato et al., 1993). Human cyclins 
D2 and D3 have been reported ( bind pRb more efficiently than does cyclin D 1, both in 
in vitro translations and when co-expressed in insect-cells. This difference may be related 
to the "HQ" insertion at the N-terminus of human cyclin D1, which is not present in the 
frog homologue (figure 3.6). However, Dowdy et al. (1993) report that cyclin D1 and 
cyclin D3 are both present in pRb immunoprecipitates from human diploid fibroblasts. 
Physical association with pRb, and pRb-specific kinase activity need not be absolutely 
correlated, and might even represent distinct functions for D-type cyclins. For instance, 
although cyclin D1 does not physically associate with pRb when over-expressed in insect 
cells, it can direct Cdk4 dependent phosphorylation of pRb in that system (Dowdy et al., 
1993; Kato et al., 1993). Furthermore, pRb kinase activity has been found associated with 
cyclin D1 and Cdk4 immunoprecipitates by several groups (Matsushime et al., 
1994). (Meyerson and Harlow, 1994). In contrast, substrates such as histone H1 do not 
seem to associate with mitotic cyclin/Cdk complexes. 
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Also, although over-expression of cyclin E, cyclin D1 or cyclin D3 is able to override 
pRb inhibition of the cell cycle in Saos-2 cells, only cyclin E causes a detectable change 
in the phosphorylation state of pRb. Cyclin D1 and cyclin D3 in this system exert their 
effect without causing pRb hyper-phosphorylation (Hinds et al., 1992; Kato et al., 1993). 
One suggested explanation for the ability of exogenous cyclin D1 to overcome pRb 
function is that cyclin D1 may have a function downstream of pRb, and that pRb may 
inhibit this function by sequestering cyclin D 1. Dowdy et al. (1993) argue that this is 
supported by their result that an N-terminal mutant of cyclin D1, which has a reduced 
affinity for pRb, is more active in their assay for the rescue of Saos-2 cells from pRb 
induced G1 arrest. However, a downstream function for cyclin D1 is difficult to reconcile 
with the results of Lukas et al. (1994,1995), which suggest that the G1 requirement for 
cyclin D1, assayed by microinjection of anti-cyclin D antibodies, is entirely bypassed in 
cells which either lack pRb, carry pRb mutations or have pRb inactivated by viral 
oncoproteins. The phenotypes of knockout mice also suggest that the role of pRb in the 
cell cycle is more absolutely necessary than that of cyclin D1. Whereas pRb-deficient 
mice die in utero at 14-15 days (Clarke et al., 1992), cyclin D1 knockout mice are viable 
and apparently healthy (V. Fantl, personal communication). 
The respective roles of pRb and D-type cyclins thus remain frustratingly unresolved. 
However, the evidence for the existence of some link between D-type cyclin function and 
pRb is reinforced by the transcriptional control of cyclin D1 by pRb. In human cells, 
cyclin D levels are generally very low in cells deficient for pRb, and exogenous 
expression of wild-type, but not mutant, pRb strongly stimulates cyclin D transcription 
(Hinds et al., 1992; Lukas et al., 1994). 
The in vitro results of this chapter add to the large body of existing evidence that D-type 
cyclins and pRb functionally interact. They also compound the uncertainty about whether 
Cdk4-mediated phosphorylation of pRb is the crucial aspect of this regulation. 
Xenopus pRb has been cloned (Destree et al., 1992), and the mRNA is reported to be 
present throughout development. Levels of pRb protein are very low until after MBT 
however. It would be interesting to know whether the microinjection of pRb into 
fertilized eggs would interfere with S-phase entry during the cleavage phase of 
development, since cyclin D absence is absent at that time. 
Recent work in yeast may provide some clues as to the relative roles of cyclin D and 
cyclin E in the regulation of the cell cycle via pRb. Surprisingly, when mammalian pRb is 
expressed in S. cerevisiae, its phosphorylation state varies through the cell cycle, much as 
it does in mammalian cells, even though no endogenous equivalent of pRb is known in 
yeast (Hatakeyama et al., 1994). The cyclic phosphorylation of pRb is dependent on the 
presence of two Clns (Cln3 and either Cln 1 or Cln2), even though only a single Cln is 
needed for viability. Crucially, Hatekayama and colleagues found that cyclin D1 could 
substitute for the Cln3 requirement and cyclin E for the Clnl/C1n2 requirement but not 
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vice versa. The expression of Cln3, which remains high in actively growing cells, and that 
of On 1 and Cln2, which vary periodically through the cycle, also mirror D- and E-type 
cyclins, respectively. Moreover, it has been shown that Clns, acting in yeast, and cyclin E, 
acting in Drosophila, must accumulate before the mitotic-cyclin destruction pathway is 
turned off to allow the accumulation of A- and B-type cyclins needed for the G2/M 
transition (Knoblich and Lehner, 1993; Amon et al., 1994). Cins and animal G1 cyclins 
are extremely evolutionarily divergent, but their functions may be more closely related 
than was first thought. 
In Xenopus, it would be interesting to know to what extent Cdk4-kinase activity is 
necessary for the regulation of post-MBT cell cycles. Is the presence of cyclin D1 
sufficient in itself to overcome the effect of pRb, or is active Cdk4 kinase required too? In 
the cultured cells in which this has so far been tested, expression of kinase-dead Cdk4 has 
not had a dominant-negative effect on the cell cycle (van den Heuvel and Harlow, 1993), 
but the early embryo is a very different system. For this reason, I asked whether 
microinjection of dominant-negative Cdk4 or specific Cdk4 inhibitors such as p16 could 
disrupt the regulation of post-MBT cell cycles. 
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Chapter 6 
Embryological experiments 
Comparison of induction of cydin D1 in isolated animal caps and in 
intact embryos at MBT 
Animal caps taken from Xenopus embryos at around stage 8 provide a useful assay for 
mesoderm induction. Although the animal region of a stage 8 embryo is normally fated to 
become ectodermal tissue, it is competent to respond to induction by vegetal cells, though 
the vegetal cells normally act to induce the cells of the marginal zone. Induction of animal 
caps causes numicKing the movements of convergent extension during normal 
gastrulation (Sudarvarti and Nieuwkoop, 1971). Isolated animal caps will also respond to 
certain growth factors in a similar way. Factors capable of inducing mesoderm include 
activin (one of the TGF family of growth factors) (Smith, 1987) and FGF (fibroblast 
growth factor) (Slack et al., 1987). 
Cyclin D1 expression is known to be induced in macrophage precursor cells by the 
proliferation- and differentiation-inducing factor CSF-1 (Matsushime et al., 1991). 
Recently it has been suggested that cyclin D expression does not correlate in a 
straightforward way with proliferation. Cyclin D1 is found to be up-regulated in 
macrophage-precursors induced to differentiate by TPA, even though this treatment 
causes dramatic down-regulation of mitotic cyclins and Cdk2, and a dramatic slowing of 
the cell cycle (Bürger et al., 1994). My preliminary results indicated that cyclin D1 was 
not expressed universally in the developing frog embryo, so I was interested to see 
whether there was any difference between the accumulation of cyclin D1 in intact 
embryos and in isolated animal caps, with or without exposure to mesoderm-inducing 
factors. 
The results of this experiment are shown in figure 6.1. Lanes 1-3 show that cyclin D1 
protein is absent or present only at low levels prior to the mid-blastula transition. The 
weak band present in all three lanes which co-migrates with in vitro translated cyclin D1 
is almost certainly part of the non-specific background staining seen on this blot. Previous 
developmental blots with the same antibody repeatedly showed that cyclin D1 protein 
only appears following MBT (chapter 4). Lanes 4-6 show that cyclin D1 protein is 
detected in approximately equal quantities in stage 13 embryos and in equivalent staged 
animal caps, and the accumulation of cyclin D1 protein is not influenced by mesoderm 
induction by FGF or activin. The effectiveness of mesoderm induction by FGF and 
activin was readily assayed visually by the elongation of the animal caps which occurs, 
modelling convergent extension. This response also served as an important control for the 
98 
viability of the animal caps, since the failure of dead animal caps to express cyclin D1 
would not have been of great interest. 
The fate of isolated animal caps, if not induced to form mesoderm, is to develop into 
disorganised epidermis-like tissue (Dawid, 1991). The results described above show that 
this default developmental pathway for isolated caps involves cyclin D1 expression 
following MBT, even though neither mesoderm induction nor neural induction take place. 
Either cyclin D1 expression is being induced by other extra-cellular signalling events 
early in the development of non-induced animal cap tissue into atypical epidermis, or else 
perhaps cyclin D1 expression is switched on by default in the majority of embryonic 
tissues post-MBT, and selectively down-regulated where it is inappropriate. This down- 
regulation may not occur in isolated animal caps. Results of cyclin D1 mRNA in 
situ hybridizations (described in the next chapter) imply that complex regulatory 
mechanisms must exist to produce the intricately restricted pattern of cyclin D1 mRNA 
expression seen in later embryos. 
Further work might be done to examine whether the expression level of cyclin D1 can be 
affected by using different concentrations of activin for induction. The type of 
mesodermal tissues into which animal caps differentiate is highly dependent on the exact 
concentration of activin used (Green et al., 1992). Also, in situ hybridization studies of 
induced animal caps at later stages of development would show whether, in the complex 
set of tissues produced by induction of intact animal caps, cyclin D1 tends to be restricted 
to one tissue type rather than another, providing an experimentally manipulable system 
for the study of the localisation pattern of cyclin D1 mRNA. 
Cdk4 activity is not essential for normal development following the mid- 
blastula transition 
The results of the expression studies described in Chapter 4 showed that Cdk4 and cyclin 
D1 both become detectable as proteins shortly after the mid-blastula transition. While it 
did not seem likely that ectopic expression of cyclin D1 or Cdk4 would have a significant 
effect on the early embryonic cleavages, I wanted to establish whether by blocking 
activation of Cdk4, we might be able to influence the post-MBT cell cycle, or any other 
aspect of the developmental process. In addition to the evidence from the study of D-type 
cyclins and Cdk-inhibitors, direct evidence has been found for the importance of down- 
regulation of Cdk4 to the growth inhibitory effect of TGF-ß on mink lung epithelial cells 
(Ewen et al., 1993b). 
To check for effects of Cdk4-inhibition on the post-MBT cell cycle, the same translatable 
kinase-dead mutant was used as for the kinase assay in the previous chapter. The 5' and 
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Figure 6.1 Cyclin D1 is induced in isolated animal caps whether or not they are 
induced by activin or fibroblast growth factor 
Animal caps were dissected at stage S, and allowed to develop in Ix MBS, supplemented 
where appropriate with an inducing factor. Cytosolic extracts were made from eggs. from 
stage 8 embryos before and after taking animal caps, from stage 13 embryos. and from 
animal caps which had been allowed to develop to the equivalent of stage 13, either with 
no growth factors, with activin (16 U/ml), or with FGF (0.5 pi ml). Extracts were 
immunoblotted using affinity-purified antibody to cyclin D 1.0.5 embryo equivalents 
were loaded per lane for embryo extracts, and an equivalent amount of total protein, as 
judged by Coomassie blue staining, was loaded for animal cap extracts. Lane 4 contains 
in vitro translated cyclin D1 protein 
3' UTRs in the vector ensured that unlike endogenous Cdk4 rRNA. the exogenous Cdk4 
mRNA was translated during the early cleavages, and has accumulated to high levels by 
MBT, when endogenous Cdk4 transcription begins. 
Embryos were microinjected with c-myc Cdk4-KR kinase dead mutant, with wild-tx he ,- 
mvc Cdk4, and with a non-binding kinase-dead Cdk4 mutant named e-myc Cdk4-KRRA. 
In the non-binding mutant, the arginine residue (R55) of the PSTAIRE motif 
which is highly conserved amongst cyclin-dependent kinases and required for cyclin 
binding (Brambilla et al., 1991) was mutated to an alanine. A GST-version of the K33R- 
R55A mutant, made in parallel to a sample of wild-type GST-Cdk4. was unable to bind 
translated D-type cyclins in vitro (data not shown). Since this mutant did not interact with 
cyclins, it would not he expected to have a dominant-negative effect and so it served as a 
negative control. 
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Figure 6.2 Both wild-type and dominant-negative-mutant Cdk4 mRNAs are 
expressed at high levels when microinjected into embryos 
50 nl T7 in vitro transcribed mRNA at 0.2 mg/ml was injected into each cell of two cell 
stage embryos. Development was then allowed to continue at 18 'C. Samples of embryos 
were taken at stage 11.5 and stage 15, and immunuhlutted using either (a) 9E 10 
monoclonal anti c-myc antibody, or (h) affinity-purified anti-Cdk4 rabbit serum 
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Figure 6.2 show immunoblots of embryos at various stages after the injection of two cell 
stage embryos with wild-type c-myc Cdk4, c-myc Cdk4-KR, or c-myc Cdk4-KRRA. 
Panel a is an immunoblot using the 9E10 anti-c-myc antibody and shows that levels of the 
exogenous tagged proteins are high both during gastrulation (lanes 2-4), and during early 
neurulation (lanes 6-8). Panel b is an immunoblot with the anti-Cdk4 affinity-purified 
antibody, and shows the relative quantities of endogenous and exogenous Cdk4 present in 
embryos following injection. Lane 1 shows that in the original uninjected egg, no Cdk4 
protein was detectable. Lanes 2-5 and 6-9 show that during gastrulation and early 
neurulation, endogenous Cdk4 was detectable (the lower band, which is present in lanes 2 
and 6, the buffer-injected samples). However, in lanes 3-5 and lanes 7-9, levels of 
exogenous c-myc tagged Cdk4 are around 5-10 fold higher than those of endogenous 
Cdk4. Sufficient Cdk4 was expressed that one might have expect to see some dominant- 
negative phenotype.,, were Cdk4 kinase function vital to development at this stage. 
Unfortunately, it was not possible to measure Cdk4-associated kinase activity in embryos 
expressing the putatively dominant-negative Cdk4 kinase, since, as mentioned in 
chapter 5, the Cdk4 antibody used in the course of this work was unable to 
immunoprecipitate Cdk4-cyclin D complexes. However, the levels of expression of 
injected Cdk4 mutant mRNAs, together with the in vitro comparison, described in chapter 
5, between the kinase activity of Cdk4-KR and wild-type Cdk4, give grounds for 
reasonable confidence that the injected Cdk4-KR had a kinase-inhibiting effect. Despite 
this, no obvious differences in the course of development were seen between buffer- 
injected, Cdk4-injected, Cdk4-KR-injected and Cdk4-KR-RA-injected embryos. 
Depending on the batch of eggs used, the trauma of microinjection resulted in lethality for 
between 5% and 25% of embryos, but this applied equally to mRNA injected and buffer- 
injected embryos. 
The microinjection of Hislp-tagged human p16, a Cdk4/Cdk6 kinase inhibitor, into two 
cell stage embryos, also produced no readily observable developmental changes, 
consistent with the hypothesis that, even in post-MBT embryos, Cdk4 function does not 
seem to be essential for normal development. 
Microinjections have also been performed by Jean Gautier (Roche Institute of Molecular 
Biology, New Jersey) using his own dominant-negative constructs based on my 
Xenopus Cdk4 cDNA clone (personal communication). He too observed no significant 
effects on the course of development. 
Cdk4 activity, unlike Cdc2 activity, is not required for maturation of 
oocytes in response to progesterone 
Angel Nebreda (ICRF, Clare Hall) performed microinjections of mRNA for Cdk4, 
dominant-negative Cdk4 and cyclin D1 into immature oocytes, to ask whether Cdk4 
associated kinase activity is required for oocyte maturation is response to progesterone. 
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Again, the injected proteins were expressed at high levels, as measured by western blots 
several hours after microinjection. However, none of these microinjected molecules either 
retarded or advanced the response of oocytes to progesterone. This contrasts with the 
results seen following microinjection of dominant-negative Cdc2 mRNA or protein into 
immature oocytes, which prevents maturation in response to progesterone by most 
oocytes (Furuno et al., 1994; Nebreda et al., submitted). 
Discussion 
In human cultured cells, supporting these results, dominant-negative Cdk4 expression was 
found to have no significant effect on the cell cycle (van den Heuvel and Harlow, 1993). 
However, p16 and similar INK4 type Cdk-inhibitors have been reported to cause pRb- 
dependent cell cycle arrest in G1 when expressed in mammalian cell lines (Guan et al., 
1994; Hirai et al., 1995), suggesting either that cell-cycle regulation differs greatly 
between mammalian cells and cleavage stage frog embryos, or that microinjected human 
p16 is not able to effectively inhibit the frog homologue of the kinase whose inhibition 
causes p16-dependent G1 arrest in mammalian cells. The results reported in chapter 5 of 
this thesis indicate that human p16 can inhibit Cdk4. It is formally possible that members 
of the Cdk4/Cdk6 kinase sub-family remain to be discovered in Xenopus, which will 
cause cleavage stage cell-cycle arrest when inhibited. However, this seems unlikely. 
It remains possible that dominant-negative Cdk4 and human p16 have subtle effects on 
the Xenopus cleavage stage embryonic cell cycle. Many of the morphogenic processes of 
development proceed correctly, even when the cell cycle has been completely blocked 
using aphidicolin (Harris and Hartenstein, 1991; Rollins and Andrews, 1991), so it is 
quite possible that injected embryos, though superficially normal, contain fewer cells than 
usual. Whether this is the case could be established by further work using time-lapse 
video comparison of injected and control embryos, or by comparing cell numbers. 
Cyclin Dl in situ hybridization 
Since cyclin D1, unlike other cyclins, is absent during early cleavages, but appears later in 
development, it is natural to ask where and when it is expressed during later stages. Does Ole 
it appear uniformly across embryo, suggesting a role as a house-keeping gene in all cells 
other than the highly atypical cells of the cleavage-stage embryo, or is it localised to 
specific regions, implying either that different cell types make use of different D-type 
cyclins, or that D-type cyclin function is not required by all cells, but correlates with the 
choice of particular developmental pathways? 
To address this question, I used the whole mount mRNA in situ hybridization technique, 
as optimised for Xenopus by Richard Harland (Hemmati-Brivanlou et al., 1990; Harland, 
199 1). Digoxygenin-labelled T7 in vitro transcribed anti-sense mRNA is used as a probe 
which hybridizes to mRNA in the embryo. The signal can then be detected with an anti- 
digoxygenin antibody coupled to alkaline phosphatase, using a substrate such as 
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Figure 6.3 Original i hole mount in situ hybridisations 
All embryos are stage 31 (a) cyclin DI sen-ýc Pýýe 
tneýhýe coýýýl) (c) cyclin Dl antisense probe kc1oseup) 
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Figure 6.4 Cyclin D1 mRNA distribution during early development 
RNA Not prohed for cyclin D 1.10 tg total ernhryunic RNA per lane 
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NBT/BCIP (nitro blue tetrazolium/5-bromo-4-chloro-3-indolyl-phosphate) which is 
converted by alkaline phosphatase into an insoluble blue/black precipitate. 
Initial results were encouraging. The anti-sense cyclin D1 probe seemed to give 
significant, though weak, staining in the eye and other anterior regions of tailbud stage 
embryos (figure 6.3 a, c). This staining was absent in the control embryos (figure 6.3 b), 
which had been hybridized with cyclin D1 sense mRNA. 
The staining was much weaker than I obtained with highly localised positive-control 
probes such as the cement gland specific marker XA-1 (Hemmati-Brivanlou et al., 1990) 
(data not shown). Reproducing the staining patterns originally seen with the cyclin D1 
probe initially proved difficult because, after extended staining with NBTBCIP, the 
cyclin D1 signal was still only just above the background level of staining due to 
endogenous alkaline phosphatases. Also, extended staining often resulted in precipitation 
of unreacted (pink) NBT. This pink precipitate would then turn blue when the embryos 
were transferred to bleach solution to remove pigmentation. To try to confirm whether the 
cyclin D1 staining which had been seen was genuine or artefactual, RNA blotting was 
performed to compare the amount of cyclin D1 mRNA in the head and body regions of 
tailbud stage embryos (figure 6.4). Disappointingly, it seemed that the head and body 
regions of these embryos contained comparable amounts of mRNA, normalised for 
ribosomal RNA content. In combination with the background problems, this initially 
dissuaded me from further work on the localisation for cyclin D1. 
However, during the course of my Ph. D., a new proprietary substrate for alkaline 
phosphatase became available from Boehringer Mannheim (BM purple AP-substrate, 
precipitating #1442 074), and when I repeated my in situ hybridizations with this 
substrate, the background signal was greatly reduced and the problem of precipitation of 
unreacted substrate was eliminated. As a result, I was able to do a much more extensive 
survey of the expression pattern of cyclin D1 and other cell-cycle related genes during 
early Xenopus development, as described in the next chapter. 
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Chapter 7 
In situ hybridization experiments 
Detailed cyclin D1 mRNA localisation 
One potential problem with the use of in situ hybridization to localise mRNAs is that it 
gives only qualitative information about where the mRNA is present. It may fail to detect 
widespread, low-level, but functionally significant gene expression, which can be 
detected by blotting experiments. This may explain the results from the previous chapter, 
showing that significant amounts of cyclin D mRNA can be detected in the bodies of 
tailbud stage embryos by RNA blotting, even though the majority of in situ hybridization 
staining appears to be in the head. Another problem with in situ hybridizations is that 
protein levels are of primary interest, but these do not necessarily correlate directly with 
mRNA levels. However, in mammalian cultured cells, D-type cyclins have very short 
half-lives, and protein levels do seem to mirror mRNA levels (Matsushime et al., 1992). 
Since neither of these problems seemed to preclude obtaining meaningful results ,I 
returned to my in situ hybridization experiments and repeated them in more detail, using 
the Boehringer Mannheim proprietary substrate. 
Figure 7.1 shows Xenopus embryos from various stages of development in situ hybridized 
with antisense cyclin D1 probe. The photographs shown were compiled from two 
separate in situ hybridization experiments, which both used the same time-series of 
formaldehyde-fixed embryos. Both experiments produced very similar results, but the 
embryos were bleached to different extents. Extensive bleaching, in one experiment, 
allowed the signal to be seen most clearly (bleaching did not seem to cause significant 
loss of signal strength), but leaving some pigment unbleached, in the other experiment, 
had the advantage of making the detailed morphology of the embryos more apparent. 
Gastrulation 
During gastrulation, as cyclin D1 mRNA is fast becoming detectable by northern 
blotting, diffuse cyclin D1 staining in whole mounts is seen in the vegetal hemisphere of 
the embryo, in an arc spanning somewhat more than 120° (figure 7.1a-d). Embryos 
hybridized with sense probe as a negative control are shown in figure 7.2. 
In bleached embryos such as these, it is difficult to be sure of the dorso-ventral orientation 
of early gastrula stage embryos. One means of establishing whether the cyclin D1 staining 
is dorsal or ventral would be to co-stain with a probe against an mRNA known to be 
expressed in the dorsal region of the gastrulating embryo, such as Snail (Essex et al., 
1993), or more simply, to establish the dorso-ventral polarity of the stained embryo 
before bleaching. 
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The expression of cyclin D1 seen at this stage is quite weak in comparison with 
Brachyury staining carried out in parallel (figure 7.4a), and less tightly restricted than the 
expression of mesodermal genes such as Snail and Brachyury, which are expressed only 
in tissue which has involuted past the dorsal lip (Essex et al., 1993). Interestingly, 
however, like both Snail (Essex et al., 1993) and Brachyury (Smith et al., 1991; this 
thesis), cyclin D1 is expressed at later stages in the tailbud (compare figure 7.4d and 
figure 7.1u). Although the expression pattern of cyclin D1 during gastrulation is very 
different from those of Snail and Brachyury, its expression in the tailbud may likewise 
reflect the biochemical similarity of the processes of gastrulation and tailbud elongation. 
Neurulation 
At the end of gastrulation and the onset of neurulation (figure 7.1e-h), cyclin D1 staining 
is more restricted, appearing in a wedge at the extreme anterior of the embryo, at the 
anterior edge of the region which will become the neural plate. Some weaker staining is 
also seen in regions slightly more dorsal and posterior. 
In later neurula stages (figure 7.1i-1), staining is seen in a bilaterally symmetric pattern on 
either side of the neural plate, with a distinct sub-division into a lower and an upper band 
of staining. Simultaneous staining with further molecular markers would be necessary to 
establish for certain whether these regions of staining correspond to midbrain or 
forebrain. Further staining is also visible at this stage extending along the neural tube, 
which is in the process of formation (figure 7.1i, k). 
Tailbud stages 
By stage 25-26 (very late neurula, just pre-tailbud, figure 7.1 m, n), cyclin D1 mRNA 
shows striking localisation to a subset of anterior cells, some of the main regions of 
staining being: 
-Embryonic eye primordia 
-Neural crest 
"Anterior neural tube (strong staining) 
"Posterior neural tube (weak staining) 
"Tailbud 
This staining is more extensive than is seen for a neural crest marker such as Slug 
(Krotoski et al., 1988), or for a marker of commitment to neuronal differentiation, such as 
Delta (Chitnis et al., 1995). The staining is distinct, although similar to, and overlapping 
with, the expression pattern seen for a gene expressed in all neurogenic ectoderm, such as 
Notch (Coffman et al., 1990). The strongly localised cyclin D1 staining in the retina is 
particularly striking, and unusual. Together with the known links between pRb and cyclin 
D1, it goes some way towards suggesting a possible mechanism through which the loss of 
a copy of the Rb gene predisposes humans to childhood retinoblastomas, rather than to 
any other type of cancer. Cell proliferation and differentiation continue in the human 
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Figure 7.5 Sections of cyclin D1 mRNA whole mount in situ hybridized stage 35- 
36 embryos 
(a)-(d) serial cross-sections along the anterior-posterior axis in the region of the 
developing eye, showing staining of the eye, neural tube, and the region behind the 
cement gland, although not the cement gland itself (e) sagittal section showing staining in 
the eye, branchial arches and otic vesicle (1) horizontal section, showing staining in the 
branchial arches. 
Since the embryos were hybridized as whole-mounts, penetration of the probe 
throughout each section is not complete. and staining is predominantly limited to the 
marginal regions. 
Labelling: rt=retina, cg=cement gland, nt=neural tube, ot=otic vesicle, hr=hranrhial arches 
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retina for several years after birth (Gilbert, 1994), so the development of the eye and the 
occurrence of hereditary retinoblastomas, which are most common in early childhood, are 
close together in time. However, mice do not experience any increase in retinal tumours 
when heterozygous for pRb, though the prevalence of other types of tumour does increase 
(Clarke et al., 1992; Jacks et al., 1992). 
Sections of whole mount in situ hybridized embryos at various tailbud stages are shown 
in figure 7.5. Expression can also be seen in the developing eye, around the otic vesicle, 
and in the most dorsal region of the neural tube, and in migrating cells of the neural crest. 
Unfortunately, when embryos are in situ hybridized as whole mounts, the hybridization 
probe and other reagents generally do not fully penetrate the embryo, which becomes 
clear when the embryos are sectioned. In figure 7.5, the restriction of staining to the 
peripheral region of the embryo is probably the result of inadequate penetration. To 
address this problem it would be desirable to carry out in situ hybridizations on sectioned 
tissue. However, since cyclin D1 staining using digoxygenin/alkaline phosphatase is 
relatively weak in whole mounts, and requires long development times, it might be 
necessary to use radioactive detection methods, since sections tend to give weaker signals 
than whole mounts, and non-radioactive staining is comparatively insensitive. 
Cyclin Al 
The staining seen using antisense cyclin D1 probe is highly distinctive and localised. This 
contrasts with the broad staining seen throughout early embryos hybridized with anti- 
sense cyclin Al mRNA probe. Cyclin Al is known to be present during the early 
cleavages, but disappears during gastrulation (Howe et al., 1995). Figure 7.3 shows 
diffuse cyclin Al mRNA staining clearly visible in blastula stage embryos, but only very 
weak staining in neurulas and no staining at all in tailbud stage embryos, even though 
there is much cell division still occurring at these later stages. 
pRb 
Figure 7.6 shows the staining in Xenopus embryos hybridized with antisense Rb probe. 
Rb mRNA is expressed in a very similar pattern to cyclin D1 mRNA during tailbud 
stages, although unlike cyclin D 1, no specific staining can be seen in the neurula stages or 
earlier, probably reflecting a relatively even distribution of the small amounts of 
Rb mRNA present at these stages. At tailbud stages, detectable levels of pRb are present 
in the retina, the branchial arches, and other regions of the head, although not in the 
tailbud. Overall, pRb was more difficult to detect by in situ hybridization than cycIin D 1. 
suggesting that the levels of expression were probably lower. 
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Discussion 
Notch, Delta, lateral inhibition and the retina 
Notch and Delta, two signalling molecules involved in determining the fate of potential 
neuronal precursors, overlap in their expression patterns with cyclin D1 during neurula 
and tailbud stages. When primary neurons are becoming committed to their fate, during 
the neurula stages, Delta, the signal molecule, is expressed at high levels only by 
presumptive neurons and inhibits neighbouring cells from becoming neurons (Chitnis et 
al., 1995). Notch , the receptor, 
is expressed throughout the region of ectoderm which is 
competent to become neuronal (Coffman et al., 1990). The expression pattern of cyclin 
D1 is closest to that of Notch. Like Notch, cyclin D1 is not restricted to isolated neuronal 
precursors, but is broadly expressed in the neuroectodermal region. However, there are 
many areas of the embryo where cyclin D1 is expressed and Notch is not. Delta is 
expressed in the retina during tailbud stages (D. Ish-Horowicz, ICRF, Oxford personal 
communication), as is Notch, and both genes are thought to be involved in lateral 
inhibition interactions which help to space photoreceptors across the retina, as in 
Drosophila. Notch is expressed at especially high levels in the peripheral proliferating 
zone region of the late tailbud frog retina (Coffman et al., 1990). More detailed in 
situ hybridizations need to be carried out on sectioned embryos to establish with cellular 
resolution how cyclin D1 expression correlates with these events. 
Cyclin D1, pRb and E2F in Xenopus development 
E2F activity, measured by a DNA binding assay, is present in Xenopus eggs and 
throughout development. However, the protein complex in Xenopus early embryos which 
associates with the E2F binding site is predominantly a fast-migrating form which does 
not contain pRb, as judged by immunoblotting (Philpott and Friend, 1994). Progressively, 
later in development between stages 10 and 23, there is an increase in the amount of pRb 
complexed to the E2F-site-binding activity. The overall level of pRb itself is relatively 
low in eggs, and increases during development, not peaking until well after MBT 
(Destree et al., 1992; Philpott and Friend, 1994). Since free E2F seems, when over- 
expressed in mammalian tissue-culture cells, sufficient to drive S-phase entry even in 
quiescent cells (Johnson et al., 1993), the role of D-type cyclins in releasing E2F from 
pRb may emerge only gradually following MBT, rather than there being any abrupt 
change in the cell cycle at the end of the cleavage phase of development. 
It has been reported that considerable variation in expression of pRb in different adult 
tissues can be detected by RNA blotting, with especially high levels present in the ovary, 
the testis, and the eye (Destree et al., 1992). Like the restricted expression pattern shown 
in figure 7.6, this suggests that pRb is not simply a house-keeping gene which must be 
present in all cells, but rather that it has specific functions in certain cell types. 
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The pattern of cell proliferation in the Xenopus embryo 
"In amphibian development the speed of cell division varies in different regions of an 
embryo and in the same region of an embryo at different developmental stages. " (Graham 
and Morgan, 1966). Graham and Morgan studied the changing pattern of cell proliferation 
in Xenopus using the kinetics of [3H]-thymidine incorporation, along with assessment of 
cell number and mitotic index, to calculate the rate of the cell cycle at different times 
during development. However, their study was limited to endodermal cells. In the 
endoderm they found a fairly steady decrease in the rate of cell division during 
development, with the percentage of cells in mitosis falling from 13 % at stage 9, to 5% 
at stage 11, to 1% at stage 18. 
Neural tissues experience much more cell division later in development than endodermal 
tissues, but only a limited amount of work has been done mapping the areas where most 
cell proliferation occurs. Cell division in the amphibian retina has been fairly well 
studied, especially during the later stages of development and metamorphosis, from stage 
50 onwards, in Xenopus (Hollyfield, 1968; Beach and Jacobson, 1979). The pattern of 
cell division in the retina of stage 35-36 embryos has been described by Dorsky et al. 
(1995), and is particularly relevant to the localisation reported here for cyclin D1. In the 
retina at this and later stages, proliferating undifferentiated cells are found almost 
exclusively in the ciliary marginal zone. Further in situ hybridizations on sectioned 
embryos would need to be carried out to confirm it, but figure 7.5 gives a preliminary hint 
that cyclin D1 expression in the embryonic retina may be similarly restricted. 
Cell division in the embryonic spinal chord of stage 35-36 tailbud embryos has also been 
studied (Hartenstein, 1989), but no overall description of the spatio-temporal patterning 
of cell division in Xenopus exists to compare with that which has been painstakingly 
recorded in Drosophila (Foe, 1989), although it seems that even during the later 
asynchronous divisions, there exist local correlations in cell division timing in Xenopus, 
as in Drosophila (Hartenstein, 1989). 
To fully evaluate the correlation between levels of cyclin D1 and the rate of cell 
proliferation would require extensive work, but could be very informative. It is unlikely 
that cyclin D1 mRNA expression is most pronounced in the eyes and neuro-ectodermal 
regions of the embryo simply because they are the most actively dividing regions. Many 
other regions of the embryo are dividing at a comparable rate - the average size of a clone 
obtained at stage 35-36 by labelling a typical neuronal precursor at stage 13 is 3.5 cells, 
around the same number as the total increase in cell number in the neural plate between 
these stages (Hartenstein, 1989). The observed restriction of the pattern of cyclin D1 
expression seen above suggests that high levels of cyclin D1 cannot be present in all 
dividing cells. 
One experiment which remains to be done is to examine the pattern of cyclin D1 
expression in embryos where the cell cycle has been blocked at some intermediate stage 
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of development by inhibition of DNA synthesis with aphidicolin/hydroxyurea. 
Differentiation and morphogenesis has been reported to proceed essentially normally for 
some time after blockage of the cell cycle (Harris and Hartenstein, 1991; Rollins and 
Andrews, 1991). Notch is still expressed as usual in the retina at stage 35 after an 
aphidicolin/hydroxyurea block from stage 20 onwards (Dorsky et al., 1995). It might be 
asked whether cyclin D1 levels also remain high. If they did not, two possibilities would 
have to be distinguished. The cell cycle block might either be causing down regulation of 
cyclin D1 directly, or it might be preventing a differentiation event which must precede 
the onset of cyclin DI expression. 
A role for cyclin D1 in differentiated cells - cellular survival? 
The results of the in situ hybridization experiments described in this chapter suggest that 
the pattern of cyclin D1 expression is not simply a correlate of cellular proliferation, 
although more information about the pattern of proliferation during Xenopus 
embryogenesis would be needed to establish the extent to which the two patterns overlap. 
Evidence outlined below suggests the hypothesis that, although it is clear that D-type 
cyclins are involved with growth control, this may not be their only function. In 
particular, cyclin D1 may have a function in differentiated cells. For example, cyclin D1 
has been found to be expressed at high levels in post-mitotic mature neurons (Tamaru et 
al., 1993). 
There are situations both in the nervous system and the haematopoetic system where cells 
which are leaving the cell cycle, or slowing down their rate of division, increase their 
expression of cyclin D1, just as levels of mitotic cyclins and cyclin E are falling. 
When PC 12 human neuronal precursor cells were induced to differentiate in vitro by 
treatment with NGF (nerve growth factor), while cyclin D2 expression was found to 
correlate with proliferation, being high in the undifferentiated cells and lower in mature 
neuronal cells, cyclin D1 showed the opposite expression pattern, being present at much 
higher levels in the non-dividing differentiated neurons (Tamara et al., 1994). Expression 
of D-type cyclins in differentiated neurons is not entirely surprising, as they have been 
found to be good in vitro partners for Cdk5, which is specifically localised to mature 
neurons (Tsai et al., 1993a). 
Two groups have independently reported that when human myeloid precursor cells are 
induced to differentiate by the phorbol ester TPA, although mitotic and E-type cyclin 
levels drop and the proportion of cells in S phase falls, cyclin D1 expression increases 
dramatically (Ajchenbaum et al., 1993; Bürger et al., 1994). 
Intriguingly, given the close regulatory loop existing between D-type cyclins and pRb, it 
is in the haematopoetic system and the developing nervous system that the major 
abnormalities occur in mice homzygously deficient for pRb. In such mice, cell death 
occurs on a massive scale when nerve cells and blood cells fail to mature properly (Lee et 
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al., 1994). However, the unpublished results that mice engineered to be totally deficient 
for the cyclin D1 gene are viable (Vera Fantl, ICRF, London, personal communication) 
argue that if cyclin D1 has a function at this point in development, it is likely to be one it 
shares redundantly with other D-type cyclins. 
In situ localisation experiments on mouse embryos have shown that D-type cyclins, in 
contrast to mitotic cyclins and Cdc2, are found not just in the region of the developing 
spinal chord which is actively proliferating, but also in the marginal zone which consists 
largely of differentiated and differentiating cells (Zhao et al., 1995). 
A further complication is that another report suggests that in post-mitotic sympathetic 
neurons, which express pRb and cyclin D 1, if NGF is withdrawn, the level of cyclin D1 
increases as cells begin to enter the apoptotic cell-death pathway (Freeman et al., 1994). 
One way to make these results consistent would be to suggest that the balance between 
pRb and cyclin D1 may be involved in the control of cell death in the developing nervous 
system. Regulated cell death is a crucial part of the development of the nervous system, 
and the aberrant cell death in mice deficient for pRb may reflect a shift in the balance 
between D-type cyclins and pRb. It would perhaps be interesting to see how mouse 
embryos engineered to be deficient for both cyclin D1 and pRb would develop. 
Not all tumour cell lines express high levels of D-type cyclins. In at least one case, the 
cell cycle was found to be inhibited when exogenous cyclin D1 was expressed in a 
mammary tumour cell line which originally did not express cyclin D1 (Han et al., 1995). 
This may explain the reports that with some cell lines there appears to be strong selective 
pressure which makes it difficult to obtain transiently transfected clones which express 
high levels of cyclin D1 (Resnitzky et al., 1994). This cell-type dependent growth- 
inhibitory effect might be explicable if, as well as causing progression through G1 in 
proliferating cells, cyclin D1 has other effects related to the differentiated state, and in 
some cell lines these effects can interfere with cell cycle progression. 
The situation in non-neuronal cell types may be somewhat different. If murine 
macrophages precursors are starved of CSF- 1, cyclin D1 levels fall so as to become 
undetectable (Matsushime et al., 1991), and the cells die within 36 hours. In human 
diploid fibroblasts, however, serum starved cells remain viable for several days, and 
during this time cyclin D1 remains detectable. Thus, in these two situations, the presence 
of cyclin D1 correlates with cellular survival, rather than cell death. 
In the haematopoetic cell line 32Dcl3, ectopic expression of cyclins D3 delayed apoptotic 
cell death in the absence of interleukin-3 (Ando et al., 1993). However, the expression 
pattern of cyclin D1 differs from cyclins D2 and D3 in many haematopoetic cell lines. 
Whereas cyclins D2 and D3 are most-frequently expressed in proliferating cells (Ando et 
al., 1993), cyclin D1 is found at increased levels in certain cell-types following the 
induction of differentiation. 
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Thus, although it is clear from the diverse results of D-type cyclin expression studies that 
different cells express different D-type cyclins, and that these D-type cyclins are regulated 
in cell-type specific ways, the general pattern emerges that cells in which cyclins D2 and 
D3 are expressed tend to be actively proliferating, whereas cyclin D 1, although frequently 
associated with proliferation, may also be expressed in differentiated cells. Perhaps this 
distinction will one day help to explain why cyclin D1 is the predominant D-type cyclin 
found to be deregulated in human cancer. 
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Appendix 1 
Xenopus laevis cyclin D1 cDNA sequence, 
translation and restriction map 
Genbank/EMBL accession number: X89475 
NCOI 
STYI 
BBVI DRAII 
APAI 
BANII 
BSP1286 HPHI BBVI NCII PSTI 
TCCATGGAGCTTCTATGCT3CGAGGTGGACACCATCGGGAGGGCCCATCTGGACAGGAACCTCATCACCGACCGGG"rGCTGCAGACCATG 
10 20 30 40 50 60 70 80 90 
MELLCCEVDTIGRAHLDRNLITDRVLQTM 
HGAI BINI XHOII FSPI EAEI 
BAL 
CTCAAAGCAGAGGAGACCTCCTGCCCCAGCATGTCTTATTTCAAGTGCGTCCAGAAGGAGATCCTGCCCAACATGCGCAAAATAGTGGCC 
100 110 120 130 140 150 160 170 180 
LKAEETSCPSMSYFKCVQKEILPNMRKIVA 
BSTNI SFANI 
FOKI MBOII AVAIL 
ACCTGGATGCTGGAGGTTTGCGAGGAGCAGAAGTGCGAAGAGGAAGTTTTCCCCCTCGCTATGAACTATTTGGACCGATTCCTGTCCGTG 
190 200 210 220 230 240 250 260 270 
TWMLEVCEEQKCEEEVFPLAMNYLDRFLSV 
BANII 
BSP1286 
BSPMII MBOII BSTNI FOKI 
GAGCCCCTCCGGAAGAGCTGGTTGCAGTPGCTGGGGGCCACTTGTATGTTCCTGG, CTTCTAAAATGAAGGAAACCATCCCACTGACCGCA 
280 290 300 310 320 330 340 350 16() 
EPLRKSWLQLLGATCMFLASKMKETIPLTA 
SFANI 
GAGAAACTTTGCATTTACACCGACAATTCCATCAGGCCAGACGAGTTACTGATAATGGAACTGCGGGTTCTGAACAAACTGAAATGGGAC 
370 380 390 400 410 420 430 440 450 
EKLCIYTDNSIRPDELLIMELRVLNKLKWD 
XMNI FOKI 
TTGGCATCTGTGACCCCCCATGACTTTATTGAACATTTTCTAAACAAAATGCCACTGACTGAGGATACCAAGCAGATCATCCGCAAACAC 
460 470 480 490 500 510 520 530 540 
LASVTPHDFIEHFLNKMPLTEDTKQIIRKH 
NSPBII NSF 
PVU 
GCCCAGACATTTGTTGCCCTCTGCGCTACAGACGTAAAI TATCTCCAATCCACCCTCCATGATCGCCGCl)GGCAGl)=GCAGCAGCT 
550 560 570 580 590 600 610 620 630 
AQTFVALCATDVNFISNPPSMIAAGSVAAA 
BBVI 
BBVI MBOII 
TTHIIII NCI 
GTTCAGGGACTAAATTTGGGAAATGCCGACAGTGTCTTCTCCACCCAACGCCTCACACTTTTCCTATCACAGGTCATCAAATGCGACCCG 
640 650 660 670 680 690 700 710 720 
VQGLNLGNADSVFSTQRLTLFLSQVIKCDP 
XBAI BBVI 
GACTGTTTACGGGCGTGCCAAGAACAGATTGAGTCCCTTCTAGAGTCCAGTTTGCGCCAAGCACAGCAGCAACACAACGCTTCATCAGAC 
730 740 750 760 770 780 790 800 810 
DCLRACQEQIESLLESSLRQAQQQHNASSD 
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FOKI AHAII 
AATII 
HINCII 
ACAAAAAACATGGTGGATGAAGTGGACATCTCCTGCACCCCAACCGATGTCCGAGACGTCAACATCTGACATCAAACGGCTCACAGACAT 
820 830 840 850 860 870 880 890 900 
TKNMVDEVDISCTPTDVRDVNI* 
TTTTTTTTC, CTCATACCTATATATAAACATATATAGCTTIC, GAGTGTGGTGGGATATAACTTGCGGAAGTGAAACAAGGCCACACCTTCT 
910 920 930 940 950 960 970 980 990 
NCII AVAII 
DRAII 
PPUMI 
HPHI 
BSTNI 
GGACACTTGTAACTTGCCGGGAGGAAAATTCTCCTTCGTGGGTCCCAGGCTCACCTCT CAAATAATTCCCAAAA 
1000 1010 1020 1030 1040 1050 1060 1070 1080 
AVAI 
XHOI 
ACTTTTCGTACAAAAGAAAAAAGGGTAAATCTCGAGGAA 
1090 1100 1110 
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Appendix 2 
Xenopus laevis cyclin D2 cDNA sequence, 
translation and restriction map 
Genbank/EMBL accession number: X89476 
BBVI 
BANII 
BSP1286 
MBOII AVAI 
NCII 
.. NCII 
.. SMAI 
FOKI HGAI STYI BAIL 
CGGCAGCGAAGAGGGGCTCAACTACAACCCGGGAACGGGGGAGGGAAAGAAGTGAGTGCGGGAAATCATCCAGTGGTAGCGTCCAAGGGT 
10 20 30 40 50 60 70 80 90 
NCOI 
STYI 
BBVI TTHIIII ESPI 
BANII 
BSP1286 
BBVI 
BBVI 
ECOB NCII HAEII TTHIIII 
AVAII 
DRAII 
PPUMI 
FOKI HPHI 
GCCATGGAACT TGTGCTGCGAGGGGGACACTGTCCGCAGGGCTCAGCCTGACCCGGCGCTGCTGCTGGATGACAGGG"TCCTGCACAAT 
100 110 120 130 140 150 160 170 180 
MELLCCEGDTVRRAQPDPALLLDDRVLHN 
BANI 
KPNI BSPMI 
BSP1286 
HGIAI FOKI EA 
CTGCTCACCGTGGAGGAGAGGTACCTGCCCCAGTGCTCCTACTTCAAATGTGTCCAGAAGGACATCCAGCCCTTCATGAGGAGGATGGTG 
190 200 210 220 230 240 250 260 270 
LLTVEERYLPQCSYFKCVQKDIQPFMRRMV 
BALI FOKI SFANI 
FOKI MBOII MBOII 
NCOI 
STYI 
EAEI 
BALI BINI 
GCCACATGGATGCTWAGGTTTCCGAAGAACAGAGGTGCGAGGAAGAAGTGI1C000ATGGCCATýAATTATTIGC, ATAGATTTTTAGCA 
280 290 300 310 320 330 340 350 360 
ATWMLEVCEEQRCEEEVFPMAMNYLDRFLA 
STYI 
GTGATCCCCACCAGAAAGTGCCATTTACAACTCCTTGGAGCTGTCTGCATGTTCTTAGCTPCCAAGCTGAAAGAGACTATCCCTTTAACT 
370 380 390 400 410 420 430 440 450 
VIPTRKCHLQLLGAVCMFLASKLKETIPLT 
PSTI BBVI 
GCAGAGAAACTTIGCATTTATACTGACAATTCTATCAAACCACAAGAGCTGCTGGAGTGGGAGCTGG'lGGTrCTGGGGAAGTTGAAGTGG 
460 470 480 490 500 510 520 530 540 
AEKLCIYTDNSIKPQELLEWELVVLGKLKW 
127 
. , 
BSTNI 
. EAEI NSPBII 
AHAII HGAI BINI BSPF 
AACCTGGCCGCTGTGACGCCACACGATTTCATAGAACACATACTAAGAAAGTTGCCCTTGCCTAAAGACAAATTACTCTTGATCCGGAAA 
550 560 570 580 590 600 610 620 630 
NLAAVTPHDFIEHILRKLPLPKDKLLLIRK 
BE 
CATGCACAAACATTCATTGCTCTT'I42=ACAGACTTTAACTTTGCAATGTACCCACCATCTATGATAGCAACTGGAAGTGTAGGAGCG 
640 650 660 670 680 690 700 710 720 
HAQTFIALCATDFNFAMYPPSMIATGSVGA 
PSTI FOKI EAEI 
BALI 
GCGATATGTGGGCTGCAGTTGGATGTTGGAGAAACCTCTCTTTCTGGCGATAGTCTCACAGAGCATTTGGCCAAGATCACTAGCACAGAT 
730 740 750 760 770 780 790 800 810 
AICGLQLDVGETSLSGDSLTEHLAKITSTD 
HINDIII HPHI BBVI 
BSTNI BBVI 
GTGGATTGCCTTAAAGCTIGTCAAGAGCAGATTGAGTCGGTGCTGGTGAGCAGCCTCAGACAGACCAGGCAGCAGACACAGCAAAGAAAC 
820 830 840 850 860 870 880 890 900 
VDCLKACQEQIESVLVSSLRQTRQQTQQRN 
BSTXI AVAII 
BSTNI 
FOKI 
NHEI 
TCGTCCAAGTCTGTGGATGAACTGGACCAGGCTAGCACTCCTACAGATGTGCAGGACATCAACCTGTGAGGAGTCCCCTACCCCCCGCGT 
910 920 930 940 950 960 970 980 990 
SSKSVDELDQASTPTDVQDIN L* 
BAI\ 
TGAAAGAGCCTTTAGCGTTCTTTATTCTA AGAACAAAACTGTTTCTATCTGTTCCCAATTAGAGAAATC; ATT , r, 'P 
1000 1010 1020 1030 1040 1050 1060 1070 1n9n 
GCCTGCAATGTCCTGTAGAAGGGAAACCCACCATTTATCTGATTGTT=CTATGATTATATTTTGTCCAATTGTAAG7r, =ATGGAAG 
1090 1100 1110 1120 1130 1140 1150 1160 1170 
BSPMI 
CATAAGGGGGACATTTGTAAAGCCTGCTCTTGTTGTGGTTTTAACGAAAAGAAACGCAGGTCTGTTATTATTATCGTTAATGTCATTATT 
1180 1190 1200 1210 1220 1230 1240 1250 1260 
NSII NSII 
TCTCAGTACAGTGTAGTCTCCTAGAATTýTGCATGTATATGCATTTTCACAATGATTATTATTTTGAATTAGAGTACAAA 
1270 1280 1290 1300 1310 1320 1330 1340 1350 
XHOII BINI 
GGCAATAGACTAATGGATTCTAGCCAAGAAAGTAACGATCTCCAAGATTTCCACCCTTCITICAAGATGATTZGGGATCTACMTIZ"1GT 
1360 1370 1380 1390 1400 1410 1420 1430 1440 
XHOII BINI MBOII BBVI HINDII 
MBOI 
TATGTTAAGA TCTTTTCATTAGTTCTG TAGCTGCTACCGAAGAAAAAGAAGCTT 
1450 1460 1470 1480 1490 1500 1510 1520 1530 
BSPMI 
MSTII 
TTTT M'I"ITATTTTPITAAýGCCTAAGGCAGGTTCTAGTCTTTAATCG 
1540 1550 1560 1570 1580 
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Appendix 3 
Xenopus laevis Cdk4 cDNA sequence, 
translation and restriction map 
Genbank/EMBL accession number: X89477 
FOKI 
. SFANI NHEI BBVI BSMI HAEII 
GGCACGAGCGGCACGAGCATCCTCCTCATGCTAGCGTGCAGCAGTGCAAGGCATGGCGTGAATGCGGGCGCTTCCATGTCAGGAGATCAG 
10 20 30 40 50 60 70 80 90 
HAEII 
ECOB MBOII 
CGCTGZGAGGTTCCCGTGCTATTCAGGACAGGGGGTTCTTGAGAAGAATACCAGTGTGGAATATGTCAAAAGAAATGAAGCGTCAATATG 
100 110 120 130 140 150 160 170 180 
MSKEMKGQYE 
HGAI AHAII ACCI BSTNI 
AVAII 
DRAII 
PPUMI 
AACCTGTCGCAGAGATTGGCGTCGGGGCTTACGGCACGGTATACAAGGCCAGGGACCTTCAAAGTGGAAAGTTTGTTGCCCTCAAAAATG 
190 200 210 220 230 240 250 260 270 
PVAEIGVGAYGTVYKARDLQSGKFVALKNV 
BSTNI 
. FOKI 'IGCGGGTGCAAACCAACGAGAATGGACTCCCCCPCTCTACGGTCAGGGAAGTGACTTTATrGAAACGCCTGGAGCATTTZGACCATCCAA 
280 290 300 310 320 330 340 350 360 
RVQTNENGLPLSTVREVTLLKRLEHFDHPK 
FOKI HGAI AFLIII 
AVAII 
ACATTGTAAAACTTATGGATGTTTGTGCTTCTGCCCGAACTGACCGAGAGACTAAAGTGACGCTGGTGTTIGAACATGTGGACCAAGACC 
370 380 390 400 410 420 430 440 450 
IVKLMDVCASARTDRETKVTLVFEHVDQDL 
MBOII MBOII 
BSTNI AVAII 
DRAII 
PPUMI XMNI BSTNI 
SCOR 
7GAAGACTTAC77GAGCAAAGTCCCACCTCCAGGTCTTCCACTGGAGACTATTAAGGACCTCAIGAAGCAG4ICCT71t'GGGCCTGGAAT 
460 470 480 490 500 510 520 530 540 
KTYLSKVPPPGLPLETIKDLMKQFLSGLEF 
APALI 
BSP1286 
HGIAI HPHI HPHI 
TCCTCCATT43MTTGCATTGTGCACCGAGACCTTAAACCGGAGAATATC GGTGAAACTTIGCCGACTTTG 
550 560 570 580 590 600 610 620 630 
LHLNCIVHRDLKPENILVTSGGQVKLADFC 
NSPBII 
PWII HPHI DRAII 
DRAII 
APAI 
BANII 
BSP1286 
GCCTAGCGAGGATATACAGCTGTCAGATGGCTCTCACGCCCGTGGTGGTGACGTTGTGGTACAGGGC 
640 650 660 670 680 690 700 710 720 
LARIYSCQMALTPVVVTLWYRAPEVLLQS7 
129 
BBVI SFANI 
MBOII 
CGTATGCCACGCCGGTAGATGTGTGGAGCGCGGGCTGCATCTTCGCAGAGATGTTCAAGCGAAAACCCCTGTTCTGCGGCAATTCAGAAG 
730 740 750 760 770 780 790 800 810 
YATPVDVWSAGCIFAEMFKRKPLFCGNSEP. 
EAEI 
. MBOII FOKI 
CTGACCAGTTGTGCAAGATATTTGATATTATTGGGCTTCCTTCTGAAGAGGAGTGGCCGGTGGATGTTACTrrGCCACGTTCTGCCTTTT 
820 830 840 850 860 870 880 890 900 
DQLCKIFDIIGLPSEEEWPVDVTLPRSAFS 
AVAI BBVI CLAI NCOI 
STYI MBOII 
SFANI 
MBOII EAEI 
BALI 
CCCCGAGGACTCAGCAGCCAGTGGACAAGTTIG'IGCCGGAAATCGATGCCATGGGAGCCGATCTTCTTCTGGCCATGCTGACCTTCAGCC 
910 920 930 940 950 960 970 980 990 
PRTQQPVDKFVPEIDAMGADLLLAMLTFSF 
SFANI BINI BSTNI 
STUI 
CTCAAAAACGTATTTCCGCCTCCGATGCTCTGCTCCACCCCTTTTTCGCTGACGATCCCCAGGCCTGCTCCAAACAAGAACACTTTACTC 
1000 1010 1020 1030 1040 1050 1060 1070 1080 
QKRISASDALLHPFFADDPQACSKQEHFTH 
FOKI 
SFANI 
FOKI BSTNI BANII 
BSP1286 
BSTNI BSP1286 
ATATCTGCACCGCAACGGATGAAGTGAAATGAAACGGCATCCCTGCCT, 000GCTCCAGGGTCGGCGCAGAT GGCACATTATTTGCT 
1090 1100 1110 1120 1130 1140 1150 1160 1170 
ICTATDEVK* 
NSPBII BINI 
TTTTCTCTGCCTTAAAGGGAGTPCTCAGCGGGAýTAAGCGATAAAG'IGACCATGTGATCCTPGTAAAACATTTCCACTT 
1180 1190 1200 1210 1220 1230 1240 1250 1260 
PFIMI 
. BSTNI BBVI HGAI 
NSPBII HAEII 
CCTGGTTGTAATGGATTTTATGCTGCAAACGTCACTGTGACCGACGCAAGATTCCGCTGTTCAGATCAGCGCCGrTTCGCATTTGTGCCT 
1270 1280 1290 1300 1310 1320 1330 1340 1350 
AVAII BANII 
BSP1286 
HGIAI 
SACI HGAI HPHI 
TATCGGTCCTTACATTTATGGT7'7RýýCCTTAACCAGAGACGCACAATAAGCTACACTATCCTCATTATTTCTGTTCTCACCGC 
1360 1370 1380 1390 1400 1410 1420 1430 1440 
BSP1286 
HGIAI BCLI 
ATTGATGGTGTCAAATCTCGGCTTTACCACAATTTTTATCACGGTGCTCTTTCTGGGGTAP. AAAAACAAAAAAGACTTATTGATCATGTG 
1450 1460 1470 1480 1490 1500 1510 1520 1530 
BANII 
BSP1286 
CTAAAATTTAGCGCACGCCAGACTGTTCGAGAGCCCGACAAATAAT TICTACCATITIIGTAC'IGTI`1TACAATAATGTTTTATATIGGA 
1540 1550 1560 1570 1580 1590 1600 1610 1620 
BSPMI 
TT TCAAGGGTATTTCTATTGCGCTGGGGTG=AAAAATTGACCTGCGGCTA=43TPCCTATGGTAAAiý. JýCATGGCAGTCTTAACC 
1630 1640 1650 1660 1670 1680 1690 1700 1710 
BINI BAMHI 
XHOII BINI 
CACTAGGGATCCACGGAATCCGCTATTTTTTTTGTTAGGCTGAATCCTCTACAAAAGATTCTGCAAAATCTGAACCCAAATT'IGCAAGTT 
1720 1730 1740 1750 1760 1770 1780 1790 1800 
130 
ECOB EAEI 
BALI EAEI 
XMAIII 
CATATTGGATAAAAACCAAGCATTTCACATTCAGTTATTGAGAGCTTAAAAGACAAATGGCCAZGAGGGTTAGGATTCGGCCGAATGTTA 
1810 1820 1830 1840 1850 1860 1870 1880 1890 
FOKI 
. PFIMI 
.. SFANI 
ATGTTTCATTAAAGZGCTAGGTTTTAACCAAAGCAACAACCAAAACTTGGCCTTGTTGCATCCCTACAACIGACATCTZGATCTTTCATG 
1900 1910 1920 1930 1940 1950 1960 1970 1980 
HPHI APAI 
BANII 
BSP1286 ECORI 
XMN 
CTGGTGAATGTTGGACGGTCATGGGCCCA7'GTGGGTATAATTTGTTCAATTTGGAGCCTGCCTCGCTAAATCCTTTAATGCAGAATTCT 
1990 2000 2010 2020 2030 2040 2050 2060 2070 
HINCII ECOK 
FSPI 
TTCCTTTTCTGAACTGCCCTTGTTTGTCTGTTGACAT'IGAAACCCCATTATCGTCGTTGGTTCAACTGCGCACGCTGTCGTTCTGAATGT 
2080 2090 2100 2110 2120 2130 2140 2150 2160 
DRAI ACCI DRAI HPHI 
TACAGTTCAGCTPTAAAGTCTACTCATAAAGTGAAGTTTAAAGCGGGTGGGAATTGCCAGATTTAGTGTGAGGG 
2170 2180 2190 2200 2210 2220 2230 2240 2250 
CTCGIGCC 
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